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Introduction 
Genome versus Epigenome 
In multicellular organisms, the large variety of cell types and cell functions originate 
from a single cell through development and differentiation. Although all cells in an 
organism have the same genome, each cell type is programmed uniquely and 
expresses a subset of all genes. To achieve this extraordinary complexity in cell types 
and cell functions, gene expression is tightly and exquisitely regulated during 
development in a stage and time-dependent manner. Once the gene expression 
pattern of individual cells is established, it needs to be stably maintained during 
multiple rounds of cell divisions and at the same time should be plastid enough to 
respond to various environmental stimuli. 
In eukaryotic cells, the genome is not ‘naked’ and to fit into the tiny volume of the 
cell’s nucleus, it is packed into a protein-DNA structure called “chromatin”. Chromatin 
consists of repeating units of ‘nucleosomes’ which are composed of DNA and basic 
proteins called histones. Each nucleosome is composed of an octamer of the four 
histones (H3, H4, H2A, and H2B) around which 147 base pairs of DNA is wrapped. 
In addition to the passive packaging of eukaryotic DNA, chromatin also serves as a 
dynamic platform to regulate accessibility to DNA in response to signaling pathways. 
For this purpose, nature has developed a number of so-called “epigenetic” mechanisms 
which are able to alter the chemical nature of chromatin. These mechanisms play a 
fundamental role in shaping and establishing the epigenetic landscape which in turn 
modulates gene expression. The best-known epigenetic mechanisms are chemical 
post-translational histone modifications and DNA modifications, energy-dependent 
chromatin remodeling, histone variants and long ncRNAs. 
DNA accessibility and DNase Hypersensitive Sites
Control of gene expression is a complex multi-layered process ranging from DNA 
sequence to special organization of chromatin in the nucleus. While tightly packed 
chromatin is associated with silencing (heterochromatin), open chromatin is 
 transcriptionally active (euchromatin). These euchromatic regions are often subject to 
nucleosome remodeling and characterized by nucleosome-free, DNase hyper-
sensitive (DHS) sites. Therefore, DNase hypersensitivity is considered a hallmark of 
open chromatin regions and is a common feature of all known regulatory elements 
such as promoters, enhancers, silencers, and insulators. Identification of these regions 
is an important step to understand transcriptional regulatory processes that control 
various biological processes. Recent developments in genome-wide chromatin 
accessibility profiling such as DNaseI-seq (Boyle et al., 2011; Hesselberth et al., 
2009; Neph et al., 2012), FAIRE-seq (Giresi et al., 2007) and ATAC-seq (Buenrostro 
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et al., 2013) allowed to map nucleosome occupancy, the binding status of transcription 
factors, and to construct gene regulatory networks.
Histone Modifications 
Covalent post-translational modifications (PTMs) of histones provide an important 
epigenetic layer of control. Although globular domains of histones are also subject to 
PTMs, the vast majority of known modifications occur in the unstructured amino- 
terminal tails of canonical histones (H2A, H2B, H3, and H4) that protrude from each 
nucleosome. These amino-terminal tails are 25–40 amino acids in length and provide 
a surface for chromatin-modifying complexes that add or remove different types of 
chemical groups from histones.
To date, the PTMs identified on histones include acetylation, methylation, phosphory-
lation, ubiquitylation, sumoylation, ADP ribosylation, biotinylation, crotonylation, and 
proline isomerization. PTMs on histones mediate chromatin-related processes in at 
least three ways: (a) neutralizing and reducing the interaction of the positively charged 
amino acid residues to negatively charged DNA, (b) disrupting interactions between 
neighboring nucleosomes, and (c) creating a binding site for specialized proteins 
containing domains that bind to post-translationally modified residues (Narlikar et al., 
2002; Sterner and Berger, 2000).
Interestingly, modified residues on one histone can cross-regulate (either positively or 
negatively) other residues on the same (in cis) or a different histone (in trans). These 
cross-talks have been shown to orchestrate distinct events such as activation/
suppression of transcription, DNA replication, recombination and repair (Jenuwein 
and Allis, 2001; Strahl and Allis, 2000; Taverna et al., 2007; Turner, 2002).
A growing body of data have demonstrated that modified residues serve as docking 
sites to recruit various types of proteins: (1) “writers” which catalyze various types of 
modifications; (2) “readers” that have a variety of domains such as bromodomain 
and chromodomain to recognize and bind to modified residues; and (3) “erasers” 
that erase modifications from histones (Tarakhovsky, 2010). 
Genome-wide Distribution pattern of Histone Marks 
Over the past few years, chromatin immunoprecipitation (ChIP) followed by high- 
throughput sequencing (ChIP-Seq) allowed mapping of different histone modifications 
along the entire genome. 
Pioneer studies have shown that different genomic elements are decorated with distinct 
chromatin signatures. Transcriptionally active regions are associated with H2A.Z, 
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H3K4me2/3, H3K9ac, H3K27ac, and H3K36me3 while inactive regions are characterized 
by the presence of modifications such as H3K9me3 and H3K27me3. Therefore, these 
epigenetic features have been extensively used to define and annotate distinct functional 
regions such as promoters and enhancers. Their dynamics during development and 
alteration in disease have received and are receiving a great deal of attention and 
provide a wealth of information on the mechanisms involved in these processes.  
Promoters.  A stretch of DNA located over the 5’ region of a gene of about ± 2 kb in 
length around the transcription start site (TSS) is generally considered as the 
mammalian promoter. H3K27ac, H3K4me1/2/3, and H3K27me3 are the currently 
known, major histone marks associated with promoters.  In mammals, it has been 
shown that promoter regions with different CG density have distinct histone 
modification patterns and therefore show different modes of gene regulation.  Based 
on CG content, promoters are generally classified into three distinct groups: HCPs 
(high CpG dense promoters), ICPs (intermediate CpG dense promoters) and LCPs 
(low CpG dense promoters) (Weber et al., 2007). Most of the HCPs are “open” 
chromatin regions and associated with either ubiquitously expressed ‘housekeeping’ 
genes or key developmental genes which are under a tight temporal regulation. In the 
active form, HCPs are enriched for H3K4me3 and RNA polymerase II (RNAPII). In 
their poised state, HCPs are simultaneously marked by both activating H3K4me3 and 
repressing H3K27me3, a chromatin signature called “bivalency” (Azuara et al., 2006; 
Bernstein et al., 2006). These promoters are found at differentiation-linked genes. 
LCPs are often “closed” regions and associated with lineage-specific genes which 
need to be selectively targeted and activated by transcription factors (TFs) in a spatio- 
temporal manner. In their active form, LCPs are marked with H3K4me3, while in their 
inactive form they might be DNA methylated or not enriched with any of the 
well-studied histone mark. Poised LCPs are enriched for H3K4me2 but not H3K4me3. 
Enhancers. Enhancers are cis-acting DNA sequences (between 200-1000 bp) that 
can bind to multiple transcription factors (TFs) and regulate gene transcription at a 
distance and regardless of their orientation (Shlyueva et al., 2014). Based on their 
chromatin state, enhancers can be classified into four different categories: latent/
inactive, primed, poised and active. Latent/inactive/primed enhancers are defined as 
a compact chromatin region with only H3K4me1 or occupied with TF that upon an 
external signal becomes accessible and active. Active enhancers are marked by 
H3K4me1/2 and H3K27ac and frequently with low levels of H3K4me3. Poised 
enhancers that are frequently found in human and mouse embryonic stem cells can 
be defined as primed enhancers that in addition to H3K4me1 contain repressive 
epigenetic mark H3K27me3 (Buecker et al., 2014).  
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DNA Modifications
DNA methylation is the most abundant and best-known modification that plays a 
crucial role in long-term gene silencing and formation of heterochromatin (Miranda 
and Jones, 2007). Methylation of DNA at the 5’ position of cytosine is a key epigenetic 
regulator during mammalian pre- and post-implantation development, differentiation 
and primordial germ cell (PGC) formation. In mammals, cytosine methylation is 
nearly exclusively found in the context of a palindromic CpG dinucleotide (CpG dyad) 
and is catalyzed by different DNA methyltransferases (DNMT’s). These enzymes are 
essential for embryogenesis and complete or partial deficiencies are lethal or 
associated with diseases/abnormalities (Meissner, 2010). Four different members of 
DNMT family have been characterized including DNMT1, DNMT3A, DNMT3B, and 
DNMT3L. Except for DNMT3L that lacks enzymatic activity, the other DNMTs can be 
categorized into two groups: (i) DNMT1 which shows a high preference for 
hemimethylated over unmethylated CpG and is the key enzyme for the maintenance 
of DNA methylation; (ii) DNMT3A and DNMT3B (Okano et al., 1999) which are known 
as de novo methyltransferases, they do not show any preference for the substrate 
and in contrast to DNMT1, are able to de novo establish DNA methylation pattern 
(Jeltsch, 2006; Jurkowska et al., 2011). Therefore, establishing a fully methylated CpG 
requires two consecutive steps: at unmethylated CpG dyads (CpG/GpC), first one 
cytosine becomes methylated by DNMT3A and/or -3B yielding hemimethylated 
dyads (mCpG/GpC); second, hemimethylated sites can then be fully methylated 
(mCpG/GpCm) by DNMT1. This non-overlapping division of labor between maintenance 
and de novo methyltransferases is the foundation of the classical model (Jones and 
Liang, 2009; Riggs and Xiong, 2004). However, over the past decades, it has been 
extensively debated whether DNMT1 solely execute this step or whether de novo 
methyltransferases contribute to maintenance activity. It has been shown that in 
Dnmt[3a-/-, 3b-/-] cell lines, DNMT1 is only able to maintain methylation at CpG-poor 
regions while DNA methylation is reduced at repeat elements (Liang et al., 2002). 
In addition, long-term culturing of Dnmt[3a-/-, 3b-/-] cells results in a gradual and global 
loss of DNA methylation (von Meyenn et al., 2016)and this thesis). These observations 
suggest that in a very long term, DNMT1 alone is not sufficient to maintain DNA 
methylation. Therefore, it has been suggested that although DNMT3’s are mostly 
implicated in de novo methylation their cooperation with DNMT1 is needed to maintain 
global methylation. DNMT3A and DNMT3B are reported to be recruited by histone 
H3K9me2/3 (Arita et al., 2012; Rothbart et al., 2012) and deposit methylation at those 
hemimethylated CpGs which has been missed by DNMT1 after it left the replication 
fork. Moreover, DNMT3A and DNMT3B can be targeted to transcribed genes by 
H3K36me3 through their PWWP domains (Baubec et al., 2015; Dhayalan et al., 2010). 
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In addition to DNA methyltransferases, it has been shown that UHRF1 (also known as 
NP95) is essential for the maintenance activity of DNMT1 (Bostick et al., 2007; Sharif 
and Koseki, 2011; Sharif et al., 2007). UHRF1 is a multi-domain protein that contains 
several DNA/chromatin binding domains, including tandem Tudor domains that bind 
H3K9me2/3 and an SRA domain that binds hemimethylated CpG. During replication, 
these domains facilitate the recruitment of UHRF1 to the replication fork that in turn 
targets DNMT1 to the newly synthesized hemimethylated CpGs and ensures high 
fidelity maintenance of DNA methylation. 
Active Demethylation
During the past few decades, DNA demethylation has been observed in many 
different biological phenomena. Although the loss of DNA methylation during 
successive rounds of replication due to impaired maintenance, so-called “replication- 
dependent or passive DNA demethylation” was widely observed, enzymatic or active 
DNA demethylation remained unsolved and it was even seen as impossible given the 
chemical stability of the bond. The discovery of Ten-eleven translocation 1, -2 and –3 
(Tet1–3) proteins has overthrown the long-standing notion that DNA methylation is 
irreversible (Kriaucionis and Heintz, 2009; Tahiliani et al., 2009). The TET proteins are 
2-oxoglutarate and Fe(II)-dependent dioxygenases that can ‘reverse’ the action of 
DNMTs using α-ketoglutarate as a co-substrate (Loenarz and Schofield, 2011). The 
carbon-carbon bond between the C5 position of cytosine and methyl group is very 
stable and breaking the bond requires substantial energy. TET enzymes can weaken 
the covalent bond through successive oxidation of 5mC into 5-hydroxymethyl-
cytosine (5hmC), 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC) derivatives. 
Eventually, the oxidized derivatives 5fC and 5caC are passively lost at replication or 
actively excised by thymine DNA glycosylase (TDG) and replaced with an unmethylated 
cytosine (Pastor et al., 2013; Wu and Zhang, 2014). Thus, DNA methylation can be 
either diluted passively through successive rounds of replication due to inaccurate 
maintenance or it can be removed enzymatically by TET enzymes. 
Early studies using quantitative mass spectrometry-based approaches demonstrated 
that in many tissues and cell types 5mC is the most abundant followed in order of 
abundance by 5hmC, 5fC and 5caC. 5hmC levels are relatively high in neurons 
(~40% of 5mC) (Globisch et al., 2010; Ito et al., 2011; Kriaucionis and Heintz, 2009; 
Szwagierczak et al., 2010) and to a less extent in mESC (~5–10% of the total level of 
5mC) (Tahiliani et al., 2009) and much lower in most other cells including immune 
cells (~1% of 5mC) (Ko et al., 2010). The levels of 5fC and 5caC are as low as ~0.03% 
and ~0.01% of 5mC in mESCs, respectively (He et al., 2011; Ito et al., 2011; Pfaffeneder 
et al., 2011).
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Tet-mediated oxidation of 5mC contributes to both global and local dynamics of 5mC 
(Wu and Zhang 2011). At the global level, 5mC to 5hmC conversion can interfere with 
maintenance of DNA methylation during replication which compromises 5mC/5hmC 
ratio at the global level. Indeed, it has been shown that DNMT1 strongly prefers 
hemimethylated (5mC:C) substrate over hemi-hydroxymethylated (5hmC:C) and 
unmodified (C:C) substrates by more than 60 fold (Hashimoto et al., 2012). Therefore, 
the 5hmC:C dyad is not or very poorly recognized by Dnmt1 during DNA replication 
(Valinluck and Sowers, 2007), resulting in passive loss of DNA methylation after each 
round of cell division. TET1 and TET3 proteins have a zinc finger Cysteine-X-X-Cyste-
ine (CXXC) domain (~60 amino acids) at their N-termini that can mediate DNA 
interaction. In contrast to TET1/3, TET2 does not contain a CXXC zinc finger domain 
and uses the CXXC domain protein CXX4/IDAX for targeting to DNA (Iyer et al., 2011; 
Iyer et al., 2009). Taken together, these observations suggest that TET proteins can 
selectively target loci and regulate dynamics of DNA methylation locally. 
Non-CpG DNA methylation 
DNA methylation occurs predominantly in a CpG dinucleotide context; methylation in 
a non-CpG context (CHG and CHH, where H is A, C or T) is a rare event in mammals. 
It occurs particularly in the brain, ESCs and oocytes (Lister et al., 2013; Lister et al., 
2009; Shirane et al., 2013; Xie et al., 2012). In in vivo studies in mouse ESCs, it has 
been shown that non-CpG methylation can be maintained in the absence of Dnmt1 
and loss of Dnmt3’s results in a global reduction in non-CpG context methylation 
(Arand et al., 2012). These observations suggest that DNMT3A and DNMT3B are 
responsible for methylation in the non-CpG context. However, in contrast to symmetrical 
CpG methylation that is maintained after each round of replication, it seems that 
non-CpG methylation needs to be re-established after each cell division in line with 
a role of de novo methyltransferases.
Genomic landscape of DNA modifications 
CpG methylation in mouse and human ESCs shows a strong bimodal distribution: 
either methylated or unmethylated. Methylation status is highly correlated with CpG 
density (Laurent et al., 2010; Lister et al., 2009; Stadler et al., 2011). In contrast to the 
CpG dinucleotides in CpG islands located at promoters and untranslated regions, 
most of the CpG dinucleotides in the genome are >90% methylated (Miranda and 
Jones, 2007) . Distal cis-regulatory elements such as enhancers, low methylated 
regions (LMRs), insulators and silencers that modulate the transcription of genes 
show low levels of 5mC (10%-30%) (Stadler et al., 2011). 
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Regardless of CpG density, CpGs located in repetitive elements including pseudo - 
genes, DNA transposons, retrotransposons, endogenous retroviruses and direct 
repeats in centromere and microsatellites are mostly methylated. Methylation of these 
elements is a key mechanism for their long-term transcriptional suppression and 
protection of the genome from transposition.  
Recent single-base resolution maps of 5hmC in mammalian cells (Booth et al., 2012; 
Yu et al., 2012) revealed that 5hmC is mainly enriched at low-to-medium CpG density 
regions including enhancers, LMRs, CTCF-binding sites or DHS sites (up to 10–20% 
of all CpGs). 
In mammals, the majority of promoters are associated with CpG-rich sequences 
(HCPs). As mentioned earlier, active HCPs are mostly unmethylated and due to the 
enrichment of H3K4me3 and H2A.Z, they are protected from methylation (Ooi et al., 
2007; Zilberman et al., 2008). In addition, a genome-wide map of TET1 occupancy 
revealed that around 80% of its binding sites colocalize with HCPs. However, affinity 
enrichment-based and TET-assisted BS-seq (TAB-seq) analyses of 5hmC distribution 
demonstrated that these promoters are devoid of 5hmC. Instead, 5hmC is 
preferentially enriched at intermediate (ICPs) and low CpG promoters (LCPs) (Yu et 
al., 2012). In Tdg-deficient cells, 5fC/5caC do not accumulate at HCPs suggesting 
that enrichment of TET proteins at HCPs might be involved in other functions such as 
stabilizing or recruiting chromatin-modifying complexes rather than in oxidative 
modification of 5mC (Shen et al., 2013; Song et al., 2013). Interestingly, in Tdg 
knockout mESCs, 5fC/5caC accumulate at bivalent promoters which are transcrip-
tionally poised. Therefore, it might be that TET1 plays a role as a “safeguard” to 
protect bivalent loci from becoming DNA methylated. 
Part I.   Dynamics of DNA methylome programming during early 
embryonic development and mouse pluripotent stem cells
The genome undergoes two waves of methylation reprogramming during mammalian 
embryonic development: Firstly after fertilization, the paternal pronucleus is actively 
demethylated, whereas the maternal pronucleus passively loses methylation in a rep-
lication-dependent manner (Wu and Zhang, 2014). From 2-cell to blastula stage, 
5mC is passively diluted and gradually reaches a steady state with the lowest 5mC 
level in the blastocyst (Wu and Zhang, 2014). Loss of 5hmC level is proportional to the 
reduction in 5mC. From ICM to epiblast, the genome becomes highly methylated 
whereas in extraembryonic issues methylation remains low (Smith et al., 2014; Smith 
et al., 2012).
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The primordial germ cells (PGCs) that arise from posterior proximal epiblast cells at 
embryonic (Lee et al., 2014), undergo a second wave of genome-wide DNA 
demethylation. In PGCs, DNA demethylation occurs in two phases: a first phase from 
E6.5 epiblast to E9.5 PGCs and a second phase from E9.5 to E13.5 PGCs 
(Seisenberger et al., 2012). It is currently unresolved whether a passive, active, or a 
combination of both mechanisms accounts for global DNA demethylation. Recent 
studies suggest that in early PGCs, global demethylation is marginally affected by 
TET-dependent active demethylation and occurs mainly by suppression of de novo 
methyltransferases as well as loss of UHRF1 which results in impaired maintenance 
methylation by Dnmt1 (Guibert et al., 2012; Seisenberger et al., 2012). In addition, 
active demethylation occurs in later phases of PGC differentiation/maturation to 
erase residual DNA methylation mainly in a loci-specific manner at ICRs and 
promoters of meiosis-specific genes (Hackett et al., 2013b). 
Naïve and Primed: Two Distinct States of Pluripotency 
Embryonic stem cells (ESCs) have the potential to differentiate into all somatic cell 
lineages and into germ line cells, a trait referred to as pluripotency. Mouse ESCs are 
self-renewing pluripotent cells that are derived from the inner cell mass (ICM) of the 
mammalian blastocyst and have the ability to contribute to chimeric embryos 
(Martello and Smith, 2014). ESCs are classically grown in the presence of serum. 
More recently, so-called ground state pluripotent ESCs have been derived in 
serum-free conditions supplemented with two kinase inhibitors (2i): PD0325901 and 
CHIR99021 targeting mitogen-activated protein kinase (Mek) and glycogen synthase 
kinase-3 (Gsk3), respectively (Ying et al., 2008).
Compared to 2i which seems to be a better representation of ICM cells, serum 
mESCs resemble the cells from the early epiblast (Nichols and Smith, 2012). Serum 
ESCs are morphologically more heterogeneous and show differential expression of 
pluripotency and lineage specific factors such as Nanog, Dppa3 and Rex1 (Zfp42) 
(Chambers et al., 2007; Hayashi et al., 2008; Kalmar et al., 2009; Marks et al., 2012; 
Toyooka et al., 2008). By switching the medium from serum to 2i, the epigenome is 
undergoing extensive reprogramming resulting in loss of H3K27me3 at bivalent loci, 
but only minor changes in H3K4me3 and H3K9me3 (Marks et al., 2012) . Recently, 
we and others have shown that the genome of 2i ESCs is globally hypomethylated 
and as such similar to the cells in the ICM, whereas serum ESCs are hypermethylated 
(Ficz et al., 2013; Habibi et al., 2013; Hackett et al., 2013a; Leitch et al., 2013) . To date, 
the molecular mechanisms regulating this conserved genome-wide demethylation in 
the naïve state are unclear.
Processed on: 17-11-2016
506677-L-bw-habibi
21
GENERAL INTRODUCTION
1
Part II.  Epigenome reprogramming during Monocyte-Macrophage 
differentiation and ‘Innate immune memory’
Immune responses in vertebrates are traditionally categorized into the innate and 
adaptive immune systems. Immediately after infection or tissue injury, the innate 
immune system identifies the source and orchestrates an inflammatory response in 
order to restore homeostasis. A controlled inflammatory response is beneficial; 
however, dysregulation in this process might cause a disastrous state like septic or 
autoimmunity (Medzhitov, 2008). Innate immune cells either reside in the tissue, such 
as macrophages and dendritic cells, or in the blood circulation, such as monocytes 
and neutrophils. They can detect infection or tissue injury using pattern recognition 
receptors (PRRs) on their cell surface and cytoplasm. These receptors are able to 
identify two classes of molecules: (i) pathogen-associated molecular patterns 
(PAMPs) that are associated with microbial pathogens such as viral nucleic acids, 
fungal β-glucan, components of the peptidoglycan bacterial cell wall, and lipopoly-
saccharide (LPS) from Gram-negative bacteria; and (ii) damage-associated 
molecular patterns (DAMPs) that are associated with cell components that are 
released from injured or dead cells (Takeuchi and Akira, 2010).
Monocytes constitute about 5-10% of white blood cells and are present in blood, 
bone marrow, and spleen and do not proliferate. During hematopoiesis in the bone 
marrow, granulocyte-monocyte progenitor cells differentiate into promonocytes, 
which leave the bone marrow and enter the blood, where they further differentiate into 
mature monocytes. Monocytes are a heterogeneous group of cells that are able to 
migrate into tissues and differentiate into diverse tissue-resident phagocytic cells 
including macrophages and dendritic cells. 
Macrophages are one of the key players of the innate immune system. These 
mononuclear phagocytes are resident in lymphoid and non-lymphoid tissues and 
play a crucial role in steady-state tissue homeostasis such as clearance of lipoproteins 
and dead cells, and the production of growth factors. Macrophages are a diverse cell 
type in both ontogenetic and functional aspects. 
Classically, immune memory is considered to be an exclusive characteristic of the 
adaptive immune system, the T- and B-cells, but not innate immune cells. However, 
recent studies in plants and invertebrates have shown that in the absence of adaptive 
immunity, the innate immune system can be primed by the first exposure to a 
pathogen and consequently respond more strongly to a second, independent and 
unrelated exposure (Kurtz, 2005; Sun et al., 2014). For instance, human monocytes 
which have been taken from healthy donors vaccinated with bacille Calmette-Guérin 
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(BCG), produced higher levels of inflammatory cytokines after a subsequent exposure 
to an unrelated bacterial and fungal infection (Kleinnijenhuis et al., 2012). Importantly, 
this ‘training’ was maintained for at least 3 months after vaccination. Interestingly, 
BCG vaccination of severe combined immunodeficiency (SCID) mice, lacking 
functional T- and B-cells, resulted in less mortality, and kidney burdens was reduced 
to 20–40% of the levels in the unvaccinated mice after a secondary lethal infection 
with C. albicans (Kleinnijenhuis et al., 2012) . In addition, Rag1-/- mice, which have 
been initially exposed to C. albicans, are also protected when re-challenged with 
either C. albicans or LPS. These findings suggest that the innate immune system 
possesses a non-specific memory independent of the adaptive immune system. An 
important distinction between the two memory models is that adaptive memory is 
specific, long-lasting (>10years) and involves genetic rearrangements, whereas the 
innate immune memory is non-specific and short-lasting (up to a few months). 
Several studies have shown that epigenetic reprogramming after the first exposure to 
the infection is crucial to build up an “innate immune memory”: genes that have 
already been activated or suppressed can be more or less responsive, respectively, 
upon reinfection in the future (Cheng et al., 2014; Foster et al., 2007; Ostuni et al., 
2013; Quintin et al., 2012; Saeed et al., 2014). 
Trained immunity and endotoxin (LPS) tolerance are two examples of innate immune 
memory.  Trained immunity is the phenomenon in which monocytes or macrophages 
can be primed by a first stimulus (infection or vaccine) in order to mount an enhanced 
and stronger recall response upon reinfection. In contrast, treating monocytes or 
macrophages with LPS inhibits cell function and causes immunoparalysis such that 
they are not able to enhance a pro-inflammatory response to re-stimulation, a process 
called LPS-induced tolerance (Netea et al., 2016).
In addition to dynamic changes in the activity state of predefined enhancers in 
macrophages, Ostuni et al. have identified a new subset of genomic loci that obtain 
enhancer characteristics through de novo deposition of histone marks in response to 
a stimulus (Ostuni et al., 2013). These so-called “latent enhancers”, defined as 
compact chromatin regions with only H3K4me1 that become accessible and active 
upon an external signal, have been shown to be associated with changes in gene 
expression that occur in response to inflammatory stimuli. Following the initial 
exposure to a stimulus, latent enhancers associated with pro-inflammatory genes in 
monocytes and macrophages get activated with a slower kinetics compared to other 
enhancers. After removing the initial stimulation, these enhancers maintain their 
epigenetic make-up and do not return to their initial state. Interestingly, in response to 
a second stimulation, these enhancers showed more rapid activation. Quintin et al. 
showed that training of monocytes with βglucan results in increased H3K4me3 level 
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at the promoters of important genes such as the pro-inflammatory cytokines TNF-a, 
IL-6, and IL-18 (Quintin et al., 2012). 
In a study by Saeed et al., circulating human monocytes from healthy volunteers were 
differentiated into macrophages (Saeed et al., 2014). Trained and endotoxin-induced 
tolerance were induced by β-glucan (BG) and lipopolysaccharide (LPS), respectively, 
during the first 24 hours and then the stimuli washed out. βglucan trained macrophages 
results in increased H3K4me1 and de novo deposition of H3K27ac at enhancers. 
After removing the βglucan stimulus, the βglucan-specific enhancers retain H3K4me1 
and are therefore primed for a future stimulus. At the transcriptional level, Saeed 
et al identified gene modules that were associated with monocyte-to-macrophage 
differentiation as well as with tolerant and trained phenotypes (Saeed et al., 2014). 
Trained modules consist of genes that show increased expression in naïve macro - 
phages and are markedly less or not expressed in LPS-trained macrophages. These 
gene modules are associated with the GO terms such as ‘cellular ketone metabolic 
process’ and ‘carboxylic acid metabolic process’ that are macrophage differentiation 
markers. However, genes in the endotoxin tolerant modules retain a more monocyte- 
like expression pattern and remain associated with GO terms ‘immune response’, 
‘response to wounding’ and ‘chemotaxis’.  
Outline of this thesis 
In chapter 1, I provide a brief overview of the basics concepts related to our works 
presented in chapter 2-4 including major epigenetic mechanisms and previous 
findings. In chapter 2, we investigated DNA methylome dynamics during the 
transition from serum to 2i. Dynamics of methylation was assessed by time-resolved 
mass spectrometry and whole-genome bisulfite sequencing at several time points 
and several cell lines including male and female ESCs during the transition from 
serum to 2i and vice versa. We compared the methylation state of serum and 2i ESCs 
with their in vivo parallels at early developmental stages. The distribution of 5mC over 
different genomic elements was compared in serum and 2i. Additionally, we investigated 
the contribution of individual small molecule inhibitors in loss of methylation. This study 
was a major game changer and added to the ‘at that time controversial’ 2i paper.
In Chapter 3, we followed up our study in chapter 2 and further explore the 
contribution of different mechanisms involved in DNA demethylation from serum to 2i. 
We determined global DNA methylation using comprehensive, time-resolved LC-MS/
MS, as well as whole-genome bisulfite sequencing (WGBS), Tet Assisted Bisulfite 
sequencing (TAB-seq), and hairpin bisulfite sequencing. We presented a mathematical 
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model as a systemic approach to estimate the relative contribution of three main 
pathways including maintenance, de novo and active demethylation. In collaboration 
with the Reik lab in Cambridge, we experimentally assessed and mathematically 
modeled the kinetics of demethylation using several knockout lines lacking one or 
more of the components of the DNA methylation machinery. We exploited the 
physiological perturbations of DNA demethylation caused by the addition of vitamin 
C to the medium. Additionally, we applied our computational kinetic analysis of the 
early embryonic DNA de-methylation phenomena at early developmental stages in 
migratory PGCs (E6.5 to E11.5) and preimplantation embryos (2-cell stage to E4).
In Chapter 4, we applied an integrated epigenomic and bioinformatic approach to 
characterize the molecular events involved in LPS-induced tolerance in a 
time-dependent manner. We investigated epigenetic and transcriptional changes in 
response to LPS and Beta-glucan compared to normal macrophages. Our analyses 
lead us to hypothesize that BG might be capable of reversing LPS induced tolerance. 
Therefore, we studied epigenetic and transcriptional response of tolerized 
macrophages to LPS re-exposure and we discovered the ability of beta-glucan 
exposure to reverse tolerance in both in vitro and in vivo LPS exposed monocytes. 
My contributions to these studies were designing and performing the experiments, 
performing bioinformatic analysis and interpreting the data. 
Chapter 5 summarizes our findings presented in this thesis and discusses the novel 
insights gained and the impact on future work. 
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SUMMARY
The use of two kinase inhibitors (2i) enables deriva-
tion of mouse embryonic stem cells (ESCs) in the
pluripotent ground state. Using whole-genome bisul-
fite sequencing (WGBS), we show that male 2i ESCs
are globally hypomethylated compared to conven-
tional ESCs maintained in serum. In serum, female
ESCs are hypomethyated similarly to male ESCs in
2i, and DNA methylation is further reduced in 2i.
Regions with elevated DNAmethylation in 2i strongly
correlate with the presence of H3K9me3 on endoge-
nous retroviruses (ERVs) and imprinted loci. The
methylome of male ESCs in serum parallels postim-
plantation blastocyst cells, while 2i stalls ESCs in a
hypomethylated, ICM-like state. WGBS analysis dur-
ing adaptation of 2i ESCs to serum suggests that
deposition of DNA methylation is largely random,
while loss of DNA methylation during reversion to 2i
occurs passively, initiating at TET1 binding sites.
Together, our analysis provides insight into DNA
methylation dynamics in cultured ESCs paralleling
early developmental processes.
INTRODUCTION
Mouse ESCs are classically grown in media containing serum
either on feeder cells or supplemented with leukemia inhibitory
factor (LIF). These ESCs, here referred to as ‘‘serum ESCs,’’
are in a metastable state characterized by the expression of
many lineage-specifying genes (Graf and Stadtfeld, 2008; Haya-
shi et al., 2008; Loh and Lim, 2011; Marks et al., 2012). The use of
two small-molecule kinase inhibitors (2i) enabled derivation of
mouse ESCs in defined serum-free conditions (Ying et al.,
2008). The two inhibitors PD0325901 and CHIR99021 target
mitogen-activated protein kinase (MEK) and glycogen synthase
kinase-3 (GSK3), respectively. ESCs established in 2i, referred
here as ‘‘2i ESCs,’’ are more homogeneous than serum ESCs
and are postulated to represent the ground state of pluripotency
(Ying et al., 2008). Recently, we showed that the transcriptome
and repressive histone mark H3K27me3, but not H3K9me3, is
markedly different and interconvertible between 2i and serum
ESCs upon simple exchange of growth media (Marks et al.,
2012). Serum ESCs are reported to contain high levels of DNA
methylation: globally, 4% of the cytosines are methylated
(Leitch et al., 2013; Stadler et al., 2011). This is most prominent
for CpG dinucleotides, which contain an average cytosine
methylation level of 80% (Stadler et al., 2011). As opposed to
the hypermethylated serum ESCs, recent analyses showed
that 2i ESCs are globally hypomethylated: only 1% of all cyto-
sines were reported to be methylated in 2i (Leitch et al., 2013).
DNA methylation is generally considered a relatively stable
mark. However, DNA methylation levels were shown to be
reversible between serum and 2i ESCs (Leitch et al., 2013). Since
these analyses were mainly performed using mass spectrom-
etry, the 2i ESC methylome is currently lacking.
In this study, we performed base-resolution whole-genome
bisulfite sequencing (WGBS) for 2i and serum ESCs, and did
so during interconversion of ESCs from 2i to serum and vice
versa. We further analyzed female ESCs, which in contrast to
male serum ESCs were reported to be globally hypomethylated
(Zvetkova et al., 2005). Our detailed genome-wide analysis of the
dynamics of deposition and removal of DNA methylation during
conversion of mouse ESCs at base-pair resolution provides
mechanistic insight into global (de)methylation and provides a
rich resource for future studies.
RESULTS
Whole-Genome Bisulfite Analysis of 2i and Serum ESCs
We set out to define the DNA methylome of (1) one male
(E14) and two female (XT and LF2) ESC lines established and
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factor (LIF). These ESCs, here referred to as ‘‘serum ESCs,’’
are in a metastable state characterized by the expression of
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mitogen-activated protein kinase (MEK) and glycogen synthase
kinase-3 (GSK3), respectively. ESCs established in 2i, referred
here as ‘‘2i ESCs,’’ are more homogeneous than serum ESCs
and are postulated to represent the ground state of pluripotency
(Ying et al., 2008). Recently, we showed that the transcriptome
and repressive histone mark H3K27me3, but not H3K9me3, is
markedly different and interconvertible between 2i and serum
ESCs upon simple exchange of growth media (Marks et al.,
2012). Serum ESCs are reported to contain high levels of DNA
methylation: globally, 4% of the cytosines are methylated
(Leitch et al., 2013; Stadler et al., 2011). This is most prominent
for CpG dinucleotides, which contain an average cytosine
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that 2i ESCs are globally hypomethylated: only 1% of all cyto-
sines were reported to be methylated in 2i (Leitch et al., 2013).
DNA methylation is generally considered a relatively stable
mark. However, DNA methylation levels were shown to be
reversible between serum and 2i ESCs (Leitch et al., 2013). Since
these analyses were mainly performed using mass spectrom-
etry, the 2i ESC methylome is currently lacking.
In this study, we performed base-resolution whole-genome
bisulfite sequencing (WGBS) for 2i and serum ESCs, and did
so during interconversion of ESCs from 2i to serum and vice
versa. We further analyzed female ESCs, which in contrast to
male serum ESCs were reported to be globally hypomethylated
(Zvetkova et al., 2005). Our detailed genome-wide analysis of the
dynamics of deposition and removal of DNA methylation during
conversion of mouse ESCs at base-pair resolution provides
mechanistic insight into global (de)methylation and provides a
rich resource for future studies.
RESULTS
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factor (LIF). These ESCs, here referred to as ‘‘serum ESCs,’’
are in a metastable state characterized by the expression of
many lineage-specifying genes (Graf and Stadtfeld, 2008; Haya-
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mouse ESCs in defined serum-free conditions (Ying et al.,
2008). The two inhibitors PD0325901 and CHIR99021 target
mitogen-activated protein kinase (MEK) and glycogen synthase
kinase-3 (GSK3), respectively. ESCs established in 2i, referred
here as ‘‘2i ESCs,’’ are more homogeneous than serum ESCs
and are postulated to represent the ground state of pluripotency
(Ying et al., 2008). Recently, we showed that the transcriptome
and repressive histone mark H3K27me3, but not H3K9me3, is
markedly different and interconvertible between 2i and serum
ESCs upon simple exchange of growth media (Marks et al.,
2012). Serum ESCs are reported to contain high levels of DNA
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(Leitch et al., 2013; Stadler et al., 2011). This is most prominent
for CpG dinucleotides, which contain an average cytosine
methylation level of 80% (Stadler et al., 2011). As opposed to
the hypermethylated serum ESCs, recent analyses showed
that 2i ESCs are globally hypomethylated: only 1% of all cyto-
sines were reported to be methylated in 2i (Leitch et al., 2013).
DNA methylation is generally considered a relatively stable
mark. However, DNA methylation levels were shown to be
reversible between serum and 2i ESCs (Leitch et al., 2013). Since
these analyses were mainly performed using mass spectrom-
etry, the 2i ESC methylome is currently lacking.
In this study, we performed base-resolution whole-genome
bisulfite sequencing (WGBS) for 2i and serum ESCs, and did
so during interconversion of ESCs from 2i to serum and vice
versa. We further analyzed female ESCs, which in contrast to
male serum ESCs were reported to be globally hypomethylated
(Zvetkova et al., 2005). Our detailed genome-wide analysis of the
dynamics of deposition and removal of DNA methylation during
conversion of mouse ESCs at base-pair resolution provides
mechanistic insight into global (de)methylation and provides a
rich resource for future studies.
RESULTS
Whole-Genome Bisulfite Analysis of 2i and Serum ESCs
We set out to define the DNA methylome of (1) one male
(E14) and two female (XT and LF2) ESC lines established and
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maintained in serum and LIF (referred to as ‘‘serum’’); (2) the
same lines adapted to 2i and LIF (‘‘2i-adapted’’); and (3) one
ESC line derived and maintained in 2i and LIF (‘‘Rex/GFP-2i’’)
(Wray et al., 2011). In line with a recent study by (Leitch et al.,
2013), mass spectrometric (MS) quantification of 5-methylcyto-
sine (5mC) revealed a >3-fold global reduction in Rex/GFP-2i
ESCs and E14 2i-adapted as compared to E14 serum ESCs (Fig-
ure 1A). This is not caused by the heterogeneity of serum ESCs:
REX1-high and -low cells (Wray et al., 2011) within the serum
ESC population have similar, high DNA methylation levels (Fig-
ure 1B). Immunocytochemistry shows a low but homogeneous
staining of 5mC in 2i, and a markedly higher and more heteroge-
neous DNA methylation in serum ESCs (Figure 1C). In line with
a previous study (Zvetkova et al., 2005), the serum female lines
(XT and LF2) show reduced DNA methylation comparable to
that of male 2i ESCs. DNA methylation in these female ESCs is
further reduced upon adaptation to 2i (Figures 1A and Figure S1A
available online). The global levels of 5-hydroxymethylcytosine
(5hmC) are proportional to the 5mC levels (Figures 1A, 1B, and
S1A). Notably, Epistem cells (EpiSCs) have similarly high 5mC
levels that male serum ESCs do, but reduced 5hmC (Figure 1D).
To obtain DNA methylation levels at base-pair resolution, we
performed WGBS (Tables S1 and S2). In line with our MS anal-
ysis, 4.1% of all covered cytosines (71%) are methylated in
male serum ESCs, while methylation in the 2i ESCs and female
XT serum ESCs are much reduced (Figure 1E). In all ESC lines,
DNA methylation predominantly occurs at CpG dinucleotides,
while non-CpG methylation levels are very low (Figure S1B).
For both non-CpG and CpG methylation, we observed a strong
reduction in overall mean methylation levels in Rex/GFP-2i, E14
2i-adapted, and XT ESCs as compared to male E14 serum ESCs
(Figure S1B). In contrast to the 2i and female ESCs, the majority
of CpGs in E14 serum ESCs are hypermethylated (Figures 1F–
1H). Pairwise comparison over individual CpG sites further un-
derpins the strongly reduced methylation in the 2i and XT
ESCs, in which the majority of CpGs are hypomethylated (Fig-
ure 1I). Notably, the methylome of E14 serum ESCs is in full
concordance with the published WGBS DNA methylome (Sta-
dler et al., 2011) on a different serum ESC line called ‘‘159-2’’
(Pearson correlation 0.85; Figures 1F and 1I). Averaging of
the methylation signals shows a consistent loss of DNA methyl-
ation over CpG-island (CGI) promoters, enhancers, and bivalent
loci for the 2i and female ESCs as compared to male E14
serum ESCs (Figure 1J). Interestingly, the intermediate DNA
methylation state described previously at enhancers (Stadler
et al., 2011) is only apparent in male serum ESCs. Therefore
increased 5mC deposition at enhancers may not be counter-
acted in full by TETs (or other enzymes involved in demethylation)
in male serum ESCs (Kriaucionis and Heintz, 2009; Matarese
et al., 2011; Pastor et al., 2011; Tahiliani et al., 2009; Williams
et al., 2011).
2i ESCs Resemble Preimplantation Blastocyst Cells
In vivo, early mouse developmental stages up to the early
preimplantation blastocyst are hypomethylated, after which a
major wave of DNA methylation occurs (Meissner, 2010; Monk
et al., 1987; Santos et al., 2002). Our genome-wide bisulfite
sequencing of 2i ESCs indicated that DNA methylation in these
cells might parallel the hypomethylated state of inner cell mass
(ICM) cells. Therefore, we compared our WGBS data with the
recently published restricted representation bisulfite sequencing
(RRBS) analysis of preimplantation ICM cells and the postim-
plantation stage E6.5 (Smith et al., 2012). The distribution of
CpG methylation in the ICM cells appears to be very similar to
that of male E14 2i-adapted, Rex/GFP-2i, and the female XT
(irrespective of the culture condition) with most of CpGs being
hypomethylated, but strikingly different from E14 serum ESCs
(Figures 2A and 2B). This is also reflected in the plotted CpG
methylation levels and the average methylation profiles over
CGI promoters (Figures 2C and S2A and Table S3). Comparison
of methylation levels of individual CpGs in ICM cells versus our
WGBS data of cultured ESCs (Figures 2D and S2B) reinforced
the idea that the methylation patterns of E14 2i-adapted, Rex/
GFP-2i, and XT ESCs reflect that of the preimplantation ICM.
Similar to the cultured 2i ESCs, staining of blastocysts shows
an even distribution of 5mC and 5hmC in ICM cells (Figure S2C).
The DNA methylome of male serum ESCs is very similar to the
RRBS data of the embryo proper of postimplantation stage
E6.5 (Figures 2 and S2). Our analysis shows that the E14 2i-
adapted DNA methylation pattern closely resembles that of the
ICM cells, further underpinning the biological significance of
the ground state 2i ESCs. The increased methylation from 2i to
serum might well reflect the global DNA methylation occurring
soon after the early blastocyst stage (Smith et al., 2012).
Remaining DNA Methylation in 2i ESCs Correlates with
H3K9me3
Our genome-wide bisulfite sequencing showed that the major
euchromatic part of the E14 2i-adapted, Rex/GFP-2i, and female
ESC genome is hypomethylated. Visual inspection revealed
small genomic patches with largely maintained DNAmethylation
as compared to serum ESCs (Figures 3A, S3A, and S3B). We
identified these regions, hereafter referred to as ‘‘maintained’’
regions, using a cut-off of E14_2i-adapted/E14_serum ratio
R 0.66 (Figure 3B and Table S4). In E14 2i-adapted ESCs, the
level of DNA methylation was slightly reduced at maintained re-
gions, but markedly declined over the flanks as compared to E14
serum ESCs (Figure 3C). In Rex/GFP-2i and (to a lesser extent)
the XT cells, these same maintained regions also display
elevated DNA methylation levels as compared to the mean
methylation levels in the euchromatic part of the genome. The
maintained regions are highly enriched for endogenous retrovi-
ruses (ERVs; Figures 3D and S3C), mainly of the intracisternal
A particle (IAP) type (Figure S3D). Targeted hairpin-bisulfite
amplicon sequencing (Arand et al., 2012) confirmed the largely
sustained DNA methylation over IAPs and to a lesser extent
satellites (Figure 3E). Interestingly, DNAmethylation at imprinted
control regions (ICRs) is maintained only in the male E14 2i-
adapted and Rex/GFP-2i ESCs, and not in female XT cells (Fig-
ure 3A). The significance of this conspicuous difference between
male and female ESCswith respect to overall level ofmethylation
and imprinting remains to be investigated.
Surprisingly, the global loss of DNA methylation upon adapta-
tion of E14 serum to 2i does not appear to be due to loss of
expression or activity of factors implicated in the so-called
maintenance methyltransferase pathway (Bostick et al., 2007;
Rothbart et al., 2012; Sharif et al., 2007). Transcript and pro-
tein levels, complex formation, and enzymatic activity of the
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same lines adapted to 2i and LIF (‘‘2i-adapted’’); and (3) one
ESC line derived and maintained in 2i and LIF (‘‘Rex/GFP-2i’’)
(Wray et al., 2011). In line with a recent study by (Leitch et al.,
2013), mass spectrometric (MS) quantification of 5-methylcyto-
sine (5mC) revealed a >3-fold global reduction in Rex/GFP-2i
ESCs and E14 2i-adapted as compared to E14 serum ESCs (Fig-
ure 1A). This is not caused by the heterogeneity of serum ESCs:
REX1-high and -low cells (Wray et al., 2011) within the serum
ESC population have similar, high DNA methylation levels (Fig-
ure 1B). Immunocytochemistry shows a low but homogeneous
staining of 5mC in 2i, and a markedly higher and more heteroge-
neous DNA methylation in serum ESCs (Figure 1C). In line with
a previous study (Zvetkova et al., 2005), the serum female lines
(XT and LF2) show reduced DNA methylation comparable to
that of male 2i ESCs. DNA methylation in these female ESCs is
further reduced upon adaptation to 2i (Figures 1A and Figure S1A
available online). The global levels of 5-hydroxymethylcytosine
(5hmC) are proportional to the 5mC levels (Figures 1A, 1B, and
S1A). Notably, Epistem cells (EpiSCs) have similarly high 5mC
levels that male serum ESCs do, but reduced 5hmC (Figure 1D).
To obtain DNA methylation levels at base-pair resolution, we
performed WGBS (Tables S1 and S2). In line with our MS anal-
ysis, 4.1% of all covered cytosines (71%) are methylated in
male serum ESCs, while methylation in the 2i ESCs and female
XT serum ESCs are much reduced (Figure 1E). In all ESC lines,
DNA methylation predominantly occurs at CpG dinucleotides,
while non-CpG methylation levels are very low (Figure S1B).
For both non-CpG and CpG methylation, we observed a strong
reduction in overall mean methylation levels in Rex/GFP-2i, E14
2i-adapted, and XT ESCs as compared to male E14 serum ESCs
(Figure S1B). In contrast to the 2i and female ESCs, the majority
of CpGs in E14 serum ESCs are hypermethylated (Figures 1F–
1H). Pairwise comparison over individual CpG sites further un-
derpins the strongly reduced methylation in the 2i and XT
ESCs, in which the majority of CpGs are hypomethylated (Fig-
ure 1I). Notably, the methylome of E14 serum ESCs is in full
concordance with the published WGBS DNA methylome (Sta-
dler et al., 2011) on a different serum ESC line called ‘‘159-2’’
(Pearson correlation 0.85; Figures 1F and 1I). Averaging of
the methylation signals shows a consistent loss of DNA methyl-
ation over CpG-island (CGI) promoters, enhancers, and bivalent
loci for the 2i and female ESCs as compared to male E14
serum ESCs (Figure 1J). Interestingly, the intermediate DNA
methylation state described previously at enhancers (Stadler
et al., 2011) is only apparent in male serum ESCs. Therefore
increased 5mC deposition at enhancers may not be counter-
acted in full by TETs (or other enzymes involved in demethylation)
in male serum ESCs (Kriaucionis and Heintz, 2009; Matarese
et al., 2011; Pastor et al., 2011; Tahiliani et al., 2009; Williams
et al., 2011).
2i ESCs Resemble Preimplantation Blastocyst Cells
In vivo, early mouse developmental stages up to the early
preimplantation blastocyst are hypomethylated, after which a
major wave of DNA methylation occurs (Meissner, 2010; Monk
et al., 1987; Santos et al., 2002). Our genome-wide bisulfite
sequencing of 2i ESCs indicated that DNA methylation in these
cells might parallel the hypomethylated state of inner cell mass
(ICM) cells. Therefore, we compared our WGBS data with the
recently published restricted representation bisulfite sequencing
(RRBS) analysis of preimplantation ICM cells and the postim-
plantation stage E6.5 (Smith et al., 2012). The distribution of
CpG methylation in the ICM cells appears to be very similar to
that of male E14 2i-adapted, Rex/GFP-2i, and the female XT
(irrespective of the culture condition) with most of CpGs being
hypomethylated, but strikingly different from E14 serum ESCs
(Figures 2A and 2B). This is also reflected in the plotted CpG
methylation levels and the average methylation profiles over
CGI promoters (Figures 2C and S2A and Table S3). Comparison
of methylation levels of individual CpGs in ICM cells versus our
WGBS data of cultured ESCs (Figures 2D and S2B) reinforced
the idea that the methylation patterns of E14 2i-adapted, Rex/
GFP-2i, and XT ESCs reflect that of the preimplantation ICM.
Similar to the cultured 2i ESCs, staining of blastocysts shows
an even distribution of 5mC and 5hmC in ICM cells (Figure S2C).
The DNA methylome of male serum ESCs is very similar to the
RRBS data of the embryo proper of postimplantation stage
E6.5 (Figures 2 and S2). Our analysis shows that the E14 2i-
adapted DNA methylation pattern closely resembles that of the
ICM cells, further underpinning the biological significance of
the ground state 2i ESCs. The increased methylation from 2i to
serum might well reflect the global DNA methylation occurring
soon after the early blastocyst stage (Smith et al., 2012).
Remaining DNA Methylation in 2i ESCs Correlates with
H3K9me3
Our genome-wide bisulfite sequencing showed that the major
euchromatic part of the E14 2i-adapted, Rex/GFP-2i, and female
ESC genome is hypomethylated. Visual inspection revealed
small genomic patches with largely maintained DNAmethylation
as compared to serum ESCs (Figures 3A, S3A, and S3B). We
identified these regions, hereafter referred to as ‘‘maintained’’
regions, using a cut-off of E14_2i-adapted/E14_serum ratio
R 0.66 (Figure 3B and Table S4). In E14 2i-adapted ESCs, the
level of DNA methylation was slightly reduced at maintained re-
gions, but markedly declined over the flanks as compared to E14
serum ESCs (Figure 3C). In Rex/GFP-2i and (to a lesser extent)
the XT cells, these same maintained regions also display
elevated DNA methylation levels as compared to the mean
methylation levels in the euchromatic part of the genome. The
maintained regions are highly enriched for endogenous retrovi-
ruses (ERVs; Figures 3D and S3C), mainly of the intracisternal
A particle (IAP) type (Figure S3D). Targeted hairpin-bisulfite
amplicon sequencing (Arand et al., 2012) confirmed the largely
sustained DNA methylation over IAPs and to a lesser extent
satellites (Figure 3E). Interestingly, DNAmethylation at imprinted
control regions (ICRs) is maintained only in the male E14 2i-
adapted and Rex/GFP-2i ESCs, and not in female XT cells (Fig-
ure 3A). The significance of this conspicuous difference between
male and female ESCswith respect to overall level ofmethylation
and imprinting remains to be investigated.
Surprisingly, the global loss of DNA methylation upon adapta-
tion of E14 serum to 2i does not appear to be due to loss of
expression or activity of factors implicated in the so-called
maintenance methyltransferase pathway (Bostick et al., 2007;
Rothbart et al., 2012; Sharif et al., 2007). Transcript and pro-
tein levels, complex formation, and enzymatic activity of the
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drop in transcript levels of Dnmt3a, Dnmt3b, and Dnmt3L is
already apparent after 2 hr and levels off after24 hr (Figure 4D),
concordant with upregulation of Prdm14. The delay in global de-
methylation as compared to reduced expression of the Dnmt3
genes might well be explained by a long half-life of DNMT3 pro-
teins. Although starting from lower methylation levels, female
cells behaved very similarly (Figures 4E, S4C, and S4D). The ob-
servations that demethylation takes12 days (equivalent to18
cell divisions) and that expression of the Tet genes remains con-
stant (Figure S4B) suggests that under our conditions, global
A
B
C
D
Figure 2. The Hypomethylated 2i ESCs Resemble ICM Cells (E3.5), while Male Serum ESCs Are Reminiscent of the Hypermethylated E6.5
Mouse Embryo Proper
(A and B) Distribution of CpGmethylation levels for all CpGs covered by in vivo RRBSmethylation assays (Smith et al., 2012) for ICM cells (E3.5) and E6.5 cells (A)
and the corresponding CpGs in WGBS of ESCs (this study; B).
(C) Averaged methylation profiles over CpG island promoters (CGI).
(D) Smoothed scatter plots of methylation levels between CpGs of cultured ESCs (WGBS) versus in vivo developmental stages (RRBS) as in Figure 1I.
See also Figure S2 and Table S3.
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DNMT1/UHRF1/PCNA complex are not altered (Figures S3E–
S3G). Apparently, the continued activity of the DNMT1/UHRF1/
PCNA complex is not sufficient to sustain the hypermethylated
genome of E14 serum ESCs upon their being cultured in 2i.
Maintenance of DNA methylation by DNMT1/UHRF1/PCNA in
the 2i ESCs, in particular on ERVs, correlates with H3K9me3,
but not with H3K27me3 (Figure 3F) (Karimi et al., 2011; Matsui
et al., 2010; Rottach et al., 2010; Rowe et al., 2010). Furthermore,
regions of maintained DNA methylation and H3K9me3 levels
show very high correlation (Figure 3G), and H3K9me3 profiles
are very similar between 2i and serum ESCs (Figure 3H).
Together, our findings corroborate and extend previous reports
(Karimi et al., 2011; Matsui et al., 2010; Rottach et al., 2010;
Rowe et al., 2010) that maintenance of DNA methylation by the
DNMT1/UHRF1/PCNA pathway is dependent on the presence
of H3K9me3.
Recently, we showed that the de novo methyltransferases
DNMT3A and DNMT3B and their cofactor DNMT3L not only
contribute to the deposition of DNA methylation, but also play a
role in context-dependent maintenance of DNA methylation
(Arand et al., 2012). In 2i, transcript and protein levels of Dnmt3s
are much lower as compared to serum ESCs (Figures S3H–S3J),
in line with other reports (Leitch et al., 2013; Yamaji et al., 2013).
This suggests that the global DNA hypermethylation observed
in serum ESCs is due to elevated levels of DNMT3A, DNMT3B,
and DNMT3L. Importantly, expression levels of all Dnmt3 genes
are 10-fold upregulated during the transition from the early
(E3.5) to the late (E4.5) blastocyst stage (Tang et al., 2010), while
Dnmt1, Uhrf1, and Pcna expression levels remain constant, ex-
tendingourobservation to in vivodevelopment andstrengthening
the purported parallel between 2i and preimplantation ICM cells.
The Hypomethylated State in 2i Is Dependent on Both
Inhibitors and LIF
We next set out to investigate the contribution of the GSK inhib-
itor (CHIR99021), the MEK inhibitor (PD0325901), and LIF in
establishing the hypomethylated state observed in 2i ESCs.
Release of 2i ESCs from both inhibitors is accompanied by an
4-fold increase of DNA methylation within 5 days, upregulation
of Dnmt3a, Dnmt3b, and Dnmt3L, and concordant downregula-
tion of Prdm14, a reported repressor of Dnmt3a, Dnmt3b, and
Dnmt3L (Yamaji et al., 2013) (Figures 4A and 4B). Downregula-
tion of Nanog and Rex1 shows that the release from both
inhibitors results in loss of pluripotency in 2i ESCs as reported
previously (Figures 4B and S4A) (Wray et al., 2010). Removal of
CHIR99021, PD0325901, or LIF resulted in downregulation of
Prdm14, accompanied by upregulation of Dnmt3a, Dnmt3b,
and Dnmt3L. Pluripotency is retained in these conditions
(Wray et al., 2010), in line with continued high expression of
Nanog, Rex1, and Oct4. Consistent with the higher expression
levels of Dnmt3s, 5mC and 5hmC gradually increase within
7 days (Figure 4A). Adding serum on top of the 2i+LIF cultures
resulted in amarginal increase in DNA (hydroxy)methylation (Fig-
ure 4A). Taken together, the combined actions of CHIR99021,
PD0325901, and LIF are essential to maintain the hypomethy-
lated ground state of pluripotency in 2i ESCs.
Dynamics of Deposition of DNA Methylation during
Adaptation from 2i to Serum
To investigate the dynamics of DNA methylation, we determined
5mC/5hmC levels by MS during adaptation from 2i to serum. For
both E14 2i-adapted and Rex/GFP-2i, 5mC and 5hmC remain
constant for 24 hr during reversion to serum but are significantly
increased by day 3, reaching a plateau at day 7 (Figure 4C: right
panels, Figures S4E and S4F). To gain further insight, we
performed WGBS analysis at days 1, 3, 5, and 7 of serum adap-
tation. The kinetics of DNA methylation determined by WGBS
(Figures 4F, 4G, S4G, and S4H) is in good agreement with the
MS measurements and hairpin BS-seq (Figures S4I and S4J).
K-means clustering of average methylation levels over 1 kb
genomic intervals during adaptation from 2i to serum revealed
little difference between the clusters (Figure 4I), hinting at
random DNA methylation deposition. Interestingly, a subset of
so-called maintained regions decorated with H3K9me3 also
seem to temporally demethylate during adaptation to serum
(Figure 4I: cluster 4), although DNA methylation is preserved at
the majority of the maintained regions (Figure 4G).
Dynamics of Demethylation upon Reversion from
Serum to 2i
DNA demethylation during adaptation from serum to 2i becomes
apparent only after 3 days and gradually reaches steady state
‘‘2i-levels’’ by day 12, with 5hmC proportional to 5mC levels dur-
ing adaptation (Figure 4C: left panels). By contrast, a marked
Figure 1. Ground State Pluripotent ESCs are Overall Hypomethylated, as Opposed to Hypermethylated Male Serum ESCs
(A) Total 5mC (left) or 5hmC (right) by mass spectrometry (MS). Data are presented as mean ± SD (MSmeasurements for three or two [female ESCs] independent
replicates).
(B) 5mC and 5hmC in the REX1-positive and -negative population within Rex/GFP-serum ESCs, as in (A). Data are presented asmean ± SD (four independentMS
measurements).
(C) 5mC and 5hmC immunostainings of E14 serum and E14 2i-adapted ESCs; DAPI staining in blue.
(D) 5mC and 5hmC in EpiSCs as in (A). Data are presented as mean ± SD (three independent MS measurements).
(E) Total 5(h)mC by WGBS. The WGBS profile of ‘‘159-2’’ ESCs was obtained from a previous study (Stadler et al., 2011).
(F) Distribution of 5(h)mC levels in CpG sequence context byWGBS. The boxplot layout is according to the Tukey five-number summary (horizontal line within the
box represents median).
(G) A typical example depicting methylation profiles of the various ESCs. Methylation levels of individual CpG sites, between 0 (unmethylated) and 1 (fully
methylated), are shown by dots.
(H) Distribution of DNA methylation levels for individual CpGs genome-wide.
(I) Smoothed scatter plot between DNA methylation levels of individual CpGs genome-wide. Density of data points ranges from yellow (low) to red (intermediate)
and black (high).
(J) Averaged methylation profiles over various functional genomic elements as characterized in E14 serum.
See also Figure S1 and Tables S1 and S2.
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drop in transcript levels of Dnmt3a, Dnmt3b, and Dnmt3L is
already apparent after 2 hr and levels off after24 hr (Figure 4D),
concordant with upregulation of Prdm14. The delay in global de-
methylation as compared to reduced expression of the Dnmt3
genes might well be explained by a long half-life of DNMT3 pro-
teins. Although starting from lower methylation levels, female
cells behaved very similarly (Figures 4E, S4C, and S4D). The ob-
servations that demethylation takes12 days (equivalent to18
cell divisions) and that expression of the Tet genes remains con-
stant (Figure S4B) suggests that under our conditions, global
A
B
C
D
Figure 2. The Hypomethylated 2i ESCs Resemble ICM Cells (E3.5), while Male Serum ESCs Are Reminiscent of the Hypermethylated E6.5
Mouse Embryo Proper
(A and B) Distribution of CpGmethylation levels for all CpGs covered by in vivo RRBSmethylation assays (Smith et al., 2012) for ICM cells (E3.5) and E6.5 cells (A)
and the corresponding CpGs in WGBS of ESCs (this study; B).
(C) Averaged methylation profiles over CpG island promoters (CGI).
(D) Smoothed scatter plots of methylation levels between CpGs of cultured ESCs (WGBS) versus in vivo developmental stages (RRBS) as in Figure 1I.
See also Figure S2 and Table S3.
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DNMT1/UHRF1/PCNA complex are not altered (Figures S3E–
S3G). Apparently, the continued activity of the DNMT1/UHRF1/
PCNA complex is not sufficient to sustain the hypermethylated
genome of E14 serum ESCs upon their being cultured in 2i.
Maintenance of DNA methylation by DNMT1/UHRF1/PCNA in
the 2i ESCs, in particular on ERVs, correlates with H3K9me3,
but not with H3K27me3 (Figure 3F) (Karimi et al., 2011; Matsui
et al., 2010; Rottach et al., 2010; Rowe et al., 2010). Furthermore,
regions of maintained DNA methylation and H3K9me3 levels
show very high correlation (Figure 3G), and H3K9me3 profiles
are very similar between 2i and serum ESCs (Figure 3H).
Together, our findings corroborate and extend previous reports
(Karimi et al., 2011; Matsui et al., 2010; Rottach et al., 2010;
Rowe et al., 2010) that maintenance of DNA methylation by the
DNMT1/UHRF1/PCNA pathway is dependent on the presence
of H3K9me3.
Recently, we showed that the de novo methyltransferases
DNMT3A and DNMT3B and their cofactor DNMT3L not only
contribute to the deposition of DNA methylation, but also play a
role in context-dependent maintenance of DNA methylation
(Arand et al., 2012). In 2i, transcript and protein levels of Dnmt3s
are much lower as compared to serum ESCs (Figures S3H–S3J),
in line with other reports (Leitch et al., 2013; Yamaji et al., 2013).
This suggests that the global DNA hypermethylation observed
in serum ESCs is due to elevated levels of DNMT3A, DNMT3B,
and DNMT3L. Importantly, expression levels of all Dnmt3 genes
are 10-fold upregulated during the transition from the early
(E3.5) to the late (E4.5) blastocyst stage (Tang et al., 2010), while
Dnmt1, Uhrf1, and Pcna expression levels remain constant, ex-
tendingourobservation to in vivodevelopment andstrengthening
the purported parallel between 2i and preimplantation ICM cells.
The Hypomethylated State in 2i Is Dependent on Both
Inhibitors and LIF
We next set out to investigate the contribution of the GSK inhib-
itor (CHIR99021), the MEK inhibitor (PD0325901), and LIF in
establishing the hypomethylated state observed in 2i ESCs.
Release of 2i ESCs from both inhibitors is accompanied by an
4-fold increase of DNA methylation within 5 days, upregulation
of Dnmt3a, Dnmt3b, and Dnmt3L, and concordant downregula-
tion of Prdm14, a reported repressor of Dnmt3a, Dnmt3b, and
Dnmt3L (Yamaji et al., 2013) (Figures 4A and 4B). Downregula-
tion of Nanog and Rex1 shows that the release from both
inhibitors results in loss of pluripotency in 2i ESCs as reported
previously (Figures 4B and S4A) (Wray et al., 2010). Removal of
CHIR99021, PD0325901, or LIF resulted in downregulation of
Prdm14, accompanied by upregulation of Dnmt3a, Dnmt3b,
and Dnmt3L. Pluripotency is retained in these conditions
(Wray et al., 2010), in line with continued high expression of
Nanog, Rex1, and Oct4. Consistent with the higher expression
levels of Dnmt3s, 5mC and 5hmC gradually increase within
7 days (Figure 4A). Adding serum on top of the 2i+LIF cultures
resulted in amarginal increase in DNA (hydroxy)methylation (Fig-
ure 4A). Taken together, the combined actions of CHIR99021,
PD0325901, and LIF are essential to maintain the hypomethy-
lated ground state of pluripotency in 2i ESCs.
Dynamics of Deposition of DNA Methylation during
Adaptation from 2i to Serum
To investigate the dynamics of DNA methylation, we determined
5mC/5hmC levels by MS during adaptation from 2i to serum. For
both E14 2i-adapted and Rex/GFP-2i, 5mC and 5hmC remain
constant for 24 hr during reversion to serum but are significantly
increased by day 3, reaching a plateau at day 7 (Figure 4C: right
panels, Figures S4E and S4F). To gain further insight, we
performed WGBS analysis at days 1, 3, 5, and 7 of serum adap-
tation. The kinetics of DNA methylation determined by WGBS
(Figures 4F, 4G, S4G, and S4H) is in good agreement with the
MS measurements and hairpin BS-seq (Figures S4I and S4J).
K-means clustering of average methylation levels over 1 kb
genomic intervals during adaptation from 2i to serum revealed
little difference between the clusters (Figure 4I), hinting at
random DNA methylation deposition. Interestingly, a subset of
so-called maintained regions decorated with H3K9me3 also
seem to temporally demethylate during adaptation to serum
(Figure 4I: cluster 4), although DNA methylation is preserved at
the majority of the maintained regions (Figure 4G).
Dynamics of Demethylation upon Reversion from
Serum to 2i
DNA demethylation during adaptation from serum to 2i becomes
apparent only after 3 days and gradually reaches steady state
‘‘2i-levels’’ by day 12, with 5hmC proportional to 5mC levels dur-
ing adaptation (Figure 4C: left panels). By contrast, a marked
Figure 1. Ground State Pluripotent ESCs are Overall Hypomethylated, as Opposed to Hypermethylated Male Serum ESCs
(A) Total 5mC (left) or 5hmC (right) by mass spectrometry (MS). Data are presented as mean ± SD (MSmeasurements for three or two [female ESCs] independent
replicates).
(B) 5mC and 5hmC in the REX1-positive and -negative population within Rex/GFP-serum ESCs, as in (A). Data are presented asmean ± SD (four independentMS
measurements).
(C) 5mC and 5hmC immunostainings of E14 serum and E14 2i-adapted ESCs; DAPI staining in blue.
(D) 5mC and 5hmC in EpiSCs as in (A). Data are presented as mean ± SD (three independent MS measurements).
(E) Total 5(h)mC by WGBS. The WGBS profile of ‘‘159-2’’ ESCs was obtained from a previous study (Stadler et al., 2011).
(F) Distribution of 5(h)mC levels in CpG sequence context byWGBS. The boxplot layout is according to the Tukey five-number summary (horizontal line within the
box represents median).
(G) A typical example depicting methylation profiles of the various ESCs. Methylation levels of individual CpG sites, between 0 (unmethylated) and 1 (fully
methylated), are shown by dots.
(H) Distribution of DNA methylation levels for individual CpGs genome-wide.
(I) Smoothed scatter plot between DNA methylation levels of individual CpGs genome-wide. Density of data points ranges from yellow (low) to red (intermediate)
and black (high).
(J) Averaged methylation profiles over various functional genomic elements as characterized in E14 serum.
See also Figure S1 and Tables S1 and S2.
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demethylation may occur by passive dilution through replication.
K-means clustering on WGBS profiles generated at days 1, 7
(midway), and 17 identified one cluster with loss of methylation
already apparent at 24 hr of adaptation (Figure 4H). The genomic
loci in cluster 4 are enriched for active promoters and enhancers
as well as for TET1 occupancy. This suggests that demethylation
is initiated at TET1 binding sites and subsequently spreads to the
remainder of the genome. Even though TET1 appears to have an
active role, demethylation at the TET binding sites and in partic-
ular for the remainder of methylated cytosines remains slow and
is only completed after �12 days.
DISCUSSION
Recent analyses of the DNAmethylome of early mouse develop-
mental stages using RRBS (Smith et al., 2012) and WGBS of
serum ESCs (Stadler et al., 2011) revealed a marked discrep-
ancy: ICM cells from preimplantation embryos are hypomethy-
lated, whereas serum ESCs are globally hypermethylated. We
use WGBS profiling to show that ESCs cultured in 2i are hypo-
methylated and closely parallel hypomethylated ICM cells.
Regions of maintained DNA methylation in 2i highly correlate
with the presence of H3K9me3. Serum conditions appear to
cause a genome-wide de novo methylation in ESCs accompa-
nied by enhanced levels of DNMT3a, DNMT3b, and DNMT3L.
Our WGBS analysis suggests that this de novo methylation
occurs stochastically, but currently we cannot exclude the pos-
sibility of initiation at methylation centers with subsequent
spread across larger regions. Conversely we find that adaptation
from serum to 2i is biphasic: demethylation initially occurs
locally, likely triggered by TET1 at its genomic binding sites,
with subsequent genome-wide demethylation likely occurring
passively. Female ESCs already contain low methylation levels
in serum, which might be the cause of their genomic instability
as reported previously (Chen et al., 1998). Altogether, our
WGBS profiling provides mechanistic insight into the dynamics
of genome-wide de novo methylation occurring during transition
of the 2i ESC ground state to serum and the demethylation
occurring during the reverse transition.
EXPERIMENTAL PROCEDURES
Cell Culture
ESCs were cultured without feeders in the presence of LIF either in DMEM
containing 10% fetal calf serum or in serum-free NDiff 227 (StemCells, Inc.)
supplemented with MEK inhibitor PD0325901 (1 mM) and GSK3 inhibitor
CHIR99021 (3 mM), together known as 2i (Ying et al., 2008). E14Tg2a are
male ESCs of 129 background established in serum and LIF. Rex/GFP-2i
ESCs (129) contain a monoallelic green fluorescent protein (GFPd2) knockin
at the Rex1 (Zfp42) locus (Wray et al., 2011) and were derived in 2i and LIF.
EpiSCs (Maruotti et al., 2010) and female XT (XT67E1) and LF2 ESCs have
been described (Marks et al., 2009).
WGBS and Hairpin-Bisulfite Amplicon Sequencing
DNA was isolated using standard phenol/chloroform extraction and ethanol
precipitation or using the Cell Culture DNA Midi Kit from QIAGEN (Cat No
13343). WGBS was performed as described previously (Kulis et al., 2012).
We performed paired-end DNA sequencing (2*100 nucleotides) using the
Illumina Hi-Seq 2000. All sequencing analyses were conducted based on the
Mus musculus NCBI m37 genome assembly (MM9). Sequencing statistics are
shown in Table S1. All WGBS data (FASTQ and bedGraph files) are present at
NCBI GEO SuperSeries GSE41923. Targeted hairpin-bisulfite amplicon
sequencing was performed as described (Arand et al., 2012) with slight mod-
ifications as follows: BsaWI was used as the restriction enzyme for L1, and for
IAP we used TTTTTTTTTTAGGAGAGTTATATTT and ATCACTCCCTAAT
TAACTACAAC primers using 40 cycles of 95�C (10), 51�C (1.50), and 72�C
(10) for PCR amplification. Amplicons were sequenced with GS FLX Titanium
or Illumina MiSeq.
Read Mapping and Calculation of Cytosine Methylation
FASTQsequence fileswere aligned usingRMAPBS (Smith et al., 2009) allowing
amaximumof 10mismatches for efficientmapping of reads containing bisulfite
converted unmethylated cytosines. Cytosine methylation levels were deter-
mined using a new pipeline developed by the Smith lab (MethPipe; http://
smithlab.usc.edu/). In short, both mates of the paired-end sequencing were
mapped separately by RMAPBS. Readsmapping equally well onmultiple posi-
tionson thegenomewereexcluded from further analysis.Matesmappingwithin
a maximum distance of 500 bp were merged and other reads were excluded
from further analysis. If multiple mated reads mapped on exactly the same
genomic coordinates (duplicates), all but one were discarded. Within a CpG
context, symmetric cytosines on both forward and reverse strands were com-
bined. Cytosine methylation level was called per individual C as #C/(#C + #T).
WGBS, RRBS-seq, ChIP-seq, and RNA-seq Data Sets
FASTQ data for ‘‘159-2’’ serum ESCs (Stadler et al., 2011) was downloaded
from GSE30206 and analyzed as described above. In vivo FASTQ RRBS
sequencing data (Smith et al., 2012) was downloaded from GSE34864. These
FASTQ files were mapped against mm9 using RRBSMAP (Xi et al., 2012) and
merged. Within the 36 bp single end reads, three mismatches were allowed.
RRMAPBS reports one random hit in case a readmaps equally well onmultiple
locations. In case of duplicate reads, all were included for further analysis.
Within a CpG context, symmetric cytosines on both forward and reverse
strands were combined. Cytosinemethylation level was calculated per individ-
ual C by a script included in RRBSMAP.
H3K4me1 ChIP-seq data was obtained from GSE30206 (Stadler et al.,
2011), H3K27ac from GSM594578 (Creyghton et al., 2010), Tet1 from
GSE24843 (Williams et al., 2011), and all other ChIP-seq data/RNA-seq from
GSE23943 (Marks et al., 2012). DNaseI hypersensitive sites (Celniker et al.,
2009) were downloaded from the UCSC genome browser.
Figure 3. Maintained DNA Methylation in 2i ESCs Correlates with H3K9me3 in Regions such as ERVs
(A) Typical example of methylation profiles across maintained regions as in Figure 1G. Red boxes (‘‘maint’’): maintained regions; green boxes (‘‘CGI’’): CpG
islands; blue triangle (‘‘ICR’’): imprinted control region. The zoom-ins show an imprinted region (Peg10/Sgce) and an additional gene locus (Dync1i1) and include
H3K9me3 occupancies and female XT ESC WGBS profiles.
(B) Smoothed scatter plot over maintained regions; color setting as in Figure 1I.
(C) Averaged DNA methylation levels over maintained regions.
(D) Enrichment of repeat families and classes within the maintained regions.
(E) Hairpin-bisulfite amplicon sequencing over CpGs in various repeats and genes, represented as described previously (Arand et al., 2012).
(F) Averaged H3K9me3 and H3K27me3 levels (matched for serum and 2i ESCs) over maintained regions.
(G) Correlation betweenH3K9me3 occupancies (x axis) and degree of maintenance of DNAmethylation in 2i (y axis; 0 = fully maintained). 25th and 75th percentiles
are indicated in green.
(H) Smoothed scatter plot of H3K9me3 over maintained regions showing high similarity between E14 serum and 2i-adapted. Color settings as in Figure 1I.
See also Figure S3 and Table S4.
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demethylation may occur by passive dilution through replication.
K-means clustering on WGBS profiles generated at days 1, 7
(midway), and 17 identified one cluster with loss of methylation
already apparent at 24 hr of adaptation (Figure 4H). The genomic
loci in cluster 4 are enriched for active promoters and enhancers
as well as for TET1 occupancy. This suggests that demethylation
is initiated at TET1 binding sites and subsequently spreads to the
remainder of the genome. Even though TET1 appears to have an
active role, demethylation at the TET binding sites and in partic-
ular for the remainder of methylated cytosines remains slow and
is only completed after �12 days.
DISCUSSION
Recent analyses of the DNAmethylome of early mouse develop-
mental stages using RRBS (Smith et al., 2012) and WGBS of
serum ESCs (Stadler et al., 2011) revealed a marked discrep-
ancy: ICM cells from preimplantation embryos are hypomethy-
lated, whereas serum ESCs are globally hypermethylated. We
use WGBS profiling to show that ESCs cultured in 2i are hypo-
methylated and closely parallel hypomethylated ICM cells.
Regions of maintained DNA methylation in 2i highly correlate
with the presence of H3K9me3. Serum conditions appear to
cause a genome-wide de novo methylation in ESCs accompa-
nied by enhanced levels of DNMT3a, DNMT3b, and DNMT3L.
Our WGBS analysis suggests that this de novo methylation
occurs stochastically, but currently we cannot exclude the pos-
sibility of initiation at methylation centers with subsequent
spread across larger regions. Conversely we find that adaptation
from serum to 2i is biphasic: demethylation initially occurs
locally, likely triggered by TET1 at its genomic binding sites,
with subsequent genome-wide demethylation likely occurring
passively. Female ESCs already contain low methylation levels
in serum, which might be the cause of their genomic instability
as reported previously (Chen et al., 1998). Altogether, our
WGBS profiling provides mechanistic insight into the dynamics
of genome-wide de novo methylation occurring during transition
of the 2i ESC ground state to serum and the demethylation
occurring during the reverse transition.
EXPERIMENTAL PROCEDURES
Cell Culture
ESCs were cultured without feeders in the presence of LIF either in DMEM
containing 10% fetal calf serum or in serum-free NDiff 227 (StemCells, Inc.)
supplemented with MEK inhibitor PD0325901 (1 mM) and GSK3 inhibitor
CHIR99021 (3 mM), together known as 2i (Ying et al., 2008). E14Tg2a are
male ESCs of 129 background established in serum and LIF. Rex/GFP-2i
ESCs (129) contain a monoallelic green fluorescent protein (GFPd2) knockin
at the Rex1 (Zfp42) locus (Wray et al., 2011) and were derived in 2i and LIF.
EpiSCs (Maruotti et al., 2010) and female XT (XT67E1) and LF2 ESCs have
been described (Marks et al., 2009).
WGBS and Hairpin-Bisulfite Amplicon Sequencing
DNA was isolated using standard phenol/chloroform extraction and ethanol
precipitation or using the Cell Culture DNA Midi Kit from QIAGEN (Cat No
13343). WGBS was performed as described previously (Kulis et al., 2012).
We performed paired-end DNA sequencing (2*100 nucleotides) using the
Illumina Hi-Seq 2000. All sequencing analyses were conducted based on the
Mus musculus NCBI m37 genome assembly (MM9). Sequencing statistics are
shown in Table S1. All WGBS data (FASTQ and bedGraph files) are present at
NCBI GEO SuperSeries GSE41923. Targeted hairpin-bisulfite amplicon
sequencing was performed as described (Arand et al., 2012) with slight mod-
ifications as follows: BsaWI was used as the restriction enzyme for L1, and for
IAP we used TTTTTTTTTTAGGAGAGTTATATTT and ATCACTCCCTAAT
TAACTACAAC primers using 40 cycles of 95�C (10), 51�C (1.50), and 72�C
(10) for PCR amplification. Amplicons were sequenced with GS FLX Titanium
or Illumina MiSeq.
Read Mapping and Calculation of Cytosine Methylation
FASTQsequence fileswere aligned usingRMAPBS (Smith et al., 2009) allowing
amaximumof 10mismatches for efficientmapping of reads containing bisulfite
converted unmethylated cytosines. Cytosine methylation levels were deter-
mined using a new pipeline developed by the Smith lab (MethPipe; http://
smithlab.usc.edu/). In short, both mates of the paired-end sequencing were
mapped separately by RMAPBS. Readsmapping equally well onmultiple posi-
tionson thegenomewereexcluded from further analysis.Matesmappingwithin
a maximum distance of 500 bp were merged and other reads were excluded
from further analysis. If multiple mated reads mapped on exactly the same
genomic coordinates (duplicates), all but one were discarded. Within a CpG
context, symmetric cytosines on both forward and reverse strands were com-
bined. Cytosine methylation level was called per individual C as #C/(#C + #T).
WGBS, RRBS-seq, ChIP-seq, and RNA-seq Data Sets
FASTQ data for ‘‘159-2’’ serum ESCs (Stadler et al., 2011) was downloaded
from GSE30206 and analyzed as described above. In vivo FASTQ RRBS
sequencing data (Smith et al., 2012) was downloaded from GSE34864. These
FASTQ files were mapped against mm9 using RRBSMAP (Xi et al., 2012) and
merged. Within the 36 bp single end reads, three mismatches were allowed.
RRMAPBS reports one random hit in case a readmaps equally well onmultiple
locations. In case of duplicate reads, all were included for further analysis.
Within a CpG context, symmetric cytosines on both forward and reverse
strands were combined. Cytosinemethylation level was calculated per individ-
ual C by a script included in RRBSMAP.
H3K4me1 ChIP-seq data was obtained from GSE30206 (Stadler et al.,
2011), H3K27ac from GSM594578 (Creyghton et al., 2010), Tet1 from
GSE24843 (Williams et al., 2011), and all other ChIP-seq data/RNA-seq from
GSE23943 (Marks et al., 2012). DNaseI hypersensitive sites (Celniker et al.,
2009) were downloaded from the UCSC genome browser.
Figure 3. Maintained DNA Methylation in 2i ESCs Correlates with H3K9me3 in Regions such as ERVs
(A) Typical example of methylation profiles across maintained regions as in Figure 1G. Red boxes (‘‘maint’’): maintained regions; green boxes (‘‘CGI’’): CpG
islands; blue triangle (‘‘ICR’’): imprinted control region. The zoom-ins show an imprinted region (Peg10/Sgce) and an additional gene locus (Dync1i1) and include
H3K9me3 occupancies and female XT ESC WGBS profiles.
(B) Smoothed scatter plot over maintained regions; color setting as in Figure 1I.
(C) Averaged DNA methylation levels over maintained regions.
(D) Enrichment of repeat families and classes within the maintained regions.
(E) Hairpin-bisulfite amplicon sequencing over CpGs in various repeats and genes, represented as described previously (Arand et al., 2012).
(F) Averaged H3K9me3 and H3K27me3 levels (matched for serum and 2i ESCs) over maintained regions.
(G) Correlation betweenH3K9me3 occupancies (x axis) and degree of maintenance of DNAmethylation in 2i (y axis; 0 = fully maintained). 25th and 75th percentiles
are indicated in green.
(H) Smoothed scatter plot of H3K9me3 over maintained regions showing high similarity between E14 serum and 2i-adapted. Color settings as in Figure 1I.
See also Figure S3 and Table S4.
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We determined enhancers by H3K4me1, H3K27ac, and DNaseI hypersensi-
tivity in E14 serum ESCs as described (Zentner et al., 2011). Bivalent loci were
defined as co-occurring active H3K4me3 and repressive H3K27me3 marks in
E14 serum ESCs.
Data Analysis
For WGBS of E14 serum, E14 2i-adapted, and Rex/GFP-2i, a CpG coverage
threshold of R10 was used; for other profiles the threshold was R5. For
WGBS and RRBS comparisons, we included common CpGs with a coverage
R5 in the RRBS data. For the analysis of RRBS data and the corresponding
WGBS data, CpGs were binned (36 bp) for analysis. CGI promoters were
defined as promoters (2 kb to +0.5 kb relative to the transcription start
site) overlapping with a CGI (UCSC genome browser CpG island). For average
plots, average values in 100 bp bins were calculated and plotted. Regions of
maintained DNA methylation in 2i were intersected with repeats as annotated
in RepeatMask (mm9). The frequencies within this intersection were compared
to the full repeat data set to obtain an observed/expected ratio for each repeat.
Probabilities were calculated using a Fisher’s exact test.
ACCESSION NUMBERS
All sequencing data are present in the NCBI GEO SuperSeries GSE41923.
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Procedures, four figures, and four tables and can be found with this article
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Figure 4. Dynamics of DNA (De)Methylation
(A and B) Levels of 5mC/5hmC by MS (A) and gene expression by RT-qPCR (B) of Rex/GFP-2i after leaving out both inhibitors, either of these, or LIF from the
culture medium, or after adding serum on top of 2i+LIF. (B) Data are presented as mean ± SD (two independent PCR measurements).
(C and D) Levels of 5mC (top) and 5hmC (bottom) asmeasured byMS (C) and gene expression by RT-qPCR (D) in E14 serum cells during adaptation to 2i and vice
versa. (D) Data are presented as mean ± SD (three [Dnmt genes] or two [Prdm14] independent PCR measurements).
(E) 5mC (top) and 5hmC (bottom) in female XT ESCs during interconversion as in Figure 4C.
(F) Mean CpG methylation dynamics of E14 serum cells during adaptation to 2i and vice versa as determined by WGBS. Black line: mean; dark blue: 25th–75th
percentile; light blue 5th–95th percentile.
(G) Mean CpG methylation dynamics of all CpGs versus the CpGs in maintained regions as characterized in Figure 3.
(H and I) K-means clustering of WGBS profiles of mean methylation levels in 1 kb genomic intervals during reversion from serum to 2i (H) and during adaptation
from 2i back to serum (I). Further (epi)genetic features of the clusters are shown underneath. The boxplot layout is according to the Tukey five-number summary
(horizontal line within the box represents median).
See also Figure S4 and Table S2.
Cell Stem Cell
The Reversible Methylomes of Two Types of mESCs
368 Cell Stem Cell 13, 360–369, September 5, 2013 ª2013 Elsevier Inc.
(legend on next page)
Cell Stem Cell
The Reversible Methylomes of Two Types of mESCs
Cell Stem Cell 13, 360–369, September 5, 2013 ª2013 Elsevier Inc. 367
Processed on: 17-11-2016
506677-L-bw-habibi
41
THE REVERSIBLE METHYLOMES OF TWO TYPES OF MESCS
2
We determined enhancers by H3K4me1, H3K27ac, and DNaseI hypersensi-
tivity in E14 serum ESCs as described (Zentner et al., 2011). Bivalent loci were
defined as co-occurring active H3K4me3 and repressive H3K27me3 marks in
E14 serum ESCs.
Data Analysis
For WGBS of E14 serum, E14 2i-adapted, and Rex/GFP-2i, a CpG coverage
threshold of R10 was used; for other profiles the threshold was R5. For
WGBS and RRBS comparisons, we included common CpGs with a coverage
R5 in the RRBS data. For the analysis of RRBS data and the corresponding
WGBS data, CpGs were binned (36 bp) for analysis. CGI promoters were
defined as promoters (2 kb to +0.5 kb relative to the transcription start
site) overlapping with a CGI (UCSC genome browser CpG island). For average
plots, average values in 100 bp bins were calculated and plotted. Regions of
maintained DNA methylation in 2i were intersected with repeats as annotated
in RepeatMask (mm9). The frequencies within this intersection were compared
to the full repeat data set to obtain an observed/expected ratio for each repeat.
Probabilities were calculated using a Fisher’s exact test.
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culture medium, or after adding serum on top of 2i+LIF. (B) Data are presented as mean ± SD (two independent PCR measurements).
(C and D) Levels of 5mC (top) and 5hmC (bottom) asmeasured byMS (C) and gene expression by RT-qPCR (D) in E14 serum cells during adaptation to 2i and vice
versa. (D) Data are presented as mean ± SD (three [Dnmt genes] or two [Prdm14] independent PCR measurements).
(E) 5mC (top) and 5hmC (bottom) in female XT ESCs during interconversion as in Figure 4C.
(F) Mean CpG methylation dynamics of E14 serum cells during adaptation to 2i and vice versa as determined by WGBS. Black line: mean; dark blue: 25th–75th
percentile; light blue 5th–95th percentile.
(G) Mean CpG methylation dynamics of all CpGs versus the CpGs in maintained regions as characterized in Figure 3.
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from 2i back to serum (I). Further (epi)genetic features of the clusters are shown underneath. The boxplot layout is according to the Tukey five-number summary
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CHAPTER 2
Supplemental figure legends 
 
Figure S1. Ground state pluripotent ESCs show minimal DNA methylation, Related 
to Figure 1 and Table S1 
(A) Total 5mC and 5hmC as in Figure 1A, including female LF2 ESCs. Data are 
presented as mean  SD (MS measurements for three or two (female ESCs) independent 
replicates). 
(B) Mean cytosine (hydroxy)methylation levels in CpG and non-CpG sequence contexts 
by WGBS. 
 
Figure S2. The 2i ESCs resemble hypomethylated ICM cells, Related to Figure 2 
and Table S3 
 (A) Boxplot representation of CpG methylation levels for all CpGs covered by in vivo 
RRBS methylation assays (Smith et al., 2012) and the corresponding CpGs in WGBS 
DNA methylation profiles of cultured ESCs (this study). Further (epi)genetic features of 
the clusters are shown underneath. The boxplot layout is according to the Tukey five-
number summary (horizontal line within the box represents median). 
(B) Smoothed scatter plot of the CpG methylation levels of Rex/GFP-2i ESCs (WGBS) 
and ICM cells (RRBS) (Smith et al., 2012). Color settings as in Figure 1I. 
(C) Distribution of 5mC and 5hmC in expanded mouse blastocyst. In vivo derived 
(3.5dpc) blastocysts were immunostained with anti-5mC and anti-5hmC specific 
antibodies. Upper panel, composed z-stack images; bottom, Z-stack images of the inner 
part of the blastocyst. 
Processed on: 17-11-2016
506677-L-bw-habibi
51
THE REVERSIBLE METHYLOMES OF TWO TYPES OF MESCS
2
Figure S3. DNA methylated sites in 2i ESCs are highly enriched for the ERV1/ 
ERVK repeat family, and its repeat member IAP, Related to Figure 3 and Table S4 
(A and B) Additional examples of maintained regions (setup as in Figure 3a; Red boxes 
(“maint”)). Whereas (A) depicts regular examples of maintained regions, (B) shows 
examples of ICRs which maintain their 50% DNA methylation level. 
(C) Averaged profiles of enrichment of ERV1 and ERVK repeat families over maintained 
regions. 
(D) Enrichment of individual ERV and ERVK repeat types over maintained regions. 
(E) RNA-Seq gene expression values (RPKM: Reads Per Kilobase per Million mapped 
reads) of Dnmt1 and its interaction partners Uhrf1 and Pcna. 
(F) Co-immunoprecipitation of DNMT1 from serum or 2i nuclear extracts, followed by 
western blotting against DNMT1, UHRF1 and PCNA. 
(G) Activity assay for DNMT1 extracted from E14 2i-adapted and E14 serum ESCs, 
respectively. DPM (Disintegrations Per Minute): a measure for DNMT1 activity. 
(H and I) Gene expression (H) and protein levels (I) of Dnmt3a, -3b and -3L. 
(J) Immunofluorescent stainings for E14 2i-adapted and E14 serum. DAPI staining is in 
blue. 
 
Figure S4. Dynamics of DNA (de)methylation, Related to Figure 4 
(A) Gene expression by RT-qPCR of Rex/GFP-2i as in Figure 4A. Data are presented as 
mean ± SD (two independent PCR measurements). 
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(B) Gene expression by RT-qPCR of E14 serum cells during adaptation to 2i and during 
transfer of the E14 2i-adapted ESCs back to serum. Data are presented as mean ± SD 
(two or three independent PCR measurements). 
(C) Levels of 5mC (top) and 5hmC (bottom) in female serum LF2 ESCs as in Figure 4E. 
(D) Gene expression by RT-qPCR in female serum LF2 (left) and XT (right) ESCs 
during adaptation from serum to 2i. Data are presented as mean ± SD (two independent 
PCR measurements). 
(E) Levels of 5mC (top) and 5hmC (bottom) in Rex/GFP-2i ESCs during adaptation from 
2i to serum as measured by MS. 
(F) Gene expression by RT-qPCR as in Figure S4E. Data are presented as mean ± SD 
(two or three independent PCR measurements). 
(G and H) Mean CpG methylation as determined by WGBS in E14 serum cells during 
adaptation to 2i and during transfer of the E14 2i-adapted ESCs back to serum over 
functional genomic elements (G) and repeat families (H). 
(I) Hairpin-bisulfite amplicon sequencing (Arand et al., 2012) over CpGs in various 
repeats and genes, represented as a summary. 
Processed on: 17-11-2016
506677-L-bw-habibi
53
THE REVERSIBLE METHYLOMES OF TWO TYPES OF MESCS
2
Supplemental tables 
Supplemental table 1. Sequencing statistics of WGBS, both strands individually. 
Belongs to analysis in all Figures. 
E14 2i-
adapted 
Rex/GFP-
2i 
E14 serum XT 2i-
adapted 
XT serum 
Bisulfite Conversion >99.99% >99.65% >99.99% >99.97% >99.97% 
TOTAL READS 386,916,428 618,551,056 1,105,660,021 124,801,666 110,584,546 
UNIQUE READS 280,771,868 448,550,851 509,506,756 100,015,754 88,385,312 
TOTAL 
SITES 
in double 
stranded 
genome 
CpG 42,684,984 
CHH* 800,539,430 
CHG* 225,216,016 
All Cs 1,068,440,430 
SITES 
COVERED 
 
CpG 34,290,675 
(80%) 
35,064,000 
(82%) 
34,543,916 
(81%) 
27,927,682 
(65%) 
30,028,901 
(70%) 
CHH* 545,255,838 
(68%) 
557,522,334 
(69%) 
543,899,337 
(68%) 
376,959,620 
(47%) 
429,522,630 
(53%) 
CHG* 179,077,232 
(80%) 
182,732,163 
(81%) 
179,033,784 
(79%) 
139,516,003 
(61%) 
152,233,749 
(67%) 
All Cs 758,623,745 
(71%) 
775,318,497 
(72%) 
757,477,037 
(71%) 
544,403,305 
(59%) 
611,785,280 
(57%) 
MEAN 
COVERAGE 
(WHEN > 0) 
CpG 9.8 23.2 10.6 6.6 5.5 
CHH* 8.1 16.1 8.7 4.9 4.4 
CHG* 9.6 20.2 10.2 5.8 5.0 
All Cs 8.5 17.4 9.1 5.3 4.6 
*H represents G, A or T 
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Supplemental table 2. Methylation statistics for CpGs by WGBS, both strands 
combined. Belongs to all analysis in Figures 1E - 4 (except for Figure 2). 
Total SITES  Coverage of ≥ 5 Mean 
methylation 
level 
Median 
methylation 
level 
E14 2i-adapted 21,342,492 17,919,431 (83%) 0.19 0.13 
Rex/GFP-2i 21,342,492 18,840,373 (88%) 0.20 0.15 
E14 serum 21,342,492 18,045370 (84%) 0.68 0.77 
XT 2i-adapted 21,342,492 13,366,474 (62%) 0.03 0.00 
XT serum 21,342,492 13,749,842 (62%) 0.19 0.16 
For analysis performed for Fig 4: 
E14_serum_2i_24h 21,342,492 16,726,954 (78%) 0.67 0.76 
E14_serum_2i_7d 21,342,492 15,592,574 (73%) 0.41 0.43 
E14_2i_serum_24h 21,342,492 15,955,700 (74%) 0.11 0.06 
E14_2i_serum_3d 21,342,492 16,621,597 (77%) 0.31 0.28 
E14_2i_serum_5d 21,342,492 14,096,144 (62%) 0.43 0.45 
E14_2i_serum_7d 21,342,492 13,185,683 (61%) 0.49 0.55 
Processed on: 17-11-2016
506677-L-bw-habibi
55
THE REVERSIBLE METHYLOMES OF TWO TYPES OF MESCS
2
Supplemental table 3. Methylation statistics for the comparison between ESCs and in 
vivo development. Belongs to all analysis in Figure 2. 
E14 2i-
adapted 
Rex/ 
GFP-2i 
E14 
serum 
XT 2i-
adapted 
XT 
serum 
ICM E6.5 
CpG 
coverage 
(≥ 5); 
bins 
36 bp 
sites 534,890 534,890 534,890 534,890 534,890 534,890 534,890 
mean 0.13 0.15 0.44 0.02 0.13 0.15 0.40 
me-
dian 
0.016 0.06 0.56 0 0.44 0.06 0.45 
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Supplemental experimental procedures 
 
Western blot analysis 
For immunoblot analysis 10µg of nuclear extracts (Ambrosino et al., 2010) were resolved 
by SDS-PAGE and blotted on nitrocellulose membranes. Membranes were blocked in 
TBS-Tween (5% milk) and incubated overnight at 4°C with the indicated antibodies. 
After incubation with secondary antibodies, HRP conjugates were detected using an 
enhanced chemiluminescence kit (ECL Plus, Amersham Biosciences). The following 
primary antibodies were used for Western: DNMT1 (60B1220.1; ab92453, lot number: 
GR85799-1, final concentration used: 3 g/ml; this antibody was also used for co-
immunoprecipitation); DNMT3A (Abcam 64B1446; ab13888, GR74808-1, 2 g/ml); 
DNMT3B (Abcam 52A1018; ab13604, GR76707-6, 3 g/ml); β-actin (Abcam ab16039, 
104192, 0.4 g/ml), UHRF1 (Abcam ab57083, GR73978-2, 3 g/ml), PCNA (Abcam 
ab18197, GR56785-1, 1 g/ml). Secondary antibodies used: HRP-conjugated polyclonal 
swine anti-rabbit IgG (Dako, P0399, 00042894, 0.075 g/ml); HRP-conjugated 
polyclonal rabbit anti-mouse IgG (Dako, P0161, 00046035, 0.45 g/ml). 
 
Co-immunoprecipitation & DNMT1 functional assay 
18µg of DNMT1 antibody immobilized on 2.2 mg Dynabeads Protein G (lot: 
101885320; Invitrogen) was incubated with 500 µg of nuclear extract (prepared 
according to the previous section) for 1.5 hr at 4°C. Beads were washed 5 times using 1 
ml buffer containing 150 mM NaCl, 50 mM Tris (pH 7.6), 5% glycerol and 0.05% NP-
40. Immunoprecipitated proteins were eluted by incubation in 50µl of SDS sample buffer 
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containing beta-mercaptoethanol for 5 min at 65°C. For western blot analysis, 10% of 
input, flowthrough and IP were used. The DNMT1 functional methylation assay was 
performed as described previously (Pereira et al., 2012). 
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the main drivers of global demethylation are neither
active mechanisms (Aicda, Tdg, and Tet1-3) nor
the reduction of de novo methylation. UHRF1 pro-
tein, the essential targeting factor for DNMT1, is
reduced upon transition to 2i, and so is recruitment
of the maintenance methylation machinery to repli-
cation foci. Concurrently, there is global loss of
H3K9me2, which is needed for chromatin binding of
UHRF1. These mechanisms synergistically enforce
global DNA hypomethylation in a replication-coupled
fashion. Our observations establish the molecular
mechanism for global demethylation in naive ESCs,
which has key parallels with those operating in pri-
mordial germ cells and early embryos.
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ture conditions have been established that favor derivation and
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et al., 2008). These conditions rely on specific inhibition of
GSK3beta and Erk1/2 and downstream signaling by two small-
molecule inhibitors (‘‘2i ESCs’’). 2i ESCs transcriptionally closely
resemble cells from the ICM (Nichols and Smith, 2012), and
serum ESCs tend to phenocopy cells from the early epiblast
and show a greater heterogeneity and differential expression of
pluripotency and differentiation factors, resulting in overt and
spontaneous differentiation if not held back by LIF (Canham
et al., 2010; Singh et al., 2007; Tang et al., 2010). Accordingly,
the state of 2i ESCs has been designated the ‘‘ground- or
naive-state’’ of pluripotency, and cells grown in 2i are believed
to be a much better representation of the cells from the ICM,
compared to ‘‘primed’’ serum ESCs (Marks et al., 2012; Martello
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In vivo, acquisition of pluripotency in both primordial germ
cells (PGCs) and the early embryo coincides with genome-
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2013; Seisenberger et al., 2012; Smith et al., 2014). During
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repressed promoters, but only minor changes in H3K4me3 and
H3K9me3 (Marks et al., 2012). Recently, we and others showed
that the genome of 2i ESCs is globally hypomethylated and as
such similar to the cells in the ICM, whereas serum ESCs are hy-
permethylated (Ficz et al., 2013; Habibi et al., 2013; Hackett
et al., 2013a; Leitch et al., 2013). To date, the molecular mecha-
nisms regulating this conserved (Guo et al., 2014; Takashima
et al., 2014; Wang et al., 2014) genome-wide demethylation in
the naive state are unclear.
In the current study, we have revisited this transition and em-
barked on a comprehensive, time-resolved experimental and
mathematical approach to reveal and verify the kinetics and
interplay between the different components of the DNA deme-
thylation machinery and to unravel the mechanistic regula-
tion of the main pathway responsible for genome-wide DNA
demethylation.
RESULTS
Demethylation Dynamics during Serum-to-2i
Reprogramming
DNA demethylation dynamics can be attributed to three major
pathways (Wu and Zhang, 2014): (1) maintenance DNA
methylation or replication dependent passive dilution, (2) de
novo DNA methylation, and (3) active DNA demethylation,
primarily via DNA hydroxymethylation (Figure 1A). During the
conversion from serum to 2i ESCs, the maintenance methyl-
ation components Dnmt1 and Uhrf1, the ten-eleven trans-
location (TET) enzymes (Tet1, Tet2, and, at low levels, Tet3),
Aicda, and Tdg, which have all been implicated in active
DNA demethylation, are expressed at similar transcriptional
levels. In contrast, the de novo methylases Dnmt3a/b and their
regulator Dnmt3l are suppressed in the 2i state (Figures 1B
and S1A).
To further understand the kinetics of the transition from serum
to 2i ESCs, we determined their DNAmethylation state at several
time points. First, we quantified global levels of 5-methylcytosine
(5mC) and 5-hydroxymethylcytosine (5hmC) by liquid chroma-
tography followed by mass spectrometry (LC-MS) (Figure 1C)
as well as by reduced representation bisulfite sequencing
(RRBS) (Figure 1D), whole-genome bisulfite sequencing
(WGBS), and TET-assisted bisulfite sequencing (TAB-seq) (Fig-
ures S1B and S1C). In line with our previous studies (Ficz
et al., 2013; Habibi et al., 2013), DNA demethylation rapidly
ensued after medium replacement (32 hr; about two rounds
of replication) and thereafter continued gradually, reaching a
steady-state level after 14 days (Figure 1C). A moderate increase
in 5hmC levels was observed up to 72 hr, suggesting the pres-
ence of TET activity.
Mathematical Modeling of DNA Demethylation Kinetics
To dissect the role and relative contribution of the three path-
ways and the various regulatory factors involved, we used math-
ematical modeling to predict DNA demethylation throughout the
time course. Since the first population-epigenetic models for
DNA methylation dynamics were published (Otto and Walbot,
1990; Pfeifer et al., 1990), several studies were undertaken to
improve the predictions by using different approaches and incor-
porating new biological concepts into the models (Arand et al.,
2012; Genereux et al., 2005; McGovern et al., 2012; Sontag
et al., 2006). Due to the lack of adequate experimental data
describing DNA methylation changes genome-wide, previous
descriptive and predictive models could not be fuelled with ac-
curate input values and precise estimates of the parameters.
To overcome this obstacle and to obtain accurate input values,
we performed genome-wide hairpin bisulfite sequencing (Zhao
et al., 2014) and combined thesewith our other sequencing data-
sets. We calculated the percentages of fully methylated CpG
dyads (mCpG/GpCm), hemi-methylated CpG dyads (mCpG/
GpC), and unmethylated CpG dyads (CpG/GpC) (Figure S1D;
Table S1) as well as the levels of hydroxymethylated CpGs
from TAB-seq data and hairpin bisulfite sequencing. These
input values along with the global 5mC values from LC-MS
were used to estimate the following parameters, which are
directly proportional to the enzyme abundance and/or activity
and reflect the amount of substrate that is converted to the prod-
uct: p1, a dynamic proportionality value for de novo methylation;
p2, a proportionality constant for maintenance methylation; and
p3, a proportionality constant for active demethylation (hydroxy-
methylation). Through several iterations of fitting the mathemat-
ical model to the 5mC data, we were able to estimate the values
of the constants for the serum-to-2i transition in E14 ESCs with
the lowest minimum mean square error (MMSE) (Figure 1E).
The model also takes into account that the rate of de novo
methylation (p1) changes gradually (Figure S1E). Using these
values, the model recapitulates 5mC dynamics and predicts
the dynamics of 5hmC in ESCs with excellent approximation
(R2 = 0.99) (Figure 1F, blue panel, dotted line). p1, p2, and p3
reflect the individual activity and overall contribution of the
three pathways to the DNA methylation dynamics observed
and predicts that maintenance methylation is significantly
impaired and a major driver of the DNA demethylation observed
(Figure 1F).
Global Demethylation Kinetics in Mutants of the DNA
Methylation Machinery
To validate and fully understand the contribution of the individual
DNA methylation and demethylation enzymes in the genome-
wide epigenetic reprogramming that characterizes the transition
(D) Percentage of 5mC methylation as measured by RRBS in E14 during serum-to-2i conversion. Horizontal bars represent the median values.
(E) Graphical representation of the mathematical modeling. The minimum mean square error (MMSE) is plotted against different values for de novo methylation
(p1) and maintenance methylation (p2).
(F) Overlay of the mathematical model predictions (dotted line) with real measurements (red line) obtained from LC-MS in E14 during serum-to-2i conversion. The
table summarizes the results of the mathematical modeling, showing the values estimated for p1, p2, and p3 in the serum steady state and in 2i. p1, proportion of
unmethylated CpGs that become hemi-methylated per average cell division; p2, proportion of hemi-methylated CpGs that become fully methylated per average
cell division; and p3, proportion of methylated CpGs that become hydroxymethylated per average cell division.
See also Figure S1 and Table S1.
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Figure 1. Dynamic Regulation of 5mC and 5hmC during Serum-to-2i Conversion of Mouse ESCs
(A) Schematic representation of cytosine methylation/demethylation cycle. Different forms of modified CpG dyads and the corresponding processes are
indicated.
(B) Expression levels of genes involved in the DNA methylation machinery during serum-to-2i transition. Error bars indicate mean ± SD from three biological
replicates.
(C) Percentage of 5mC (top) and 5hmC (bottom) as measured by LC-MS in E14 during serum-to-2i conversion. Error bars indicate mean ± SD from three
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and reflect the amount of substrate that is converted to the prod-
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methylation). Through several iterations of fitting the mathemat-
ical model to the 5mC data, we were able to estimate the values
of the constants for the serum-to-2i transition in E14 ESCs with
the lowest minimum mean square error (MMSE) (Figure 1E).
The model also takes into account that the rate of de novo
methylation (p1) changes gradually (Figure S1E). Using these
values, the model recapitulates 5mC dynamics and predicts
the dynamics of 5hmC in ESCs with excellent approximation
(R2 = 0.99) (Figure 1F, blue panel, dotted line). p1, p2, and p3
reflect the individual activity and overall contribution of the
three pathways to the DNA methylation dynamics observed
and predicts that maintenance methylation is significantly
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Methylation Machinery
To validate and fully understand the contribution of the individual
DNA methylation and demethylation enzymes in the genome-
wide epigenetic reprogramming that characterizes the transition
(D) Percentage of 5mC methylation as measured by RRBS in E14 during serum-to-2i conversion. Horizontal bars represent the median values.
(E) Graphical representation of the mathematical modeling. The minimum mean square error (MMSE) is plotted against different values for de novo methylation
(p1) and maintenance methylation (p2).
(F) Overlay of the mathematical model predictions (dotted line) with real measurements (red line) obtained from LC-MS in E14 during serum-to-2i conversion. The
table summarizes the results of the mathematical modeling, showing the values estimated for p1, p2, and p3 in the serum steady state and in 2i. p1, proportion of
unmethylated CpGs that become hemi-methylated per average cell division; p2, proportion of hemi-methylated CpGs that become fully methylated per average
cell division; and p3, proportion of methylated CpGs that become hydroxymethylated per average cell division.
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Figure 1. Dynamic Regulation of 5mC and 5hmC during Serum-to-2i Conversion of Mouse ESCs
(A) Schematic representation of cytosine methylation/demethylation cycle. Different forms of modified CpG dyads and the corresponding processes are
indicated.
(B) Expression levels of genes involved in the DNA methylation machinery during serum-to-2i transition. Error bars indicate mean ± SD from three biological
replicates.
(C) Percentage of 5mC (top) and 5hmC (bottom) as measured by LC-MS in E14 during serum-to-2i conversion. Error bars indicate mean ± SD from three
biological replicates.
(legend continued on next page)
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CHAPTER 3
Locus-Specific Involvement of TET-Dependent
Demethylation
The increased levels of 5hmC during the serum-to-2i conversion
as well as publications showing further TET-dependent hypome-
thylation in vitamin C (vitC)-treated 2i ESCs (Blaschke et al.,
2013; Chung et al., 2010; Yin et al., 2013) raised the possibility
that TET proteins could contribute to the observed demethyla-
tion dynamics. We determined the 5mC and 5hmC levels of
ESCs at several time points during the serum-to-2i conversion
in the presence or absence of vitC (Figure 3A) and observed a
significant increase in 5hmC upon vitC treatment, which resulted
in an accelerated rate of demethylation and further global hypo-
methylation. To confirm that this effect was TET dependent, we
measured the levels of 5mC and 5hmC in Tet1/2 KO cells in the
presence or absence of vitC (Figure 3B), showing that the
increased rate of demethylation (and hydroxymethylation) is
dependent on the activity of TET proteins. Using the values of
p1 and p2 from E14 ESCs (Figure 1F), we estimated an 4-fold
increase of active demethylation (p3) in the presence of vitC.
Mathematical modeling of the dynamics of 5hmC accurately pre-
dicts the observed 5hmC levels during the serum-to-2i conver-
sion in the presence of vitC (Figure S3A).
Having established that exclusively in the presence of vitC TET
proteins contribute to global loss of 5mC in the serum-to-2i con-
version, we asked whether TET-dependent hydroxymethylation
is essential for locus specific demethylation. We performed
TAB-seq in parallel to WGBS on the same DNA during the early
phase of the time course in the presence or absence of vitC (Fig-
ure S3B) as well as RRBS from Tet1/2/3 KO cells and corre-
sponding wild-type control ESCs during different time points of
the serum-to-2i conversion (Figure S3C). These datasets
confirmed that TET-dependent hydroxymethylation does not
significantly contribute to global demethylation, unless their ac-
tivity was enhanced by vitC (3-fold increase in 5hmC in the first
32 hr). We analyzed the distribution of 5mC and 5hmC over func-
tionally distinct genomic regions with 5hmC enrichment in serum
(Figure 3C) and stratified promoters into high-, intermediate-,
and low-CpG-density promoters (HCP, ICP, and LCP, respec-
tively) (Weber et al., 2007). The majority of HCPs (n = 3,121)
are very low methylated in serum, and only a small subgroup
are intermediate (n = 143) or intermediate-low (n = 563) methyl-
ated, containing some germ cell-specific genes (e.g., Dazl,
Prdm14, and Dppa3) (Figure S3D). In the absence of vitC, we
observe only minor if any change in 5mC/5hmC levels over any
of the three classes of promoters. In the presence of vitC, how-
ever, conversion of 5mC to 5hmC is already apparent as early as
4 hr, and the speed of 5mC loss correlates with CpG density and
is different for each class. The kinetics of 5mC to 5hmC conver-
sion and subsequent loss of 5hmC (73% loss) is fastest at
HCPs, while ICPs show less dramatic changes (32% loss), with
substantial loss of 5hmC being apparent only later. At LCPs,
5hmC slowly accumulates over the time period investigated. En-
hancers, defined as elements overlapping H3K4me1, H3K27ac,
and DNaseI hypersensitivity and excluding transcription start
sites (TSS) (±2 kb) in E14 serum ESCs, show 10%–40% 5mC
levels in serum ESCs, in line with previous studies showing
that enhancers have low abundance of 5mC (Stadler et al.,
2011) and follow kinetics similar to ICPs. The largest part of the
genome behaves similar to LCPs; conversion to 5hmC and sub-
sequent erasure is very slow (Figure 3C).
Finally, we analyzed themethylome in Tet1/2/3KO cells. Using
k-means clustering on average DNA methylation over 500-bp
tiles across the genome, we found a cluster of tiles (n = 3,770)
that maintains methylation in Tet1/2/3 KO cells, but not in the
corresponding wild-type control cells (Figure 3D). These regions
have higher 5mC levels in the Tet1/2/3 KO cells, but we could not
identify any significant functional enrichment associated with
them (Table S2).
UHRF1 Is Downregulated at the Protein Level during the
Serum-to-2i Transition
The mathematical model had predicted that maintenance
methylation is significantly impaired and a major driver of
the DNA demethylation observed (Figure 1F). Subsequently,
we confirmed the rapid demethylation upon deletion of Dnmt1
orUhrf1 (Figure 2B) and also showed that loss of de novomethyl-
ation does not explain the demethylation dynamics observed
(Figures 2C and 2D). In order to understand the mechanistic
regulation of this impairment, we focused on the individual com-
ponents of the maintenance methylation machinery, in particular
on the role of Uhrf1.
In primordial germ cells, maintenance methylation was re-
ported to be impaired in part by nuclear exclusion of UHRF1 (Sei-
senberger et al., 2012). We analyzed the subcellular localization
of UHRF1 and DNMT1 in ESCs grown in serum and 2i (Figure 4A)
and did not detect any nuclear exclusion of either UHRF1 or
DNMT1 in ESCs. However, we observed a reduction in the signal
intensity of UHRF1 protein in the 2i samples. Our initial transcrip-
tomic analysis of the cells undergoing serum-to-2i transition (Fig-
ure 1B) did show that the expression of Dnmt3a and Dnmt3b,
together with the catalytically inactive regulatory isoformDnmt3l,
was substantially reduced in 2i, while Uhrf1 mRNA levels were
unchanged. In contrast, UHRF1 protein levels were significantly
reduced (3-fold by western blot; 2-fold by quantitative mass
spectrometry) in 2i ESCs (Figures 4B–4D), as were the levels of
the de novo DNMTs (Figure S4A). We found heterogeneous
expression of UHRF1 in serum and 2i ESCs (Figure 4C), which
did not correlate with the expression of the pluripotency marker
NANOG (Figure S4B) but can be attributed to the cell-cycle-
dependent regulation of UHRF1 (Bonapace et al., 2002). To
further confirm the observation that UHRF1 is regulated at
the protein level, we generated an ESC line with constitutive
overexpression of an UHRF1-GFP fusion protein. Similar to our
observations on endogenous UHRF1, fluorescence-activated
cell sorting (FACS) analysis of the UHRF1-GFP cell line showed
that UHRF1-GFP was expressed in serum ESCs but was rapidly
lost upon serum-to-2i conversion (Figures 4E and S4C), while
mRNA levels of endogenous Uhrf1 and exogenous Uhrf1-Gfp
remained stable (Figure S4D). Interestingly, we also observed
a rapid increase of UHRF1-GFP protein levels upon transfer
back to serum growth conditions (Figure S4E), suggesting that
the changed signaling environment in 2i specifically affects
UHRF1 protein stability.
To confirm whether the regulation of UHRF1 at the protein
level was also relevant in human ESCs, we assessed mRNA
and protein levels in conventional and naive (Takashima et al.,
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from serum to 2i ESCs, we examined the dynamics of this loss of
methylation in mouse embryonic stem cells in which one or more
of the components of the DNA methylation machinery had been
deleted. To this end, we determined the DNA methylation state
at several time points in serum and during the transition from
serum to 2i ESCs (Figure 2A) with inducible deletion of Dnmt1
(Dnmt1fl/fl); Uhrf1 (Uhrf1fl/fl); Dnmt3a/b (Dnmt3afl/fl 3 Dnmt3bfl/fl)
or constitutive deletion of Aicda (Aicda/); Tdg (Tdg/);
Tet1/2 (Tet1/ 3 Tet2/); Tet1/2/3 (Tet1/ 3 Tet2/ 3
Tet3/) and in corresponding wild-type control ESCs and
compared these to the predictions of our model.
All mutant ESCs tested displayed global loss of 5mC upon
serum-to-2i conversion. We specifically compared the rate of
demethylation in ESCs lacking eitherDnmt1 orUhrf1with control
ESCs and observed an increased rate of demethylation (Fig-
ure 2B), showing that loss of DNA methylation maintenance re-
sults in increased demethylation rates. This supports the predic-
tion from the mathematical model (dotted lines in the colored
boxes) and implicates a failure of DNA methylation maintenance
in 2i ESCs, albeit not a complete loss. Next, we compared the
demethylation kinetics in ESCs lacking Dnmt3a and Dnmt3b.
Interestingly, deletion of Dnmt3a/b in serum grown ESCs results
in only a marginal decrease in the genomic level of 5mC (Fig-
ure 2C), and the kinetics of DNA demethylation are unaltered in
the serum-to-2i conversion (Figure 2D), showing that loss of de
novo methylation is not responsible for global loss of DNA
methylation. Finally, we assessed the contribution of enzymes
involved in active demethylation pathways in the serum-to-2i
conversion. As predicted by the model, ESCs lacking Tet1/2/3,
Tdg, or Aicda showed strikingly similar demethylation dynamics
to their wild-type control counterparts (Figures 2E, S2A,
and S2B). Since TET-driven oxidation has been previously
suggested as a potential driver of demethylation in the serum-
to-2i conversion, we confirmed the loss of 5hmC in Tet1/2/3
knockout (KO) cells (Figure 2F). This shows that the TET
enzymes are actively oxidizing 5mC during the serum-to-2i con-
version but are neither sufficient nor necessary for global DNA
demethylation.
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Figure 2. Global Demethylation Kinetics in
Mutants of the DNA Methylation Machinery
(A) Schematic representation of the experimental
setup. Mutants for candidate genes related to
global demethylation in the serum-to-2i conversion
were initially grown in serum medium. At day 0,
culture medium was switched to 2i. Cells were
harvested after indicated times. DNAwas extracted
and analyzed for 5mC and 5hmC levels by LC-MS
and/or RRBS.
(B) Levels of 5mC in Uhrf1 and Dnmt1 KO ESCs
during the serum-to-2i transition, measured by
mass spectrometry. The colored box shows the
overlay between the mathematical model predic-
tion (dotted line) with p2 = 0% and the normalized
measured 5mCdata. Error bars indicatemean ± SD
from three biological replicates.
(C) Levels of 5mC in inducible Dnmt3a/b KO after
induction of deletion in serum media measured by
mass spectrometry. The colored box shows the
overlay between the mathematical model predic-
tion (dotted line) with p1 = 0% and the normalized
measured 5mC data. p2 z 90% since the cells
were maintained in serum. Error bars indicate
mean ± SD from three biological replicates.
(D) Levels of 5mC in inducible Dnmt3a/b KO during
the serum-to-2i transition. The colored box shows
the overlay between the mathematical model pre-
diction (dotted line) with p1 = 0% and the normal-
ized measured 5mC data. Error bars indicate
mean ± SD from three biological replicates.
(E) Levels of 5mC in Tet1/2/3 KO and controls
during the serum-to-2i transition measured by
mass spectrometry. The colored box shows the
overlay between the mathematical model predic-
tion (dotted line) with p3 = 0% and the normalized
measured 5mCdata. Error bars indicatemean ± SD
from three biological replicates.
(F) Levels of 5hmC in Tet1/2/3 KO and controls
during the serum-to-2i transition measured by
mass spectrometry. Error bars indicate mean ± SD
from three biological replicates.
See also Figure S2.
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Locus-Specific Involvement of TET-Dependent
Demethylation
The increased levels of 5hmC during the serum-to-2i conversion
as well as publications showing further TET-dependent hypome-
thylation in vitamin C (vitC)-treated 2i ESCs (Blaschke et al.,
2013; Chung et al., 2010; Yin et al., 2013) raised the possibility
that TET proteins could contribute to the observed demethyla-
tion dynamics. We determined the 5mC and 5hmC levels of
ESCs at several time points during the serum-to-2i conversion
in the presence or absence of vitC (Figure 3A) and observed a
significant increase in 5hmC upon vitC treatment, which resulted
in an accelerated rate of demethylation and further global hypo-
methylation. To confirm that this effect was TET dependent, we
measured the levels of 5mC and 5hmC in Tet1/2 KO cells in the
presence or absence of vitC (Figure 3B), showing that the
increased rate of demethylation (and hydroxymethylation) is
dependent on the activity of TET proteins. Using the values of
p1 and p2 from E14 ESCs (Figure 1F), we estimated an 4-fold
increase of active demethylation (p3) in the presence of vitC.
Mathematical modeling of the dynamics of 5hmC accurately pre-
dicts the observed 5hmC levels during the serum-to-2i conver-
sion in the presence of vitC (Figure S3A).
Having established that exclusively in the presence of vitC TET
proteins contribute to global loss of 5mC in the serum-to-2i con-
version, we asked whether TET-dependent hydroxymethylation
is essential for locus specific demethylation. We performed
TAB-seq in parallel to WGBS on the same DNA during the early
phase of the time course in the presence or absence of vitC (Fig-
ure S3B) as well as RRBS from Tet1/2/3 KO cells and corre-
sponding wild-type control ESCs during different time points of
the serum-to-2i conversion (Figure S3C). These datasets
confirmed that TET-dependent hydroxymethylation does not
significantly contribute to global demethylation, unless their ac-
tivity was enhanced by vitC (3-fold increase in 5hmC in the first
32 hr). We analyzed the distribution of 5mC and 5hmC over func-
tionally distinct genomic regions with 5hmC enrichment in serum
(Figure 3C) and stratified promoters into high-, intermediate-,
and low-CpG-density promoters (HCP, ICP, and LCP, respec-
tively) (Weber et al., 2007). The majority of HCPs (n = 3,121)
are very low methylated in serum, and only a small subgroup
are intermediate (n = 143) or intermediate-low (n = 563) methyl-
ated, containing some germ cell-specific genes (e.g., Dazl,
Prdm14, and Dppa3) (Figure S3D). In the absence of vitC, we
observe only minor if any change in 5mC/5hmC levels over any
of the three classes of promoters. In the presence of vitC, how-
ever, conversion of 5mC to 5hmC is already apparent as early as
4 hr, and the speed of 5mC loss correlates with CpG density and
is different for each class. The kinetics of 5mC to 5hmC conver-
sion and subsequent loss of 5hmC (73% loss) is fastest at
HCPs, while ICPs show less dramatic changes (32% loss), with
substantial loss of 5hmC being apparent only later. At LCPs,
5hmC slowly accumulates over the time period investigated. En-
hancers, defined as elements overlapping H3K4me1, H3K27ac,
and DNaseI hypersensitivity and excluding transcription start
sites (TSS) (±2 kb) in E14 serum ESCs, show 10%–40% 5mC
levels in serum ESCs, in line with previous studies showing
that enhancers have low abundance of 5mC (Stadler et al.,
2011) and follow kinetics similar to ICPs. The largest part of the
genome behaves similar to LCPs; conversion to 5hmC and sub-
sequent erasure is very slow (Figure 3C).
Finally, we analyzed themethylome in Tet1/2/3KO cells. Using
k-means clustering on average DNA methylation over 500-bp
tiles across the genome, we found a cluster of tiles (n = 3,770)
that maintains methylation in Tet1/2/3 KO cells, but not in the
corresponding wild-type control cells (Figure 3D). These regions
have higher 5mC levels in the Tet1/2/3 KO cells, but we could not
identify any significant functional enrichment associated with
them (Table S2).
UHRF1 Is Downregulated at the Protein Level during the
Serum-to-2i Transition
The mathematical model had predicted that maintenance
methylation is significantly impaired and a major driver of
the DNA demethylation observed (Figure 1F). Subsequently,
we confirmed the rapid demethylation upon deletion of Dnmt1
orUhrf1 (Figure 2B) and also showed that loss of de novomethyl-
ation does not explain the demethylation dynamics observed
(Figures 2C and 2D). In order to understand the mechanistic
regulation of this impairment, we focused on the individual com-
ponents of the maintenance methylation machinery, in particular
on the role of Uhrf1.
In primordial germ cells, maintenance methylation was re-
ported to be impaired in part by nuclear exclusion of UHRF1 (Sei-
senberger et al., 2012). We analyzed the subcellular localization
of UHRF1 and DNMT1 in ESCs grown in serum and 2i (Figure 4A)
and did not detect any nuclear exclusion of either UHRF1 or
DNMT1 in ESCs. However, we observed a reduction in the signal
intensity of UHRF1 protein in the 2i samples. Our initial transcrip-
tomic analysis of the cells undergoing serum-to-2i transition (Fig-
ure 1B) did show that the expression of Dnmt3a and Dnmt3b,
together with the catalytically inactive regulatory isoformDnmt3l,
was substantially reduced in 2i, while Uhrf1 mRNA levels were
unchanged. In contrast, UHRF1 protein levels were significantly
reduced (3-fold by western blot; 2-fold by quantitative mass
spectrometry) in 2i ESCs (Figures 4B–4D), as were the levels of
the de novo DNMTs (Figure S4A). We found heterogeneous
expression of UHRF1 in serum and 2i ESCs (Figure 4C), which
did not correlate with the expression of the pluripotency marker
NANOG (Figure S4B) but can be attributed to the cell-cycle-
dependent regulation of UHRF1 (Bonapace et al., 2002). To
further confirm the observation that UHRF1 is regulated at
the protein level, we generated an ESC line with constitutive
overexpression of an UHRF1-GFP fusion protein. Similar to our
observations on endogenous UHRF1, fluorescence-activated
cell sorting (FACS) analysis of the UHRF1-GFP cell line showed
that UHRF1-GFP was expressed in serum ESCs but was rapidly
lost upon serum-to-2i conversion (Figures 4E and S4C), while
mRNA levels of endogenous Uhrf1 and exogenous Uhrf1-Gfp
remained stable (Figure S4D). Interestingly, we also observed
a rapid increase of UHRF1-GFP protein levels upon transfer
back to serum growth conditions (Figure S4E), suggesting that
the changed signaling environment in 2i specifically affects
UHRF1 protein stability.
To confirm whether the regulation of UHRF1 at the protein
level was also relevant in human ESCs, we assessed mRNA
and protein levels in conventional and naive (Takashima et al.,
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from serum to 2i ESCs, we examined the dynamics of this loss of
methylation in mouse embryonic stem cells in which one or more
of the components of the DNA methylation machinery had been
deleted. To this end, we determined the DNA methylation state
at several time points in serum and during the transition from
serum to 2i ESCs (Figure 2A) with inducible deletion of Dnmt1
(Dnmt1fl/fl); Uhrf1 (Uhrf1fl/fl); Dnmt3a/b (Dnmt3afl/fl 3 Dnmt3bfl/fl)
or constitutive deletion of Aicda (Aicda/); Tdg (Tdg/);
Tet1/2 (Tet1/ 3 Tet2/); Tet1/2/3 (Tet1/ 3 Tet2/ 3
Tet3/) and in corresponding wild-type control ESCs and
compared these to the predictions of our model.
All mutant ESCs tested displayed global loss of 5mC upon
serum-to-2i conversion. We specifically compared the rate of
demethylation in ESCs lacking eitherDnmt1 orUhrf1with control
ESCs and observed an increased rate of demethylation (Fig-
ure 2B), showing that loss of DNA methylation maintenance re-
sults in increased demethylation rates. This supports the predic-
tion from the mathematical model (dotted lines in the colored
boxes) and implicates a failure of DNA methylation maintenance
in 2i ESCs, albeit not a complete loss. Next, we compared the
demethylation kinetics in ESCs lacking Dnmt3a and Dnmt3b.
Interestingly, deletion of Dnmt3a/b in serum grown ESCs results
in only a marginal decrease in the genomic level of 5mC (Fig-
ure 2C), and the kinetics of DNA demethylation are unaltered in
the serum-to-2i conversion (Figure 2D), showing that loss of de
novo methylation is not responsible for global loss of DNA
methylation. Finally, we assessed the contribution of enzymes
involved in active demethylation pathways in the serum-to-2i
conversion. As predicted by the model, ESCs lacking Tet1/2/3,
Tdg, or Aicda showed strikingly similar demethylation dynamics
to their wild-type control counterparts (Figures 2E, S2A,
and S2B). Since TET-driven oxidation has been previously
suggested as a potential driver of demethylation in the serum-
to-2i conversion, we confirmed the loss of 5hmC in Tet1/2/3
knockout (KO) cells (Figure 2F). This shows that the TET
enzymes are actively oxidizing 5mC during the serum-to-2i con-
version but are neither sufficient nor necessary for global DNA
demethylation.
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Figure 2. Global Demethylation Kinetics in
Mutants of the DNA Methylation Machinery
(A) Schematic representation of the experimental
setup. Mutants for candidate genes related to
global demethylation in the serum-to-2i conversion
were initially grown in serum medium. At day 0,
culture medium was switched to 2i. Cells were
harvested after indicated times. DNAwas extracted
and analyzed for 5mC and 5hmC levels by LC-MS
and/or RRBS.
(B) Levels of 5mC in Uhrf1 and Dnmt1 KO ESCs
during the serum-to-2i transition, measured by
mass spectrometry. The colored box shows the
overlay between the mathematical model predic-
tion (dotted line) with p2 = 0% and the normalized
measured 5mCdata. Error bars indicatemean ± SD
from three biological replicates.
(C) Levels of 5mC in inducible Dnmt3a/b KO after
induction of deletion in serum media measured by
mass spectrometry. The colored box shows the
overlay between the mathematical model predic-
tion (dotted line) with p1 = 0% and the normalized
measured 5mC data. p2 z 90% since the cells
were maintained in serum. Error bars indicate
mean ± SD from three biological replicates.
(D) Levels of 5mC in inducible Dnmt3a/b KO during
the serum-to-2i transition. The colored box shows
the overlay between the mathematical model pre-
diction (dotted line) with p1 = 0% and the normal-
ized measured 5mC data. Error bars indicate
mean ± SD from three biological replicates.
(E) Levels of 5mC in Tet1/2/3 KO and controls
during the serum-to-2i transition measured by
mass spectrometry. The colored box shows the
overlay between the mathematical model predic-
tion (dotted line) with p3 = 0% and the normalized
measured 5mCdata. Error bars indicatemean ± SD
from three biological replicates.
(F) Levels of 5hmC in Tet1/2/3 KO and controls
during the serum-to-2i transition measured by
mass spectrometry. Error bars indicate mean ± SD
from three biological replicates.
See also Figure S2.
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CHAPTER 3
2014) human ESCs by immunofluorescence (IF). Similar to our
observations in mouse ESCs, UHRF1 and DNMT1 mRNA levels
are not changed between the two states (Figure S4F), but UHRF1
protein levels were significantly reduced (�2-fold reduced) in the
naive cells (Figure S4G), pointing to a conserved regulation of
UHRF1 in naive ESCs.
UHRF1 Recruitment to Replication Foci Is Impaired in 2i
ESCs
The rapid, though not complete, loss of UHRF1 protein in 2i con-
ditions prompted us to ask whether recruitment of the DNA
(B) Percentage of 5mC (top) and 5hmC (bottom) as measured by LC-MS in Tet1/2 KO during serum-to-2i transition in the absence (gray line) or presence of vitC
(green line). Error bars indicate mean ± SD from three biological replicates.
(C) Distribution of 5mC (top) and 5hmC levels (bottom) during the first 32 hr of reprogramming from serum (gray) to 2i (green) or 2i+vitC (orange) measured by
WGBS and TAB-seq over high-CpG promoters (HCP), intermediate-CpG promoters (ICP), low-CpG promoters (LCP) and enhancers. For each class of genomic
element, only the subset having 5hmC enrichment in serum (T = 0 hr) was considered. The horizontal line within the box plots represents the median.
(D) Average methylation levels over 500-bp tiles in Tet1/2/3 KO cells and corresponding control cells (Tet WT). Tet-dependent regions were identified using
k-means clustering.
See also Figure S3 and Table S2.
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Figure 4. UHRF1 Is Regulated at the Protein
Level in 2i
(A) Cellular localization of UHRF1 (green) and
DNMT1 (red) in mouse PGCs (E11.5), serum ESCs,
24-hr 2i ESCs, and long-term (LT) 2i ESCs. DAPI
(blue) labels the nucleus. The RGB profiles show
the signal intensity for each pixel along the hori-
zontal yellow line.
(B) Western blot analysis for UHRF1 protein in
serum and LT 2i ESCs. Relative quantifications of
the signal intensities of the bands on the western
blot are shown in the bar chart.
(C) Immunofluorescence staining for UHRF1
(green), DNMT1 (red) and DAPI (blue) in serum and
LT 2i ESCs. Scale bar represents 20 mm.
(D) Protein levels of UHRF1 detected by protein
mass spectrometry (label-free quantification [LFQ])
at different time points during serum-to-2i conver-
sion, relative to serum ESCs. Error bars indicate
mean ± SD from two biological replicates.
(E) FACS analysis of UHRF1-GFP fusion protein in
ESCs during serum-to-2i conversion. Histograms
show the GFP signal intensity at different time
points during the conversion. The black arrow de-
picts the threshold used to quantify the percentage
of GFP+ cells, shown in the line graph. Error
bars indicate mean ± SD from three biological
replicates.
(F) Percentage of replication foci with co-localiza-
tion of UHRF1 in serum, 24-hr 2i and LT 2i ESCs.
Images from serum ESCs showing examples for
the two quantified states; arrows indicate EdU+
replication foci.
See also Figure S4.
maintenance methylation machinery to
the replication forks was impaired. Previ-
ous IF experiments in cells lacking Uhrf1
proved that the presence of UHRF1 is
absolutely required for recruitment of
DNMT1 to replication foci (Sharif et al., 2007). We labeled repli-
cation foci by incubating serum or 2i ESCs for 8 min prior to fix-
ation with 5-ethynyl-20-deoxyuridine (EdU), which is incorpo-
rated into newly synthesized DNA. Co-staining for UHRF1 and
EdU allowed us to count the number of cells with EdU-positive
foci for co-localization of UHRF1 with replication foci. While
UHRF1 co-localizes with EdU-positive replication foci in the ma-
jority of cells in serum conditions, this number is significantly
reduced under 2i conditions (Figure 4F). The recruitment
of UHRF1 to EdU-positive replication foci is further reduced
with time in 2i. These results suggest that DNA demethylation
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Figure 3. TET-Dependent Demethylation Dynamics during Reprogramming of Serum-to-2i ESCs
(A) Percentage of 5mC (top) and 5hmC (bottom) asmeasured by LC-MS in E14 during serum-to-2i transition in the absence (blue line) or presence of vitC (red line).
Error bars indicate mean ± SD from three biological replicates.
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3
2014) human ESCs by immunofluorescence (IF). Similar to our
observations in mouse ESCs, UHRF1 and DNMT1 mRNA levels
are not changed between the two states (Figure S4F), but UHRF1
protein levels were significantly reduced (�2-fold reduced) in the
naive cells (Figure S4G), pointing to a conserved regulation of
UHRF1 in naive ESCs.
UHRF1 Recruitment to Replication Foci Is Impaired in 2i
ESCs
The rapid, though not complete, loss of UHRF1 protein in 2i con-
ditions prompted us to ask whether recruitment of the DNA
(B) Percentage of 5mC (top) and 5hmC (bottom) as measured by LC-MS in Tet1/2 KO during serum-to-2i transition in the absence (gray line) or presence of vitC
(green line). Error bars indicate mean ± SD from three biological replicates.
(C) Distribution of 5mC (top) and 5hmC levels (bottom) during the first 32 hr of reprogramming from serum (gray) to 2i (green) or 2i+vitC (orange) measured by
WGBS and TAB-seq over high-CpG promoters (HCP), intermediate-CpG promoters (ICP), low-CpG promoters (LCP) and enhancers. For each class of genomic
element, only the subset having 5hmC enrichment in serum (T = 0 hr) was considered. The horizontal line within the box plots represents the median.
(D) Average methylation levels over 500-bp tiles in Tet1/2/3 KO cells and corresponding control cells (Tet WT). Tet-dependent regions were identified using
k-means clustering.
See also Figure S3 and Table S2.
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Figure 4. UHRF1 Is Regulated at the Protein
Level in 2i
(A) Cellular localization of UHRF1 (green) and
DNMT1 (red) in mouse PGCs (E11.5), serum ESCs,
24-hr 2i ESCs, and long-term (LT) 2i ESCs. DAPI
(blue) labels the nucleus. The RGB profiles show
the signal intensity for each pixel along the hori-
zontal yellow line.
(B) Western blot analysis for UHRF1 protein in
serum and LT 2i ESCs. Relative quantifications of
the signal intensities of the bands on the western
blot are shown in the bar chart.
(C) Immunofluorescence staining for UHRF1
(green), DNMT1 (red) and DAPI (blue) in serum and
LT 2i ESCs. Scale bar represents 20 mm.
(D) Protein levels of UHRF1 detected by protein
mass spectrometry (label-free quantification [LFQ])
at different time points during serum-to-2i conver-
sion, relative to serum ESCs. Error bars indicate
mean ± SD from two biological replicates.
(E) FACS analysis of UHRF1-GFP fusion protein in
ESCs during serum-to-2i conversion. Histograms
show the GFP signal intensity at different time
points during the conversion. The black arrow de-
picts the threshold used to quantify the percentage
of GFP+ cells, shown in the line graph. Error
bars indicate mean ± SD from three biological
replicates.
(F) Percentage of replication foci with co-localiza-
tion of UHRF1 in serum, 24-hr 2i and LT 2i ESCs.
Images from serum ESCs showing examples for
the two quantified states; arrows indicate EdU+
replication foci.
See also Figure S4.
maintenance methylation machinery to
the replication forks was impaired. Previ-
ous IF experiments in cells lacking Uhrf1
proved that the presence of UHRF1 is
absolutely required for recruitment of
DNMT1 to replication foci (Sharif et al., 2007). We labeled repli-
cation foci by incubating serum or 2i ESCs for 8 min prior to fix-
ation with 5-ethynyl-20-deoxyuridine (EdU), which is incorpo-
rated into newly synthesized DNA. Co-staining for UHRF1 and
EdU allowed us to count the number of cells with EdU-positive
foci for co-localization of UHRF1 with replication foci. While
UHRF1 co-localizes with EdU-positive replication foci in the ma-
jority of cells in serum conditions, this number is significantly
reduced under 2i conditions (Figure 4F). The recruitment
of UHRF1 to EdU-positive replication foci is further reduced
with time in 2i. These results suggest that DNA demethylation
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Figure 3. TET-Dependent Demethylation Dynamics during Reprogramming of Serum-to-2i ESCs
(A) Percentage of 5mC (top) and 5hmC (bottom) asmeasured by LC-MS in E14 during serum-to-2i transition in the absence (blue line) or presence of vitC (red line).
Error bars indicate mean ± SD from three biological replicates.
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Figure 5. H3K9me2 Is Rapidly Reduced in 2i ESCs
(A) Western blot analysis for H3K9me2 in serum and 2i ESCs.
(B) Immunofluorescence staining for H3K9me2 (green), 5mC (red) and DAPI (blue) in serum and LT 2i ESCs. Scale bar represents 20 mm.
(C) Correlation of the quantified signals of H3K9me2 and 5mC in immunofluorescence staining of serum, 24-hr 2i, and LT 2i ESCs. The dashed line represents the
linear regression between H3K9me2 and 5mC signals in serum ESCs.
(D) 5mC levels in H3K9me2-bound DNA and corresponding input samples from serum and LT 2i ESCs, measured by H3K9me2-ChIP-BS-seq.
(E) 5mC levels in regions with high or low H3K9me enrichment in serum and LT 2i ESCs.
(F) Levels of 5mC, determined by RRBS at H3K9me2 enriched regions during the serum-2i transition in E14, Uhrf1 WT, and Uhrf1 KO ESCs.
(G) Relative protein levels of known H3K9modifiers detected by protein mass spectrometry (label-free quantification [LFQ]) at different time points during serum-
to-2i conversion. Levels are normalized to serum ESCs.
Student’s t test was performed for the indicated comparisons (***p < 0.001).
See also Figure S5.
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in the serum-to-2i conversion is a consequence of impaired
DNA methylation maintenance through impaired recruitment of
DNMT1 by UHRF1 to the replication fork.
H3K9me2 Is Reduced in 2i ESCs
The drastic impairment of recruitment of UHRF1 to replication
sites was surprising, as the levels of UHRF1 were reduced albeit
still detectable in 2i conditions. The recruitment of UHRF1 de-
pends on the recognition of both hemimethylated CpGs via
its SRA domain and of methylated lysine 9 on histone 3 (H3K9)
through its Tudor domain (Citterio et al., 2004; Karagianni
et al., 2008; Rothbart et al., 2012). Loss of H3K9 methyltransfer-
ase G9a results in loss of global DNA methylation (Zhang et al.,
2016), and similarly, it has been concluded that loss of H3K9
methylation, in particular H3K9me2, is an additional key step
leading to genome-wide demethylation in PGCs (Kurimoto
et al., 2015). H3K9me3 localization is relatively unchanged
between serum and 2i ESCs and mainly enriched at repetitive
elements (Marks et al., 2012), but the importance of loss of
H3K9me2 is not clear (Walter et al., 2016). We found a significant
reduction in the levels of H3K9me2 upon serum-to-2i conversion
(2-fold reduction) (Figures 5A, 5B, and S5A). Interestingly, loss
of H3K9me2was rapid, andwe detected aweak correlation by IF
between the global levels of H3K9me2 and DNA methylation in
serum ESCs (Figure 5C), in line with the notion that H3K9me2-
dependent recruitment of UHRF1 plays a key role in DNAmethyl-
ation maintenance in ESCs, possibly explaining the drastic
impairment of recruitment of UHRF1 to the replication foci.
To understand any locus-specific effects of the loss of
H3K9me2, we performed H3K9me2 chromatin immunoprecipi-
tation sequencing (ChIP-seq) analysis. While the overall pattern
of H3K9me2 enrichment did not change during the serum-to-2i
conversion, regions with low H3K9me2 enrichment further flat-
tened out (Figure S5B). To correlate the presence of H3K9me2
with the levels of 5mC, we performed H3K9me2 chromatin
immunoprecipitation followed by bisulfite sequencing (ChIP-
BS-seq) (Brinkman et al., 2012). The 5mC levels in serum
ESCs as well as 2i ESCs were significantly increased in the
H3K9me2-bound DNA when compared to corresponding input
samples (Figure 5D). We then divided the genome into regions
with high or low H3K9me2 enrichment and found a significant in-
crease in the 5mC levels at H3K9me2-high regions (Figure 5E).
Next, we generated RRBS libraries of Uhrf1/ and corre-
sponding wild-type control ESCs during the serum-to-2i conver-
sion (Figure S5C) to identify regions that are only maintained in
the presence of UHRF1. Computational analyses of these and
E14, Tet1/2/3KO, andwild-type control lines identified a number
of genomic regions resistant to DNA demethylation in wild-type
cells, but not upon deletion of Uhrf1 (Figure S5D; blue cluster),
indicating strong locus specific recruitment. These regions are
enriched for H3K9me2 in 2i ESCs and for H3K9me3 in 2i and
serum ESCs (Figures S5E and 5F). We next measured 5mC
levels over H3K9me2- (Figure 5F) and H3K9me3-enriched
(Figure S5G) regions (Marks et al., 2012) and found that these
regions retain high levels of DNA methylation in 2i ESCs in an
UHRF1-dependent manner.
Finally, we asked how H3K9me2 levels were regulated during
the serum-to-2i conversion. We quantified mRNA levels of key
H3K9 methylases and demethylases by RNA-seq (Figure S5H)
and protein levels by mass spectrometry (Figure 5G). Interest-
ingly, we found that several H3K9 demethylases, including
KDM3A, KDM3B, and KDM4A, were upregulated specifically
at the protein level in 2i conditions. Conversely, a number of
H3K9 methylases, such as EHMT1 (GLP) and EHMT2 (G9A),
were downregulated.
DISCUSSION
Genome-wide DNA methylation erasure is a distinguishing
epigenetic feature of preimplantation embryos (Guo et al.,
2014; Smith et al., 2014; Wang et al., 2014), developing PGCs
(Gkountela et al., 2015; Guo et al., 2015; Hackett et al., 2013b;
Seisenberger et al., 2012; Tang et al., 2015), and naive ESCs
(Ficz et al., 2013; Habibi et al., 2013; Leitch et al., 2013; Taka-
shima et al., 2014). Here, we have developed a mathematical
model that is able to accurately estimate 5mC levels and the
individual activity of the three main pathways relevant to DNA
methylation dynamics (p1, de novo; p2, maintenance; and p3,
active demethylation) and predicts with great accuracy corre-
sponding 5hmC kinetics in all instances of global epigenetic
reprogramming. Validation of the model in different mutant
ESC lines during serum-to-2i conversion demonstrates the po-
wer and the high prediction accuracy of the algorithm. Using
methylation levels (5mC) from previously published datasets
for migratory PGCs (E6.5–E11.5) (Seisenberger et al., 2012)
and preimplantation embryos (two-cell stage to E4) (Okamoto
et al., 2016; Wang et al., 2014), we have estimated the in vivo ac-
tivity of the DNA methylation pathways and the dynamics of
5hmC levels during these phases of global DNA demethylation
(Figures 6A and S6). All examples of global demethylation in
the mouse can hence be accurately modeled and the predicted
activities of the three pathways are mirrored by the levels and
regulation of the enzymes and factors involved (where this is
known). This leads to a unified view of genome-wide demethyla-
tion mechanisms.
In all instances of epigenetic reprogramming, global methyl-
ation is lost in a replication-dependent manner as a consequence
of impaired maintenance methylation (p2). The individual mainte-
nance activity dictates the rate of global demethylation, which is
fastest in PGCs, where the rate of demethylation is almost as
fast as that brought about by complete loss of maintenance
methylation (Dnmt1 KO ESCs). This result agrees with
the observations made in preimplantation embryos, where an
oocyte-specific cytoplasmic DNMT1 isoform is predominantly
expressed and the somatic DNMT1 isoform is only expressed at
low levels, but shows some activity, in particular at imprinted re-
gions (Cirio et al., 2008;Dean, 2008;Hirasawaet al., 2008). Similar
to 2i ESCs, themodel predicts a significant impairment of de novo
methylation in preimplantation embryos andmigratory PGCs (p1,
10- and 30-fold reduction in activity) when compared to the
steady-state levels found in serum ESCs. This is in agreement
with substantial downregulation of DNMT3A/B in PGCs (Hackett
et al., 2013b; Seisenberger et al., 2012; Wu and Zhang, 2014)
andnaiveESCs (Ficz et al., 2013;Habibi et al., 2013) andsuggests
that de novomethylation is not active prior to E4 in early embryos
and the expression of de novo DNMTs is only needed for
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Figure 5. H3K9me2 Is Rapidly Reduced in 2i ESCs
(A) Western blot analysis for H3K9me2 in serum and 2i ESCs.
(B) Immunofluorescence staining for H3K9me2 (green), 5mC (red) and DAPI (blue) in serum and LT 2i ESCs. Scale bar represents 20 mm.
(C) Correlation of the quantified signals of H3K9me2 and 5mC in immunofluorescence staining of serum, 24-hr 2i, and LT 2i ESCs. The dashed line represents the
linear regression between H3K9me2 and 5mC signals in serum ESCs.
(D) 5mC levels in H3K9me2-bound DNA and corresponding input samples from serum and LT 2i ESCs, measured by H3K9me2-ChIP-BS-seq.
(E) 5mC levels in regions with high or low H3K9me enrichment in serum and LT 2i ESCs.
(F) Levels of 5mC, determined by RRBS at H3K9me2 enriched regions during the serum-2i transition in E14, Uhrf1 WT, and Uhrf1 KO ESCs.
(G) Relative protein levels of known H3K9modifiers detected by protein mass spectrometry (label-free quantification [LFQ]) at different time points during serum-
to-2i conversion. Levels are normalized to serum ESCs.
Student’s t test was performed for the indicated comparisons (***p < 0.001).
See also Figure S5.
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in the serum-to-2i conversion is a consequence of impaired
DNA methylation maintenance through impaired recruitment of
DNMT1 by UHRF1 to the replication fork.
H3K9me2 Is Reduced in 2i ESCs
The drastic impairment of recruitment of UHRF1 to replication
sites was surprising, as the levels of UHRF1 were reduced albeit
still detectable in 2i conditions. The recruitment of UHRF1 de-
pends on the recognition of both hemimethylated CpGs via
its SRA domain and of methylated lysine 9 on histone 3 (H3K9)
through its Tudor domain (Citterio et al., 2004; Karagianni
et al., 2008; Rothbart et al., 2012). Loss of H3K9 methyltransfer-
ase G9a results in loss of global DNA methylation (Zhang et al.,
2016), and similarly, it has been concluded that loss of H3K9
methylation, in particular H3K9me2, is an additional key step
leading to genome-wide demethylation in PGCs (Kurimoto
et al., 2015). H3K9me3 localization is relatively unchanged
between serum and 2i ESCs and mainly enriched at repetitive
elements (Marks et al., 2012), but the importance of loss of
H3K9me2 is not clear (Walter et al., 2016). We found a significant
reduction in the levels of H3K9me2 upon serum-to-2i conversion
(2-fold reduction) (Figures 5A, 5B, and S5A). Interestingly, loss
of H3K9me2was rapid, andwe detected aweak correlation by IF
between the global levels of H3K9me2 and DNA methylation in
serum ESCs (Figure 5C), in line with the notion that H3K9me2-
dependent recruitment of UHRF1 plays a key role in DNAmethyl-
ation maintenance in ESCs, possibly explaining the drastic
impairment of recruitment of UHRF1 to the replication foci.
To understand any locus-specific effects of the loss of
H3K9me2, we performed H3K9me2 chromatin immunoprecipi-
tation sequencing (ChIP-seq) analysis. While the overall pattern
of H3K9me2 enrichment did not change during the serum-to-2i
conversion, regions with low H3K9me2 enrichment further flat-
tened out (Figure S5B). To correlate the presence of H3K9me2
with the levels of 5mC, we performed H3K9me2 chromatin
immunoprecipitation followed by bisulfite sequencing (ChIP-
BS-seq) (Brinkman et al., 2012). The 5mC levels in serum
ESCs as well as 2i ESCs were significantly increased in the
H3K9me2-bound DNA when compared to corresponding input
samples (Figure 5D). We then divided the genome into regions
with high or low H3K9me2 enrichment and found a significant in-
crease in the 5mC levels at H3K9me2-high regions (Figure 5E).
Next, we generated RRBS libraries of Uhrf1/ and corre-
sponding wild-type control ESCs during the serum-to-2i conver-
sion (Figure S5C) to identify regions that are only maintained in
the presence of UHRF1. Computational analyses of these and
E14, Tet1/2/3KO, andwild-type control lines identified a number
of genomic regions resistant to DNA demethylation in wild-type
cells, but not upon deletion of Uhrf1 (Figure S5D; blue cluster),
indicating strong locus specific recruitment. These regions are
enriched for H3K9me2 in 2i ESCs and for H3K9me3 in 2i and
serum ESCs (Figures S5E and 5F). We next measured 5mC
levels over H3K9me2- (Figure 5F) and H3K9me3-enriched
(Figure S5G) regions (Marks et al., 2012) and found that these
regions retain high levels of DNA methylation in 2i ESCs in an
UHRF1-dependent manner.
Finally, we asked how H3K9me2 levels were regulated during
the serum-to-2i conversion. We quantified mRNA levels of key
H3K9 methylases and demethylases by RNA-seq (Figure S5H)
and protein levels by mass spectrometry (Figure 5G). Interest-
ingly, we found that several H3K9 demethylases, including
KDM3A, KDM3B, and KDM4A, were upregulated specifically
at the protein level in 2i conditions. Conversely, a number of
H3K9 methylases, such as EHMT1 (GLP) and EHMT2 (G9A),
were downregulated.
DISCUSSION
Genome-wide DNA methylation erasure is a distinguishing
epigenetic feature of preimplantation embryos (Guo et al.,
2014; Smith et al., 2014; Wang et al., 2014), developing PGCs
(Gkountela et al., 2015; Guo et al., 2015; Hackett et al., 2013b;
Seisenberger et al., 2012; Tang et al., 2015), and naive ESCs
(Ficz et al., 2013; Habibi et al., 2013; Leitch et al., 2013; Taka-
shima et al., 2014). Here, we have developed a mathematical
model that is able to accurately estimate 5mC levels and the
individual activity of the three main pathways relevant to DNA
methylation dynamics (p1, de novo; p2, maintenance; and p3,
active demethylation) and predicts with great accuracy corre-
sponding 5hmC kinetics in all instances of global epigenetic
reprogramming. Validation of the model in different mutant
ESC lines during serum-to-2i conversion demonstrates the po-
wer and the high prediction accuracy of the algorithm. Using
methylation levels (5mC) from previously published datasets
for migratory PGCs (E6.5–E11.5) (Seisenberger et al., 2012)
and preimplantation embryos (two-cell stage to E4) (Okamoto
et al., 2016; Wang et al., 2014), we have estimated the in vivo ac-
tivity of the DNA methylation pathways and the dynamics of
5hmC levels during these phases of global DNA demethylation
(Figures 6A and S6). All examples of global demethylation in
the mouse can hence be accurately modeled and the predicted
activities of the three pathways are mirrored by the levels and
regulation of the enzymes and factors involved (where this is
known). This leads to a unified view of genome-wide demethyla-
tion mechanisms.
In all instances of epigenetic reprogramming, global methyl-
ation is lost in a replication-dependent manner as a consequence
of impaired maintenance methylation (p2). The individual mainte-
nance activity dictates the rate of global demethylation, which is
fastest in PGCs, where the rate of demethylation is almost as
fast as that brought about by complete loss of maintenance
methylation (Dnmt1 KO ESCs). This result agrees with
the observations made in preimplantation embryos, where an
oocyte-specific cytoplasmic DNMT1 isoform is predominantly
expressed and the somatic DNMT1 isoform is only expressed at
low levels, but shows some activity, in particular at imprinted re-
gions (Cirio et al., 2008;Dean, 2008;Hirasawaet al., 2008). Similar
to 2i ESCs, themodel predicts a significant impairment of de novo
methylation in preimplantation embryos andmigratory PGCs (p1,
10- and 30-fold reduction in activity) when compared to the
steady-state levels found in serum ESCs. This is in agreement
with substantial downregulation of DNMT3A/B in PGCs (Hackett
et al., 2013b; Seisenberger et al., 2012; Wu and Zhang, 2014)
andnaiveESCs (Ficz et al., 2013;Habibi et al., 2013) andsuggests
that de novomethylation is not active prior to E4 in early embryos
and the expression of de novo DNMTs is only needed for
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remethylation in the epiblast (Guenatri et al., 2013;Hirasawaet al.,
2008). Finally, the importance of active demethylation (p3) for
global loss of DNAmethylation is estimated to be very low in all in-
stances of epigenetic reprogramming. The 5hmC predictions of
themodel recapitulate 5hmCdynamics in ESCsand in preimplan-
tation embryos (with the exception of a reportedpeak at the eight-
cell stage) and also predict 5hmC dynamics in PGCs (Figures 6A
and S6). Noteworthy, the dynamics inmigratory PGCs can be ex-
plained by two solutions,which both accuratelymimic 5mC levels
but predict different 5hmC dynamics. One solution predicts that
both maintenance methylation and TET activity are strongly
reduced (‘‘impaired maintenance methylation’’) (Figure 6A), while
the second solution predicts thatmaintenancemethylation is only
2-fold reduced and TET activity is high (‘‘TET-dependent deme-
thylation’’) (Figure S6). In mouse PGCs, UHRF1 levels are signifi-
cantly decreased and high levels of hemi-methylated CpG dyads
were found (Seisenberger et al., 2012), both supporting a strong
impairment of maintenance methylation. In addition, loss of
H3K9me2 was reported in in vivo and in vitro PGCs (Kurimoto
et al., 2015; Seki et al., 2005) and knockdown of Tet1 and 2 did
not affect global DNA demethylation in vitro (Vincent et al.,
2013). Thus, we reason that the ‘‘impaired maintenance methyl-
ation’’ model (Figure 6A) faithfully recapitulates the in vivo
situation.
Mechanistically, we have dissected the different pathways
relevant to DNA methylation dynamics in primed (serum) and
naive (2i) ESCs (Wu and Zhang, 2014) and shown that global
demethylation is, contrary to previous assumptions, a conse-
quence of neither loss of de novo methylation nor active Tet-
dependent demethylation but caused by impaired maintenance
methylation. DNMT1 is recruited to the replication fork through
UHRF1, which itself interacts with both hemimethylated CpG
dyads and methylated H3K9 and loss of either interaction im-
pairs recruitment (Liu et al., 2013). In naive mouse and human
ESCs, protein levels of UHRF1 are reduced, limiting the recruit-
ment of DNMT1. In addition, loss of H3K9me2 further reduces
UHRF1 recruitment and in turn impairs DNA methylation mainte-
nance by DNMT1 (Figure 6B). UHRF1 is regulated at the protein
level in human and mouse ESCs, as well as in human and mouse
PGCs (Gkountela et al., 2015; Pastor et al., 2016; Seisenberger
et al., 2012; Tang et al., 2015). Interestingly, inmouse PGCs there
is also transcriptional silencing of Uhrf1 (Kurimoto et al., 2015;
Magnu´sdo´ttir et al., 2013; Nakaki et al., 2013; Seisenberger
et al., 2012), which may well underlie the considerably faster de-
methylation kinetics in mouse PGCs when compared to naive
ESCs. Hence, several pathways have apparently evolved that
modulate maintenance methylation by controlling UHRF1 activ-
ity at different levels. The additional level of transcriptional regu-
lation in mouse PGCs suggests that the short time frame of
epigenetic resetting in themouse germline necessitated an addi-
tional regulatory layer, ensuring almost complete impairment of
maintenance methylation and thus rapid demethylation (Fig-
ure 6A). This is in contrast to human PGCs, where demethylation
occurs with slower, potentially intra-individual-specific kinetics
(von Meyenn and Reik, 2015).
In addition to the reduction of UHRF1 protein levels, the
signaling changes imposed by 2i in ESCs (MAPK and GSK3
signaling inhibition) elicit a decrease in the levels of H3K9me2,
thereby synergistically driving genome-wide DNA demethyla-
tion, while allowingmethylationmaintenance of specific genomic
loci. This regulation of H3K9me2 is also evident in PGCs, with
apparent loss of H3K9me2 in mouse (Kurimoto et al., 2015;
Seki et al., 2005) and human PGCs (Tang et al., 2015). We found
that regions with high levels of H3K9me2 in naive ESCs are also
characterized by higher level of DNA methylation (Figure 5F) and
regions resistant to DNA demethylation in the presence of
UHRF1 show significant enrichment of H3K9me2 (Figure S5E).
We propose that in the face of global demethylation, locus-spe-
cific enrichment of H3K9me2/3 allows DNA methylation mainte-
nance at specific regions via recruitment of UHRF1. Similarly,
while TET enzymes were dispensable for global epigenetic re-
programming, TET-dependent demethylation was evident at a
limited number of specific loci. WGBS and TAB-seq experiments
revealed that active demethylation is restricted to a small propor-
tion of the genome, predominantly including active promoters
and enhancers.
Taken together, loss of DNA methylation in ESCs, PGCs, and
preimplantation embryos is the result of the concerted regulation
of two pathways, namely reduction of UHRF1 protein levels and
global loss of H3K9me2, thereby impairing recruitment of
DNMT1 to the replication fork. This elegant mechanism facili-
tates the maintenance of methylation at specific loci while the
genome is simultaneously demethylated on a global scale.
EXPERIMENTAL PROCEDURES
Cell Culture
Mouse ESCs were cultured in the presence of LIF in DMEM containing 15%
fetal calf serum. A tamoxifen-inducible Cre recombinase was used to induce
recombination of loxP sites in the floxed cell lines 48 hr prior to the experiment.
For serum-to-2i transition, serummedium was replaced by serum-free N2B27
supplemented with LIF, mitogen-activated protein kinase kinase (MEK) inhib-
itor PD0325901 (1 mM), and GSK3 inhibitor CHIR99021 (3 mM).
Mass Spectrometry of Nucleosides
Mass spectrometry of nucleosides was performed as previously described
(Ficz et al., 2013; Kroeze et al., 2014). Briefly, 150–1,000 ng genomic DNA
was digested using DNA Degradase Plus (Zymo Research) according to the
manufacturer’s instructions and analyzed by liquid chromatography-tandem
mass spectrometry.
Next-Generation Sequencing
WGBS, RRBS, and TAB-seq were performed as described previously (Lister
et al., 2008; Smallwood et al., 2011; Yu et al., 2012). Whole-genome hairpin
in migratory PGCs can be can be explained by two solutions of the mathematical model. The first solution is shown here and the second solution is shown in
Figure S6.
(B) Cartoon representation of the proposed model. In serum cells, UHRF1 is recruited to replication foci by binding to hemi-methylated DNA and H3K9me2
chromatin marks. Switching to 2i conditions results in passive loss of 5mC driven by a multilayer of regulation: downregulation of UHRF1 at the protein level, and
loss of H3K9me2, which results in impaired recruitment to replication foci.
See also Figure S6.
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Figure 6. Dual Regulation of DNA Demethylation during Serum-2i Transition
(A) Mathematical modeling of serum-2i transition, preimplantation development, and migratory PGC demethylation. The model estimates the activity of the main
pathways related to DNA methylation dynamics, i.e., de novo methylation (p1), maintenance methylation (p2), and active demethylation (p3). The first column
shows measured (solid lines) and estimated (dotted lines) global levels 5mC (values have been scaled) during serum-2i transition, preimplantation development,
andmigratory PGC demethylation. The second column summarizes the estimated activities of the three pathways in each condition. The steady-state activities in
serumESCs are included as a comparison. The third column shows the predicted (dotted lines) global 5hmC values (scaled) and, if available, alsomeasured (solid
lines) 5hmC levels. *Themathematical modeling did not predict a peak of global 5hmC levels in eight-cell embryos (Okamoto et al., 2016). **Global 5mC dynamics
(legend continued on next page)
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remethylation in the epiblast (Guenatri et al., 2013;Hirasawaet al.,
2008). Finally, the importance of active demethylation (p3) for
global loss of DNAmethylation is estimated to be very low in all in-
stances of epigenetic reprogramming. The 5hmC predictions of
themodel recapitulate 5hmCdynamics in ESCsand in preimplan-
tation embryos (with the exception of a reportedpeak at the eight-
cell stage) and also predict 5hmC dynamics in PGCs (Figures 6A
and S6). Noteworthy, the dynamics inmigratory PGCs can be ex-
plained by two solutions,which both accuratelymimic 5mC levels
but predict different 5hmC dynamics. One solution predicts that
both maintenance methylation and TET activity are strongly
reduced (‘‘impaired maintenance methylation’’) (Figure 6A), while
the second solution predicts thatmaintenancemethylation is only
2-fold reduced and TET activity is high (‘‘TET-dependent deme-
thylation’’) (Figure S6). In mouse PGCs, UHRF1 levels are signifi-
cantly decreased and high levels of hemi-methylated CpG dyads
were found (Seisenberger et al., 2012), both supporting a strong
impairment of maintenance methylation. In addition, loss of
H3K9me2 was reported in in vivo and in vitro PGCs (Kurimoto
et al., 2015; Seki et al., 2005) and knockdown of Tet1 and 2 did
not affect global DNA demethylation in vitro (Vincent et al.,
2013). Thus, we reason that the ‘‘impaired maintenance methyl-
ation’’ model (Figure 6A) faithfully recapitulates the in vivo
situation.
Mechanistically, we have dissected the different pathways
relevant to DNA methylation dynamics in primed (serum) and
naive (2i) ESCs (Wu and Zhang, 2014) and shown that global
demethylation is, contrary to previous assumptions, a conse-
quence of neither loss of de novo methylation nor active Tet-
dependent demethylation but caused by impaired maintenance
methylation. DNMT1 is recruited to the replication fork through
UHRF1, which itself interacts with both hemimethylated CpG
dyads and methylated H3K9 and loss of either interaction im-
pairs recruitment (Liu et al., 2013). In naive mouse and human
ESCs, protein levels of UHRF1 are reduced, limiting the recruit-
ment of DNMT1. In addition, loss of H3K9me2 further reduces
UHRF1 recruitment and in turn impairs DNA methylation mainte-
nance by DNMT1 (Figure 6B). UHRF1 is regulated at the protein
level in human and mouse ESCs, as well as in human and mouse
PGCs (Gkountela et al., 2015; Pastor et al., 2016; Seisenberger
et al., 2012; Tang et al., 2015). Interestingly, inmouse PGCs there
is also transcriptional silencing of Uhrf1 (Kurimoto et al., 2015;
Magnu´sdo´ttir et al., 2013; Nakaki et al., 2013; Seisenberger
et al., 2012), which may well underlie the considerably faster de-
methylation kinetics in mouse PGCs when compared to naive
ESCs. Hence, several pathways have apparently evolved that
modulate maintenance methylation by controlling UHRF1 activ-
ity at different levels. The additional level of transcriptional regu-
lation in mouse PGCs suggests that the short time frame of
epigenetic resetting in themouse germline necessitated an addi-
tional regulatory layer, ensuring almost complete impairment of
maintenance methylation and thus rapid demethylation (Fig-
ure 6A). This is in contrast to human PGCs, where demethylation
occurs with slower, potentially intra-individual-specific kinetics
(von Meyenn and Reik, 2015).
In addition to the reduction of UHRF1 protein levels, the
signaling changes imposed by 2i in ESCs (MAPK and GSK3
signaling inhibition) elicit a decrease in the levels of H3K9me2,
thereby synergistically driving genome-wide DNA demethyla-
tion, while allowingmethylationmaintenance of specific genomic
loci. This regulation of H3K9me2 is also evident in PGCs, with
apparent loss of H3K9me2 in mouse (Kurimoto et al., 2015;
Seki et al., 2005) and human PGCs (Tang et al., 2015). We found
that regions with high levels of H3K9me2 in naive ESCs are also
characterized by higher level of DNA methylation (Figure 5F) and
regions resistant to DNA demethylation in the presence of
UHRF1 show significant enrichment of H3K9me2 (Figure S5E).
We propose that in the face of global demethylation, locus-spe-
cific enrichment of H3K9me2/3 allows DNA methylation mainte-
nance at specific regions via recruitment of UHRF1. Similarly,
while TET enzymes were dispensable for global epigenetic re-
programming, TET-dependent demethylation was evident at a
limited number of specific loci. WGBS and TAB-seq experiments
revealed that active demethylation is restricted to a small propor-
tion of the genome, predominantly including active promoters
and enhancers.
Taken together, loss of DNA methylation in ESCs, PGCs, and
preimplantation embryos is the result of the concerted regulation
of two pathways, namely reduction of UHRF1 protein levels and
global loss of H3K9me2, thereby impairing recruitment of
DNMT1 to the replication fork. This elegant mechanism facili-
tates the maintenance of methylation at specific loci while the
genome is simultaneously demethylated on a global scale.
EXPERIMENTAL PROCEDURES
Cell Culture
Mouse ESCs were cultured in the presence of LIF in DMEM containing 15%
fetal calf serum. A tamoxifen-inducible Cre recombinase was used to induce
recombination of loxP sites in the floxed cell lines 48 hr prior to the experiment.
For serum-to-2i transition, serummedium was replaced by serum-free N2B27
supplemented with LIF, mitogen-activated protein kinase kinase (MEK) inhib-
itor PD0325901 (1 mM), and GSK3 inhibitor CHIR99021 (3 mM).
Mass Spectrometry of Nucleosides
Mass spectrometry of nucleosides was performed as previously described
(Ficz et al., 2013; Kroeze et al., 2014). Briefly, 150–1,000 ng genomic DNA
was digested using DNA Degradase Plus (Zymo Research) according to the
manufacturer’s instructions and analyzed by liquid chromatography-tandem
mass spectrometry.
Next-Generation Sequencing
WGBS, RRBS, and TAB-seq were performed as described previously (Lister
et al., 2008; Smallwood et al., 2011; Yu et al., 2012). Whole-genome hairpin
in migratory PGCs can be can be explained by two solutions of the mathematical model. The first solution is shown here and the second solution is shown in
Figure S6.
(B) Cartoon representation of the proposed model. In serum cells, UHRF1 is recruited to replication foci by binding to hemi-methylated DNA and H3K9me2
chromatin marks. Switching to 2i conditions results in passive loss of 5mC driven by a multilayer of regulation: downregulation of UHRF1 at the protein level, and
loss of H3K9me2, which results in impaired recruitment to replication foci.
See also Figure S6.
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Figure 6. Dual Regulation of DNA Demethylation during Serum-2i Transition
(A) Mathematical modeling of serum-2i transition, preimplantation development, and migratory PGC demethylation. The model estimates the activity of the main
pathways related to DNA methylation dynamics, i.e., de novo methylation (p1), maintenance methylation (p2), and active demethylation (p3). The first column
shows measured (solid lines) and estimated (dotted lines) global levels 5mC (values have been scaled) during serum-2i transition, preimplantation development,
andmigratory PGC demethylation. The second column summarizes the estimated activities of the three pathways in each condition. The steady-state activities in
serumESCs are included as a comparison. The third column shows the predicted (dotted lines) global 5hmC values (scaled) and, if available, alsomeasured (solid
lines) 5hmC levels. *Themathematical modeling did not predict a peak of global 5hmC levels in eight-cell embryos (Okamoto et al., 2016). **Global 5mC dynamics
(legend continued on next page)
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Input 
Dyads Symbol  initial 
values 
Value determination methods 
CpG/GpC x1  177038  Hairpin BS-seq 
mCpG/GpC x2  176187  Hairpin BS-seq 
mCpG/GpCm x3  553158  Hairpin BS-seq 
hmCpG/GpCm x4  55783  Hairpin BS-seq and TAB-seq 
hmCpG/GpChm x5 14991  Hairpin BS-seq and TAB-seq 
hmCpG/GpC x6  8894  Hairpin BS-seq and TAB-seq 
Parameters Function 
p1 De novo methylation 
p2 Maintenance methylation 
p3 hydroxymethylation 
d Cell division rate 
Table S1, Related to Figure 1 and S1:
 List of initial values and parameters employed in the mathematical modeling
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SUPPLEMENTAL FIGURE LEGENDS 
Figure S1. Dynamic regulation of 5mC and 5hmC during serum-to-2i conversion of mESCs, 
Related to Figure 1 and Table S1 
(A) Expression level of Aicda and Tdg during the serum-to-2i transition. Error bars indicate mean ±
SD from three biological replicates.
(B) Percentage of 5mC as measured by WGBS in E14 ESCs during serum-to-2i conversion.
(C) Percentage of 5hmC as measured by TAB-Seq in E14 ESCs during serum-to-2i conversion.
(D) Distribution of methylation levels in CpG dyads, measured by Hairpin-BS-Seq, in serum and 2i
ESCs
(E) Dynamic changes of DNMT3A/B proteins, as predicted by the mathematical modeling (changes
in p1) and corresponding real protein levels, determined by protein mass spectrometry (compare
Figure S4A).
Figure S2. Global demethylation kinetics in mutants of the DNA methylation machinery, 
Related to Figure 2 
(A) Levels of 5mC in Aicda KO and controls ESCs (Aicda WT) during the serum-to-2i transition,
measured by mass spectrometry. Error bars indicate mean ± SD from three biological replicates.
(B) Levels of 5mC in Tdg KO and controls ESCs (Tdg Het) during the serum-to-2i transition,
measured by mass spectrometry. Error bars indicate mean ± SD from three biological replicates.
Figure S3. Global demethylation kinetics in mutants of the TET proteins, Related to Figure 3 
and Table S2 
(A) Mathematical modeling of 5mC and 5hmC dynamics during the serum-to-2i transition in the
presence of vitC. The estimated value for active demethylation p3 was estimated using measured
5mC values only. The overlay between the mathematical model prediction (dotted line) and the
normalized measured (red line) 5mC and 5hmC data is shown with p3=3.5%.
(B) Global changes in absolute 5mC and 5hmC levels during the first 32h of reprogramming from
serum (wheat) to 2i (purple) or 2i+vitC (light blue) measured by WGBS (left panel) and TAB-seq
(right panel), respectively.
(C) Bean-plot showing methylation data from RRBS-seq in Tet WT and Tet1/2/3 KO datasets during
the serum-to-2i transition. Horizontal bars represent the median values.
(D) 5mC levels at HCPs, subdivided into three main clusters. Shown is the overall trend and the
boundaries of the shaded area in each plot indicate the 25th percentiles and the 75th percentiles of
each cluster in E14 ESCs with and without vitC.
Figure S4. Uhrf1 is regulated at the protein level also in human ESCs, Related to Figure 4 
(A) Relative protein levels of DNMTs and TETs determined by protein mass spectrometry signal
(label-free quantification (LFQ)) at different time points during serum-to-2i conversion.
(B) Correlation of the quantified signals of UHRF1 and NANOG in immunofluorescence staining of
serum ESCs. The black line represents the linear regression between UHRF1 and NANOG
signals in serum ESCs.
(C) FACS gating strategy used to quantify GFP positive cells in the UHRF1-GFP fusion protein ESC
line. Shown is one representative sample grown in primed serum ESC conditions.
(D) mRNA levels of Uhrf1, Gfp and Dnmt3l from UHRF1-GFP fusion protein ESC line during the
serum-to-2i transition and the 2i-to-serum transition. Error bars indicate mean ± SD from three
biological replicates.
(E) FACS analysis of UHRF1-GFP fusion protein in ESCs during 2i-to-serum conversion.
Histograms show the GFP signal intensity at different time points during the conversion. The
black arrow depicts the threshold used to quantify the percentage of GFP+ cells, shown in the line
graph. Error bars indicate mean ± SD from three biological replicates.
(F) Graph shows the quantification of GFP+ cells at each time-point. Error bars indicate mean ± SD
from three biological replicates.
(G) Expression levels of UHRF1 and DNMT1 in conventional and naive human ESCs. RPKM values
from (Takashima et al., 2014). Error bars indicate mean ± SD.
(H) Immunofluorescence staining of DAPI (blue), UHRF1 (red) and DNMT1 (green) in conventional
and naive human ESCs. Scale bar represents 20µm.
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Figure S5. UHRF1 and H3K9me2 are necessary to maintain methylation at specific loci, Related 
to Figure 5 
(A) Semi-quantification of H3K9me2 immunofluorescence staining in serum, 24h 2i and LT 2i ESCs.
The y-axis corresponds to arbitrary units of mean values of pixel intensity.
(B) ChIP-Seq track for H3K9me2 at the Prdm1 locus (50 kb) from serum, 24h 2i and LT 2i ESCs.
(C) Bean-plot showing methylation data from RRBS-Seq in Uhrf1 WT and Uhrf1 KO datasets during
the serum-to-2i transition.
(D) Heatmap showing methylation levels of the genomic features that display highest degree of
resistance to demethylation in Uhrf1 KO ESCs. Blue cluster highlights a group of regions
resistant to demethylation in cells with UHRF1.
(E) Enrichment of H3K9me2 and (F) H3K9me3 over regions identified to resist DNA demethylation
during the serum-to-2i transition (blue cluster from (D)).
(G) Levels of 5mC, determined by RRBS at H3K9me3 enriched regions (from (Marks et al., 2012))
during the serum-to-2i transition in E14, Uhrf1 WT and Uhrf1 KO ESCs.
(H) Expression levels of known H3K9 modifiers. Error bars indicate mean ± SD from three biological
replicates.
Student’s t test was performed for the indicated comparisons. ***p<0.001 
Figure S6. Mathematical modeling of PGCs, Related to Figure 6 
Summary of the 2nd solution of the mathematical modeling of migratory PGC demethylation. The 
first column shows measured (solid lines) and estimated (dotted lines) global levels of 5mC 
(values have been scaled) in migratory PGCs. The second column summarizes the estimated 
activities of the three pathways. The third column shows the predicted (dotted lines) global 5hmC 
values (scaled). 
SUPPLEMENTAL TABLE LEGENDS 
Table S1, Related to Figure 1 and S1: List of initial values and parameters employed in the 
mathematical modeling. 
Table S2, Related to Figure 3 and S3: List of 500bp regions higher methylated in Tet1/2/3 KO cells 
compared to Tet WT cells. Reads were mapped to the mouse NCBIM37 genome build using Bismark 
and average CpG methylations were calculated over each 500bp region in Seqmonk. 
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SUPPLEMENTAL EXPERIMENTAL PROCEDURES 
Cell Culture 
All mouse ESC lines including E14 (129/Ola), J1 (129S4/SvJae), Tdg-/- (129/C57BL6)	(Cortázar et al., 
2011), Aicda-/- (C57BL6), Tet[1-/-,2-/-,3-/-] (C57BL6/129/FVB) (Hu et al., 2014), and their control lines 
were cultured without feeders in the presence of LIF in DMEM containing 15% fetal calf serum. 
Dnmt1fl/fl (C57BL6), Uhrf1fl/fl (C57BL6) (Sharif et al., 2016), Dnmt[3afl/fl, 3bfl/fl] (129/Ola/C57BL6), 
Tet[1-/-,2-/-] (129/C57BL6) (Dawlaty et al., 2013), and their control lines were expanded on feeder and 
purified from feeders by sequential pre-plating. Tamoxifen inducible Cre recombinase was used to 
induce recombination of loxP sites in the floxed cell lines. Tamoxifen (Sigma) was added directly to 
the media 48 hours prior to the experiment. For serum-to-2i transition, serum medium was replaced by 
serum-free N2B27 (N2 & B27; Gibco) or NDiff227 (StemCells, Inc.) supplemented with LIF, MEK 
inhibitor PD0325901 (1 µM) and GSK3 inhibitor CHIR99021 (3 µM),  together known as 2i  (Ying et 
al., 2008). For serum-to-2i switching in the presence of vitamin C (L-ascorbic acid, Sigma), 17 µM of 
vitamin C (dissolved in water) was added to 2i. The media were refreshed every day and cells were 
passaged every 2-3 days. Primed human ESCs H9 (WiCell Research Institute) (Thomson et al., 1998) 
were maintained as previously described (E8 media, StemCells, Inc.) on vitronectin; naive human 
ESCs (H9) were obtained from Austin Smith and maintained in defined naive growth conditions 
(Takashima et al., 2014) on feeders.
Generation of Dnmt[3afl/fl, 3bfl/fl] lines 
Dnmt[3afl/fl, 3bfl/fl] cell lines were derived as previously reported (Nesterova et al., 2008) from XY 
embryos homozygous for conditional mutations of Dnmt3a and Dnmt3b genes (Dodge et al., 2005; 
Kaneda et al., 2004) and heterozygous for tamoxifen-inducible Cre-recombinase targeted into the 
Rosa26 locus (Vooijs et al., 2001). Eight-cell embryos were flushed from oviducts and incubated in 
M16 medium (Sigma-Aldrich) supplemented with PDO325901 (1µM, Miltenyi Biotec Ltd) and 
CHIR99021 (3µM, Miltenyi Biotec Ltd) for 24 - 48 hours. After further 24 hours of incubation in 
NDiff227 medium (StemCells, Inc.) supplemented with 2i and LIF, hatched blastocysts were moved 
individually into wells of 4-well plates and allowed to grow for 4 to 7 days until ESC-like outgrowths 
could be seen. Dissected and trypsinised outgrowths were seeded on 4-well plates and cell lines were 
expanded and genotyped by PCR.  
WGBS, RRBS, TAB-seq and Hairpin-Bisulfite Sequencing 
DNA was isolated using the Cell Culture DNA Midi Kit from QIAGEN (Cat No 13343), GenElute™ 
Mammalian Genomic DNA Miniprep Kit (Cat No G1N350, Sigma), or Beckman Coulter's Agencourt 
RNAdvance Cell v2 kit. WGBS, RRBS and TAB-Seq was performed as described previously (Lister et 
al., 2008; Smallwood et al., 2011; Yu et al., 2012). We performed paired-end DNA sequencing (2*100 
nucleotides) using the Illumina Hi-Seq 2000 for WGBS, and single-end DNA sequencing (50 
nucleotides) using the Illumina Hi-Seq 2000 for RRBS. Whole genome hairpin bisulfite sequencing 
was performed as described (Zhao et al., 2014) and sequencing was performed on Illumina MiSeq. 
ChIP-Seq and ChIP-BS-Seq 
For chromatin immunoprecipitation, cells were cross-linked with 1% methanol-free formaldehyde in 
fresh medium for 10 minutes. Cross-linking reaction was quenched with glycine at a final 
concentration of 0.2M. Cells were washed twice with ice-cold PBS and harvested. Cell pellets were 
resuspended in LB1 buffer (50 mM Hepes-KOH, pH 7.5; 140 mM NaCl; 1 mM EDTA;10% Glycerol; 
0.5% NP-40 or Igepal CA-630; 0.25% Triton X-100, protease inhibitors) for 10 minutes at 4°C, 
pelleted and resuspended in LB2 buffer (10 mM Tris-HCl, pH8.0; 200 mM NaCl; 1 mM EDTA; 0.5 
mM EGTA, protease inhibitors) for 10 minutes at 4°C. Cells were pelleted, resuspended in LB3 buffer 
(10 mM Tris-HCl, pH 8; 100 mM NaCl; 1 mM EDTA; 0.5 mM EGTA; 0.1% Na-Deoxycholate; 0.5% 
N-lauroylsarcosine, protease inhibitors) and sonicated using Misonix Sonicator 3000. After addition of 
Triton-X to a final concentration of 1%, the lysate was centrifuged at 20,000g for 10 minutes to pellet 
debris. Sonicated chromatin was added to the bead-antibody complexes and incubated overnight at 
4°C. Bead-antibody were prepared as follows: Protein G-coupled Dynabeads were incubated overnight 
with primary antibodies (anti-H3K9me2; Abcam ab1220) in PBS added with 5 mg/ml BSA. Beads 
were washed extensively with RIPA buffer (50mM HEPES pH 7.6, 1mM EDTA, 0.7% Na-
Deoxycholate, 1% NP-40, 0.5M LiCl), once with 1x TE buffer and eluted in 200ul of buffer containing 
1% SDS and 0.1M NaHCO3. Cross-linking was reversed by incubation at 65°C overnight, followed by 
RNAse A treatment at 37°C for 1 hour and Proteinase K treatment at 55°C for 2 hours. DNA was then 
extracted using Beckman Coulter's Agencourt RNAdvance Cell v2 kit following the manufacture’s
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instructions. Eluted DNA was then used for ChIP-Seq library preparation using the MicroPlex Library 
Preparation Kit v2 (Diagenode) or alternatively treated as WGBS samples as described above. 
 
Proteomics 
Total proteins for each sample were isolated and tryptic digested following a published label-free 
proteomics protocol (Liu et al., 2012). Protein identification and quantification were performed using 
MaxQuant software (version 1.3.5.7) with standard settings (Cox and Mann, 2008) and search against 
the UniProtKB/Swiss-Prot human database (generated from version 06-2012).  
 
RNA-Seq and Reverse Transcription Quantitative Real-Time PCR  
Total RNA for each sample was extracted using Beckman Coulter's Agencourt RNAdvance Cell v2 kit 
following the manufacture’s instructions. Extracted RNA was PolyA-enriched and used for library 
preparation using the TruSeq RNA Library Prep Kit v2 (Illumina) following the manufacturer’s 
instructions. Libraries were indexed using Illumina Indexes and 50 bp single-end sequencing was 
performed on Illumina HiSeq 2000 instruments using TruSeq reagents (Illumina, San Diego, CA, 
USA), according to manufacturer’s instructions. Quantitative PCR experiments were performed 
following standard protocols. Complementary DNA (cDNA) was prepared from DNAse treated total 
RNA using SuperScript III (Invitrogen) and oligo-dT primers. At least two independent samples were 
assayed for all quantitative PCR reactions. Endogenous controls (Atp5b, Hspcb) were used to 
normalize expression. Primers are listed below.  
 
Gene Primer Sequence 
Uhrf1 msRT_UHRF1_F GCTCCAGTGCCGTTAAGACC 
 msRT_UHRF1_R CACGAGCACGGACATTCTTG 
Gfp RT_eGFP_F CAACAGCCACAACGTCTATATCAT 
 RT_eGFP_R ATGTTGTGGCGGATCTTGAAG 
Hspcb msRT_Hspcb_F GCTGGCTGAGGACAAGGAGA 
 msRT_Hspcb_R CGTCGGTTAGTGGAATCTTCATG 
Atp5b msRT_Atp5b_F GGCCAAGATGTCCTGCTGTT 
 msRT_Atp5b_R GCTGGTAGCCTACAGCAGAAGG 
Dnmt3l msRT_DNMT3L_F ATGGACAATCTGCTGCTGACTG 
 msRT_DNMT3L_R CGCATAGCATTCTGGTAGTCTCTG 
 
Analysis of nucleoside mass spectrometry 
Nucleosides levels were quantified by integrating peak areas for the fragment ions from extracted mass 
spectrometry ion chromatograms of the relevant scans and calibrated relative to external standards 
obtained by digestion of nucleotide triphosphates. 
 
Fluorescence-activated cell sorting (FACS) 
A stable mouse ESC line, overexpressing UHRF1 fused to GFP, was generated. Stable integration of 
the exogenous DNA was selected for with blasticidin, which is expressed from the same promoter as 
Uhrf1-Gfp using an internal ribosome entry site (IRES) connecting the two cDNAs. UHRF1-GFP cells 
were grown under serum or 2i conditions. Media was switched to 2i or serum, respectively, and cells 
were cultured for the indicated time periods. Cells were then dissociated into single cells and analyzed 
on a LSR Fortessa Cell Analyzer (BD). Cells were gated for singlets and living cells were identified 
using the level of DAPI incorporation and the level of GFP signal was recorded for each cell. The 
expression of GFP in long-term 2i conditions was set as negative background and the percentage of 
cells with higher GFP signal in each condition was plotted. 
 
Immunofluorescence and Imaging 
Antibody staining was performed as previously described (Santos et al., 2003) on ESCs grown on 
coverslips or cytospun, after fixation with 2% PFA for 30 minutes at room temperature. Briefly, cells 
were permeabilised with 0.5% TritonX-100 in PBS for 1h; blocked with 1% BSA in 0.05%Tween20 in 
PBS (BS) for 1h; incubation of the appropriate primary antibody diluted in BS; followed by wash in 
BS and secondary antibody. For simultaneous detection with DNA methylation, after first round of 
antibody staining, samples were washed in PBS, post-fixed in 2% PFA for 10 minutes, treated with 2N 
HCl for 30 minutes at 37ºC and washed extensively with PBS before incubating with anti-5mC, diluted 
in BS. All secondary antibodies were Alexa Fluor conjugated (Molecular Probes) diluted 1:1000 in BS 
and incubated for 30 minutes. Incubations were performed at room temperature unless otherwise 
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stated. Staining of replication foci was performed by adding 10µM EdU for 8 minutes to the culture 
medium prior to fixation and visualized with a Click-iT EdU Imaging kit (Molecular Probes). DNA 
was counterstained with 5µg/mL DAPI in PBS. Single optical sections were captured with a Zeiss 
LSM780 microscope (63x oil-immersion objective) and the images pseudo-colored using Adobe 
Photoshop. For visualization, images were corrected for brightness and contrast, within the 
recommendations for scientific data. Single cell RGB profiles were plotted with ImageJ 1.44p (NIH) 
after removing the background around the cells. Fluorescence semi-quantification analyses were 
performed with Volocity 6.3 (Improvision). Antibodies used are listed below.  
 
Antibody Cat.no. Company Dilution 
Anti-mUHRF1 (Th-10a) D289-3 MBL 1:250 
Anti-hUHRF1 (H-8) sc-373750 Santa Cruz 1:100 
Anti-DNMT1 ab87654 Abcam 1:1000 
Anti-H3K9me2 ab1220 Abcam 1:200 
Anti-5mC BI-MECY-0100 Eurogentec 1:500 
Anti-NANOG ab80892 Abcam 1:500 
 
Western blot analysis  
Whole cell protein extracts were prepared using 1xRIPA buffer (Thermo Scientific, 89900) with 
protease and phosphatase inhibitors (Fisher Scientific, PN87786 and PN78420). 10 µg of proteins were 
resolved by SDS-PAGE and transferred on nitrocellulose membranes. Membranes were blocked in 
PBS-0.1%Tween (PBST) containing 5% BSA (blocking buffer) overnight at 4˚C. Primary antibody 
incubation was done at room temperature for 2 hours, followed by two washes with PBST and 
incubated with HRP conjugated secondary antibodies (1:6000) in blocking buffer. HRP conjugates 
were detected with enhanced chemiluminescence (ECL, Amersham Biosciences). Antibodies used are 
listed below. 
 
Antibody Cat.no. Company Dilution 
Anti-mUHRF1 (Th-10a) sc-98817 Santa Cruz 1:1000 
Anti-H3K9me2 07-212 Millipore 1:1000 
Anti-HSP90 (H-114) sc-7947 Santa Cruz 1:1000 
 
Bioinformatics 
Raw sequence reads were trimmed to remove poor quality reads, adapter contamination, and the first 6 
base pairs, using Trim Galore (http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/).  
For RRBS, WGBS, TAB-Seq, and ChIP-BS-Seq, the remaining sequences were mapped to the mouse 
reference genome NCBIM37 using Bismark (Krueger and Andrews, 2011) or rmapbs-pe (Song et al., 
2013). CpG methylation calls were extracted and analyzed using SeqMonk 
(www.bioinformatics.babraham.ac.uk/projects/seqmonk/) and/or custom R scripts. For TAB-Seq, hmC 
protection/non-protection and mC non-conversion rates were quantified and estimated levels were 
corrected as described in detail previously (Lister et al., 2013; Yu et al., 2012). A maximum likelihood 
method (Qu et al., 2013) on the combined data from WGBS and TAB-Seq were used to estimate 
absolute levels for 5mC and 5hmC. 
For RNA-Seq data analysis, trimmed sequencing reads were aligned to mouse genome assembly 
GRCm38 using TopHat. SeqMonk, and custom R scripts were used to normalize the data and perform 
pair-wise comparisons of genes at each time point. 
For ChIP-Seq data analysis, trimmed sequencing reads were aligned to mouse genome assembly 
NCBIM37 using Bowtie2 and analyzed using SeqMonk and/or custom R scripts. 
 
Mathematical modeling 
The structure (equations) of the model was adapted from (McGovern et al., 2012). Equations were 
solved numerically using the Runge-Kutta 4th order method. We implemented the code in Perl and 
parallelized using the Many-Core Engine (MCE) Perl module (https://code.google.com/p/many-core-
engine-perl/).  
As input values, the percentages of unmethylated CpG dyads (CpG/GpC; x1), hemi-methylated CpG 
dyads (mCpG/GpC; x2) and fully methylated CpG dyads (mCpG/GpCm; x3) were extracted directly 
from WGBS and hairpin BS-Seq. Total percentage of hmCpG was directly calculated from TAB-seq 
data. Due to the lack of hairpin TAB-seq data, we estimated hemi-hydroxymethylated CpG 
(hmCpG/GpC; x4), hemi-methylated hemi-hydroxymethylated CpG dyads (mCpG/GpChm; x5) and 
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fully hydroxymethylated CpG (hmCpG/GpChm, x6), by considering the fraction of 
methylated/hemimethylated CpG compared to total mCpG dyads and the proportion of total mCpG to 
the total hmCpG dyads.  
 
 
 
 
𝜕𝜕𝑥𝑥!
𝜕𝜕𝜕𝜕
= (𝑑𝑑 − 𝑙𝑙 − 𝑝𝑝!)𝑥𝑥! + 𝑑𝑑𝑥𝑥! + 𝑑𝑑𝑥𝑥! 
𝜕𝜕𝑥𝑥!
𝜕𝜕𝜕𝜕
= 𝑝𝑝!𝑥𝑥! − (𝑙𝑙 + 𝑝𝑝! + 𝑝𝑝!)𝑥𝑥! + 2𝑑𝑑𝑥𝑥! + 𝑑𝑑𝑥𝑥! 
𝜕𝜕𝑥𝑥!
𝜕𝜕𝜕𝜕
= 𝑝𝑝!𝑥𝑥! − (𝑑𝑑 + 𝑙𝑙 + 𝑝𝑝!)𝑥𝑥! 
𝜕𝜕𝑥𝑥!
𝜕𝜕𝜕𝜕
= 𝑝𝑝!𝑥𝑥! − (𝑑𝑑 + 𝑙𝑙 + 𝑝𝑝!)𝑥𝑥! 
𝜕𝜕𝑥𝑥!
𝜕𝜕𝜕𝜕
= 𝑝𝑝!𝑥𝑥! − (𝑑𝑑 + 𝑙𝑙)𝑥𝑥! 
𝜕𝜕𝑥𝑥!
𝜕𝜕𝜕𝜕
= 𝑝𝑝!𝑥𝑥! + 𝑑𝑑𝑥𝑥! + 2𝑑𝑑𝑥𝑥! − 𝑙𝑙𝑥𝑥! 
 
Four types of parameters have been defined in the model: 
 
p1: proportionality constant for de novo methylation 
p2: proportionality constant for maintenance methylation 
p3-5: proportionality constants for hydroxymethylation (p3=p4/2=p5) 
**Although in theory, p4 seems to be twice of p3 or p5, our simulations with different combinations of 
parameters shows that for the best fits these values adopt almost similar values. Therefore, during our 
simulations we assumed p3=p4=p5. 
d: cell division rate (population growth rate) is the number of doublings that occur per unit of time and 
is calculated as follow: 
 
𝑇𝑇! =
!"# (!)
!"# (!!!)
 ≈
!.!
!
 ⟹ 𝑑𝑑 ≈ 0.7 / 𝑇𝑇!    Td = doubling time 
 
For serum and 2i, the doubling time was set to 13 and 16, respectively. Adaptation of cell cycle 
(doubling time) during serum to 2i transition occurs quite fast (after ~8h; unpublished data), therefore 
we set doubling time/growth rate before and after 8h as serum and 2i, respectively. 
To estimate the parameters, a hypothetical parameter space (𝜃𝜃!) was defined encompassing every 
combination of the following setting: 𝜃𝜃!! and 𝜃𝜃! oscillating in the range of 0 ≤  𝜃𝜃!!,!!! ≤ 1 with step-
size 0.00125. To reduce the dimensionality, we restricted 𝜃𝜃!!to vary in the range of 0 ≤  𝜃𝜃!! ≤ 1 with 
step-size of 0.05. We implemented dynamic changing instead of single, non-variable p1-p5 constants to 
mimic the anticipated gradual change in protein abundance and/or enzymatic activity throughout the 
interconversion. We divided the time-course into non-overlapping time segments from 0-4h, 4-8h, 8-
16h, 16-24h, 24-32h, 32-72h, 72-144h, 144-432h. Consequently, whenever a number from the 
parameter space is assigned to the initial p1-p5 values, these values are dynamically changed in each 
subsequent time interval to reflect the predicted fold change in protein abundances. 
The simulations were performed with all combinations of the parameter spaces (θp and fk) and for each 
set of parameters, the percentages of dyads (the level of 5mC as well as 5hmC) was generated for every 
point throughout the time course. Then, using the least square optimization we compared measured 
data to all simulated data.  
The least squares method finds its optimum when the sum, S, of squared residuals 
𝑆𝑆 =  (𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚! − 𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝!)
!
!
!!!
 
is a minimum. A residual is defined as the difference between the actual value of the dependent 
variable and the value predicted by the model. 
Simulated profiles with the least minimum error values were selected and the median of their related 
parameters were considered as the optimal parameters for further predictions.  
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SUMMARY
Innate immune memory is the phenomenon whereby
innate immune cells such as monocytes or macro-
phages undergo functional reprogramming after
exposure to microbial components such as lipopoly-
saccharide (LPS). We apply an integrated epige-
nomic approach to characterize the molecular events
involved in LPS-induced tolerance in a time-depen-
dent manner. Mechanistically, LPS-treated mono-
cytes fail to accumulate active histone marks at
promoter and enhancers of genes in the lipid meta-
bolism and phagocytic pathways. Transcriptional
inactivity in response to a second LPS exposure in to-
lerizedmacrophages is accompanied by failure to de-
posit active histone marks at promoters of tolerized
genes. In contrast, b-glucan partially reverses the
LPS-induced tolerance in vitro. Importantly, ex vivo
b-glucan treatment of monocytes from volunteers
with experimental endotoxemia re-instates their ca-
pacity for cytokine production. Tolerance is reversed
at the level of distal element histone modiﬁcation
and transcriptional reactivation of otherwise unre-
sponsive genes.
INTRODUCTION
Accumulating evidence suggests thatmonocytes can be reprog-
rammed by exposure to microbe-associated molecular patterns
(MAMPs) during their time in the circulation (Quintin et al., 2014).
In this model, immune tolerance in myeloid cells, be they mono-
cytes in the circulation or macrophages in the tissues (lipopoly-
saccharide macrophages [LPS-Mfs]), represents one extreme
in the spectrum of innate immune memory and can be induced
by high bacterial burden in vivo or lipopolysaccharide (LPS)
exposure in vitro (Netea et al., 2016). On the other hand, trained
immunity can be induced by exposure to certain vaccines,
microbial components, or metabolites, and is a state character-
ized by increased pro-inﬂammatory response to secondary un-
related infections (Netea et al., 2016). We recently showed that
tolerance (induced by LPS) and trained immunity (induced by
Candida albicans b-glucan [BG]) are both associated with spe-
ciﬁc epigenomic states (Cheng et al., 2014; Saeed et al., 2014).
Most notably, the identity of these macrophage subtypes was
speciﬁed by differences in primed and active distal element rep-
ertoires (Saeed et al., 2014).
Monocytes and macrophages play an important role in the
pathophysiology of sepsis and inﬂammation, along with other
innate and adaptive immune cells (Biswas and Lopez-Collazo,
2009). Transcriptome analysis of tolerant monocytes from
sepsis patients (Shalova et al., 2015) and amouse sepsis model
(Foster et al., 2007) reveals that the tolerized phenotype cannot
be explained purely through failure of speciﬁc signaling path-
ways induced by pattern recognition receptors to activate
downstream genes. This implicates a role for local chromatin
architecture and speciﬁc transcriptional regulators in control-
ling the expression of tolerized genes (Glass and Natoli,
2016). Further, studies in human cancers have revealed com-
monalities between inﬂammation and cancer associated toler-
ance, including the role for IDO1 in both (Bessede et al.,
2014). Accordingly, several anti-cancer drugs, such as bromo-
domain and extraterminal domain family (BET) inhibitors and a
topoisomerase inhibitor, have proven efﬁcacious in blocking
inﬂammation-associated death in mice (Nicodeme et al.,
2010; Rialdi et al., 2016). The speciﬁc epigenetic and transcrip-
tional remodeling induced by the initial LPS exposure and the
extent to which it speciﬁes tolerance to future LPS exposure
are unknown.
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CHAPTER 4
Here, as part of the BLUEPRINT epigenome consortium (http://
www.blueprint-epigenome.eu), we report the time-resolved,
comprehensive epigenomes of human monocyte-to-macro-
phage differentiation and induction of tolerance with LPS and
training with BG. Our epigenomic analysis revealed that tolerance
and trained immunity involve opposing regulation of common
pathways during early exposure to antigens, leading to distinct
epigenomic states in the two macrophage subtypes. We there-
fore hypothesized that BG may be capable of reversing LPS-
induced tolerance. We show that ex vivo BG exposure can rein-
state a responsive phenotype in both monocytes tolerized by
ex vivo LPS exposure and monocytes tolerized by in vivo exper-
imental endotoxemia in healthy volunteers. This reversal of toler-
ance involves epigenomic reprogramming of macrophages.
RESULTS
Distinct Temporal Epigenetic Remodeling in Response
to Microbial Components
Two innate immune memory states can be induced in culture
through an initial exposure of primary humanmonocytes to either
LPS or BG for 24 hr, followed by removal of stimulus and differ-
entiation to macrophages for an additional 5 days (Figures 1A
and S1; Quintin et al., 2012; Saeed et al., 2014). The three sub-
types of macrophages generated in this study were untreated
naive macrophages (naive-Mfs), LPS-exposed tolerized macro-
phages (LPS-Mfs), and BG-exposed trained macrophages (BG-
Mfs). To gain insight into the mechanisms and order of events
that ultimately lead to these three subtypes, we generated epi-
genomic data at several time points during this process (two do-
nors; summarized in Table S1 and Figure S1; GEO: GSE85246).
Depending on the modiﬁcation, 2%–31% of marked regions
showed dynamics during differentiation or LPS or BG exposure,
with H3K27ac at promoters and enhancers being the most dy-
namic mark in number and range (Figure S1; Table S1). Interest-
ingly, epigenetic changes were observable as early as 1 hr in
response to LPS and 4 hr to BG (Figure 1B). The overall
H3K27ac pattern at dynamic promoters and enhancers indicates
that the most pronounced changes are associated with differen-
tiation (principal component 1 [PC1]), with BG- and RPMI-
treated monocytes partially establishing macrophage-speciﬁc
active regions already by day 1 (Figure 1B). Conversely, LPS
treatment results in establishment of pro-inﬂammatory associ-
ated active elements (PC2) and stunted differentiation, followed
by partial ‘‘catch up’’ establishment of differentiation marks
following removal of stimulus (Figures 1B and S1). Contrary to
this catch up of H3K27ac marked enhancers, the H3K4me1
marked enhancer repertoire of LPS-Mfs is signiﬁcantly different
from those of naive-Mfs and BG-Mfs (Figure 1B). Repressive
marks, H3K9me3 and H3K27me3, showed no dynamics during
the ﬁrst 24 hr, indicating little role in the early, priming phase of
innate immune memory (Figure S1C; Table S1).
In total, 17,500 enhancers with dynamic H3K27ac were identi-
ﬁed (Figure S1B). The two largest clusters show gain (n = 4,028) or
loss (n = 6,462) of H3K27ac during differentiation in all three
macrophage subtypes (Figure 1C and S1B). The closest genes
associatedwith differentiation gain or loss clusters are associated
with leukocyte differentiation, activation, metabolism, and phago-
cytosis (Table S2). Uponmonocyte exposure to LPS, H3K27ac in-
duction precedes a temporally delayed H3K4me1 (Figures 1C
and S1B). The closest genes associated with these enhancers
are involved in cytokine response and nuclear factor kB (NF-kB)
signaling, among other well-known LPS-response pathways (Ta-
ble S2). The ‘‘BG up/LPS down’’ enhancer cluster shows acceler-
ated H3K27ac deposition in BG-exposed monocytes and little to
no H3K27ac accumulation in LPS-exposedmonocytes relative to
naive-Mfs (Figure 1C). This cluster is composed of >3,200 en-
hancers and shows concordant increase in H3K4me1 to day 6
(Figure S1B). Chromatin segmentation analysis using EpicSeq
(Mammana and Chung, 2015) revealed that these regions gain
H3K4me1 at the expense of repressive H3K27me3 markings in
naive-Mfs and BG-Mfs (Figure S1D). Conversely, LPS-Mfs main-
tain a chromatin state more similar to monocytes, primarily low
H3K4me1 with the presence of H3K27me3 (Figure S1D). The
closest genes to these enhancers are involved in lipid biosyn-
thesis and lysosome and leukocyte differentiation (Table S2), indi-
cating that BG exposure leads to the accumulation of membrane
components necessary for phagocytosis and cytokine release,
whereas LPS exposure prevents their activation (Figure 1C).
Transcriptome Changes Modulated by LPS and
b-Glucan
RNA sequencing (RNA-seq) was performed on the same time
points as epigenetic marks (n = 2 donors; Figure 1A). General ki-
netics similar to those unveiled for epigenetic remodeling was
observable, with monocytes clustering after a short exposure
to BG and LPS (Figure 1D). Over the time course, the major
changes in gene expression patterns were associated with dif-
ferentiation (PC1, 55.8% of the variance) and LPS exposure
(PC2, 10.8% of the variance), which is most pronounced at
4 hr and day 1 (Figure 1D). Over 5,700 protein-coding genes
showed dynamic expression (fold change [FC] > 2, adjusted p
value [padj] < 0.05) in our model between either treatments or
time points (Table S3; Figures 1E and S2A). LPS-induced genes
(C) A total of 17,500 H3K27ac dynamic gene-distal regions were identiﬁed and can be clearly separated into four clusters: BG up/LPS down, LPS up, differ-
entiation gain, and differentiation loss. Solid lines aremedian log-FC relative to day 0, and shaded areas represent the 25th and 75th quartile. Naive cells are shown
as a green line, LPS as a red line, and BG as a purple line. H3K4me1 at these regions can be seen in Figure S1B; LPS induces early H3K27ac accumulation,
followed by long-term H3K4me1 marking, while BG induces concurrent accumulation of H3K27ac and H3K4me1.
(D) PCA plots showing the relationships among all samples based on dynamic gene expression. PC1 explains most of the variation and is associated with
differentiation. PC2 is LPS related, with LPS 4 hr and LPS day 1 samples separating from the corresponding naive and BG samples.
(E) Heatmap of differentiation associated genes, aswell as those induced by LPS or BGexposure. The general trend in expression is that BG exposed cells start to
express differentiation associated genes faster (at day 1) than naive cells, while LPS exposed cells lag behind.
(F) Top pathways associated with differentiation and showing opposing directions in response to BG and LPS.
See also Figures S1, S2, and S3 and Tables S1, S2, S3, and S4.
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Figure 1. Epigenomic and Transcriptomic Remodeling of Monocytes Induced by Exposure to LPS or BG
(A) Experimental setup for epigenomic interrogation of monocyte-to-macrophage differentiation and induction of tolerance (with LPS) or trained immunity (with BG).
(B) PCA plots of H3K27ac and H3K4me1 dynamic enhancers (monocytes, red circle; naive, circle; LPS, triangle; BG, square; 1 hr, blue; 4 hr, black; day 1, green;
and day 6, brown). Dynamic H3K27ac patterns show a clear deviation from the differentiation pathway (PC1) in LPS-treated cells. On the other hand, BG-treated
cells at day 1 are well on their way toward a full macrophage epigenetic proﬁle.
(legend continued on next page)
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and S1B). The closest genes associated with these enhancers
are involved in cytokine response and nuclear factor kB (NF-kB)
signaling, among other well-known LPS-response pathways (Ta-
ble S2). The ‘‘BG up/LPS down’’ enhancer cluster shows acceler-
ated H3K27ac deposition in BG-exposed monocytes and little to
no H3K27ac accumulation in LPS-exposedmonocytes relative to
naive-Mfs (Figure 1C). This cluster is composed of >3,200 en-
hancers and shows concordant increase in H3K4me1 to day 6
(Figure S1B). Chromatin segmentation analysis using EpicSeq
(Mammana and Chung, 2015) revealed that these regions gain
H3K4me1 at the expense of repressive H3K27me3 markings in
naive-Mfs and BG-Mfs (Figure S1D). Conversely, LPS-Mfs main-
tain a chromatin state more similar to monocytes, primarily low
H3K4me1 with the presence of H3K27me3 (Figure S1D). The
closest genes to these enhancers are involved in lipid biosyn-
thesis and lysosome and leukocyte differentiation (Table S2), indi-
cating that BG exposure leads to the accumulation of membrane
components necessary for phagocytosis and cytokine release,
whereas LPS exposure prevents their activation (Figure 1C).
Transcriptome Changes Modulated by LPS and
b-Glucan
RNA sequencing (RNA-seq) was performed on the same time
points as epigenetic marks (n = 2 donors; Figure 1A). General ki-
netics similar to those unveiled for epigenetic remodeling was
observable, with monocytes clustering after a short exposure
to BG and LPS (Figure 1D). Over the time course, the major
changes in gene expression patterns were associated with dif-
ferentiation (PC1, 55.8% of the variance) and LPS exposure
(PC2, 10.8% of the variance), which is most pronounced at
4 hr and day 1 (Figure 1D). Over 5,700 protein-coding genes
showed dynamic expression (fold change [FC] > 2, adjusted p
value [padj] < 0.05) in our model between either treatments or
time points (Table S3; Figures 1E and S2A). LPS-induced genes
(C) A total of 17,500 H3K27ac dynamic gene-distal regions were identiﬁed and can be clearly separated into four clusters: BG up/LPS down, LPS up, differ-
entiation gain, and differentiation loss. Solid lines aremedian log-FC relative to day 0, and shaded areas represent the 25th and 75th quartile. Naive cells are shown
as a green line, LPS as a red line, and BG as a purple line. H3K4me1 at these regions can be seen in Figure S1B; LPS induces early H3K27ac accumulation,
followed by long-term H3K4me1 marking, while BG induces concurrent accumulation of H3K27ac and H3K4me1.
(D) PCA plots showing the relationships among all samples based on dynamic gene expression. PC1 explains most of the variation and is associated with
differentiation. PC2 is LPS related, with LPS 4 hr and LPS day 1 samples separating from the corresponding naive and BG samples.
(E) Heatmap of differentiation associated genes, aswell as those induced by LPS or BGexposure. The general trend in expression is that BG exposed cells start to
express differentiation associated genes faster (at day 1) than naive cells, while LPS exposed cells lag behind.
(F) Top pathways associated with differentiation and showing opposing directions in response to BG and LPS.
See also Figures S1, S2, and S3 and Tables S1, S2, S3, and S4.
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Figure 1. Epigenomic and Transcriptomic Remodeling of Monocytes Induced by Exposure to LPS or BG
(A) Experimental setup for epigenomic interrogation of monocyte-to-macrophage differentiation and induction of tolerance (with LPS) or trained immunity (with BG).
(B) PCA plots of H3K27ac and H3K4me1 dynamic enhancers (monocytes, red circle; naive, circle; LPS, triangle; BG, square; 1 hr, blue; 4 hr, black; day 1, green;
and day 6, brown). Dynamic H3K27ac patterns show a clear deviation from the differentiation pathway (PC1) in LPS-treated cells. On the other hand, BG-treated
cells at day 1 are well on their way toward a full macrophage epigenetic proﬁle.
(legend continued on next page)
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CHAPTER 4
were involved in immune response, whereas LPS-delayed genes
were generally differentiation associated (Figure 1E; Table S4).
The major ontologies of BG-induced genes (662 genes at day
1) were lipid biosynthesis, metabolism, and the lysosome
pathway (Figure 1E; Table S4). Intersection between exposure-
dependent gene expression and promoter acetylation patterns
showed a strong overlap between H3K27ac and gene expres-
sion temporal proﬁles (Figures S2B and S2C).
LPS-Speciﬁc DNA (De)methylation Signatures
Recent studies have revealed extensive DNA methylation re-
modeling during B cell (Kulis et al., 2015) and osteoclast differen-
tiation (de la Rica et al., 2013; Nishikawa et al., 2015). Con-
sidering that our ex vivo differentiation model occurs in the
absence of cell division, we were interested to see the extent
to which (de)methylation plays a role during monocyte-to-
macrophage differentiation and innate immune memory. Unlike
the comprehensive histone modiﬁcation remodeling, consistent
DNA methylation change (at least 30% change and four or
more signiﬁcant differentially methylated CpGs per differentially
methylated region [DMR]) was limited to a few hundred genomic
regions (Figure S3). The vast majority of DMRs showed loss of
methylation during monocyte-to-macrophage differentiation
irrespective of MAMP exposure (Figure S3B), consistent with
recent ﬁndings in macrophages and dendritic cells (Vento-
Tormo et al., 2016). We did not observe a role for DNA methyl-
ation in ‘‘training’’ the macrophages for future transcriptional
response to infection. More than 90%of DMRs occurred at distal
elements marked by H3K4me1, and only 6% occurred at pro-
moters (Figure S3C). Cumulatively, our data indicate that LPS-
speciﬁc DNA methylation changes occur and, due to the more
stable nature of this mark, may represent a useful biomarker
for LPS-induced macrophage tolerance (Figures S3D and S3E).
LPS- and b-Glucan-Speciﬁc Transcriptional Networks
Motif analysis was used to gain insight into which pathways
and transcription factors (TFs) regulate the epigenetic changes
associated with differentiation and LPS or BG exposure. Four
clusters of enhancers and promoters were designated based
on H3K27ac dynamics over time: BG up/LPS down, ‘‘LPS up,’’
‘‘differentiation gain,’’ and ‘‘differentiation loss’’ (Figures 1C
and S1B). Two classiﬁers (random forest [RF] and a partial
least-squares [PLS]) were trained, using the TF motifs found by
GIMME (van Heeringen and Veenstra, 2011). Both score features
(TF motifs) were based on their ability to separate the clusters—
the so-called feature importance score (between 0 and 100)—
which is a measure of how characteristic the presence or
absence of the TF motif is for the considered cluster. Both
classiﬁers were trained with the caret R-package using 10-fold
cross-validation, repeated ﬁve times. We deﬁne positive (green
dots) and negative predictors (red dots) as TF motifs that are
more or less abundant of the considered cluster compared to
the other clusters, respectively.
Enhancers that show differentiation gain in H3K27ac were en-
riched for the SPI1 (PU.1) motif, while LPS-induced active en-
hancers were enriched for NF-kBmotif (Figures 2A and 2B).
The top positive predictor motif for the BG up/LPS down cluster
was EGR2, with a score of 100, followed by ARNT (Figure 2A).
EGR2 is downstream of dectin-1 (Goodridge et al., 2007) and
shows prominent, transient induction in BG-exposedmonocytes
(Figure S4A). Enhancers with EGR2motifs are mainly associated
with genes involved in lipid metabolism and biosynthesis and
lysosome function (Figures 1E and 1F). The early activation of
these pathways in BG may account for the higher expression
of LAMP1, the major component of the mature lysosome, in
BG-Mfs (Figure S4A).
Interestingly, LPS-exposed monocytes do not transiently acti-
vate EGR2 (Figure S4A). The discordant effect of BG and LPS on
EGR2 expression, the differential H3K27ac deposition at associ-
ated enhancers, and expression of downstream lipidmetabolism
genes suggests that this pathway plays a role in inducing trained
immunity as opposed to tolerance. In order to further conﬁrm the
relationship between EGR2 and downstream lipid pathways, the
DNA-binding motif of EGR2 was scanned at the promoters of
known transcription factors, as well as lipid metabolism and
lysosome genes that are induced in BG-Mfs compared to mono-
cytes (Figure S4B). The EGR2motif was found at the promoter of
several highly expressed TFs, including MITF, which is a positive
identiﬁer for the differentiation gain promoter cluster (Figure 2A),
and is also not activated in LPS-exposed monocytes (Fig-
ure S4A). Cumulatively, EGR2, MITF, and downstream TF motifs
were found at the promoters of 79% of induced lipid metabolism
and lysosome genes (Figure 2B). This analysis suggests that BG/
dectin-1-induced EGR2 activation leads to higher expression of
downstreamTFs (e.g., MITF) and the establishment of promoters
and enhancers that drive the expression of lysosomal and lipid
metabolism genes (Figure 2C). Given the importance of lipid
pathways in macrophage function, the opposing effect of LPS
and BG on these genes suggests that this pathway may play a
critical role in the low cytokine release in LPS-Mfs and elevated
release in BG-Mfs.
Transcriptional Response of Tolerized Macrophages to
LPS Re-exposure
Previous analysis in an ex vivomousemodel showed that tolerant
LPS-Mfs are impaired in their ability to produce pro-inﬂammatory
enhancer cluster, NF-kB for the LPS up cluster, SPI1 (PU.1) for the differentiation gain cluster, and JUNB for the differentiation loss cluster. At the promoter
regions NF-kB was a positive feature for LPS up cluster, MITF for the differentiation gain cluster, and CREB1 and JUNB for the differentiation loss cluster.
(B) Motif enrichment is plotted as absolute difference in abundance compared to background (yellow, higher abundance than background; blue, lower
abundance than background) for the top enriched motifs. Consistently identiﬁed transcription factor motifs include SPI1 at differentiation associated enhancers,
NF-kB at LPS enhancers, and EGR2 and MITF at BG enhancers. Abundance increase over background supports the level of importance score.
(C) A diagram of the transcription factor network based on EGR2 andMITFmotif occurrence at BG-induced lysosome and lipid metabolism genes. Purple arrows
indicate the direction of expression induced by BG exposure, and red arrows indicate the direction of expression induced by for LPS exposure. BG exposure
induces transient expression of the genes, while LPS exposure inhibits activation. The full network based on promoter abundance is shown in Figure S4B.
See also Figure S4.
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Figure 2. Motif Enrichment at Epigenetically Dynamic Promoters and Enhancers and Associated Transcription Factor Networks
Motif enrichment analysis was performed on ATAC-sequencing (nucleosome-free) peaks that overlap H3K27ac dynamic enhancers and H3K27ac promoters.
(A) Random forest (RF) and a partial least-squares (PLS) classiﬁers were trained using the TF motifs found by GIMME to determine features (TF motifs) based on
their ability to separate the 4 H3K27ac clusters shown in Figure 1C. Both classiﬁers produce a feature importance score (between 0 and 100), which is a measure
of how ‘‘characteristic’’ the presence or absence of the TF motif is for the considered cluster. Green dots represent positive features (motif over-represented in
cluster), and red dots represent negative features (motif under-represented in cluster). The EGR2motif was the strongest positive feature for the BG up/LPS down
(legend continued on next page)
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were involved in immune response, whereas LPS-delayed genes
were generally differentiation associated (Figure 1E; Table S4).
The major ontologies of BG-induced genes (662 genes at day
1) were lipid biosynthesis, metabolism, and the lysosome
pathway (Figure 1E; Table S4). Intersection between exposure-
dependent gene expression and promoter acetylation patterns
showed a strong overlap between H3K27ac and gene expres-
sion temporal proﬁles (Figures S2B and S2C).
LPS-Speciﬁc DNA (De)methylation Signatures
Recent studies have revealed extensive DNA methylation re-
modeling during B cell (Kulis et al., 2015) and osteoclast differen-
tiation (de la Rica et al., 2013; Nishikawa et al., 2015). Con-
sidering that our ex vivo differentiation model occurs in the
absence of cell division, we were interested to see the extent
to which (de)methylation plays a role during monocyte-to-
macrophage differentiation and innate immune memory. Unlike
the comprehensive histone modiﬁcation remodeling, consistent
DNA methylation change (at least 30% change and four or
more signiﬁcant differentially methylated CpGs per differentially
methylated region [DMR]) was limited to a few hundred genomic
regions (Figure S3). The vast majority of DMRs showed loss of
methylation during monocyte-to-macrophage differentiation
irrespective of MAMP exposure (Figure S3B), consistent with
recent ﬁndings in macrophages and dendritic cells (Vento-
Tormo et al., 2016). We did not observe a role for DNA methyl-
ation in ‘‘training’’ the macrophages for future transcriptional
response to infection. More than 90%of DMRs occurred at distal
elements marked by H3K4me1, and only 6% occurred at pro-
moters (Figure S3C). Cumulatively, our data indicate that LPS-
speciﬁc DNA methylation changes occur and, due to the more
stable nature of this mark, may represent a useful biomarker
for LPS-induced macrophage tolerance (Figures S3D and S3E).
LPS- and b-Glucan-Speciﬁc Transcriptional Networks
Motif analysis was used to gain insight into which pathways
and transcription factors (TFs) regulate the epigenetic changes
associated with differentiation and LPS or BG exposure. Four
clusters of enhancers and promoters were designated based
on H3K27ac dynamics over time: BG up/LPS down, ‘‘LPS up,’’
‘‘differentiation gain,’’ and ‘‘differentiation loss’’ (Figures 1C
and S1B). Two classiﬁers (random forest [RF] and a partial
least-squares [PLS]) were trained, using the TF motifs found by
GIMME (van Heeringen and Veenstra, 2011). Both score features
(TF motifs) were based on their ability to separate the clusters—
the so-called feature importance score (between 0 and 100)—
which is a measure of how characteristic the presence or
absence of the TF motif is for the considered cluster. Both
classiﬁers were trained with the caret R-package using 10-fold
cross-validation, repeated ﬁve times. We deﬁne positive (green
dots) and negative predictors (red dots) as TF motifs that are
more or less abundant of the considered cluster compared to
the other clusters, respectively.
Enhancers that show differentiation gain in H3K27ac were en-
riched for the SPI1 (PU.1) motif, while LPS-induced active en-
hancers were enriched for NF-kBmotif (Figures 2A and 2B).
The top positive predictor motif for the BG up/LPS down cluster
was EGR2, with a score of 100, followed by ARNT (Figure 2A).
EGR2 is downstream of dectin-1 (Goodridge et al., 2007) and
shows prominent, transient induction in BG-exposedmonocytes
(Figure S4A). Enhancers with EGR2motifs are mainly associated
with genes involved in lipid metabolism and biosynthesis and
lysosome function (Figures 1E and 1F). The early activation of
these pathways in BG may account for the higher expression
of LAMP1, the major component of the mature lysosome, in
BG-Mfs (Figure S4A).
Interestingly, LPS-exposed monocytes do not transiently acti-
vate EGR2 (Figure S4A). The discordant effect of BG and LPS on
EGR2 expression, the differential H3K27ac deposition at associ-
ated enhancers, and expression of downstream lipidmetabolism
genes suggests that this pathway plays a role in inducing trained
immunity as opposed to tolerance. In order to further conﬁrm the
relationship between EGR2 and downstream lipid pathways, the
DNA-binding motif of EGR2 was scanned at the promoters of
known transcription factors, as well as lipid metabolism and
lysosome genes that are induced in BG-Mfs compared to mono-
cytes (Figure S4B). The EGR2motif was found at the promoter of
several highly expressed TFs, including MITF, which is a positive
identiﬁer for the differentiation gain promoter cluster (Figure 2A),
and is also not activated in LPS-exposed monocytes (Fig-
ure S4A). Cumulatively, EGR2, MITF, and downstream TF motifs
were found at the promoters of 79% of induced lipid metabolism
and lysosome genes (Figure 2B). This analysis suggests that BG/
dectin-1-induced EGR2 activation leads to higher expression of
downstreamTFs (e.g., MITF) and the establishment of promoters
and enhancers that drive the expression of lysosomal and lipid
metabolism genes (Figure 2C). Given the importance of lipid
pathways in macrophage function, the opposing effect of LPS
and BG on these genes suggests that this pathway may play a
critical role in the low cytokine release in LPS-Mfs and elevated
release in BG-Mfs.
Transcriptional Response of Tolerized Macrophages to
LPS Re-exposure
Previous analysis in an ex vivomousemodel showed that tolerant
LPS-Mfs are impaired in their ability to produce pro-inﬂammatory
enhancer cluster, NF-kB for the LPS up cluster, SPI1 (PU.1) for the differentiation gain cluster, and JUNB for the differentiation loss cluster. At the promoter
regions NF-kB was a positive feature for LPS up cluster, MITF for the differentiation gain cluster, and CREB1 and JUNB for the differentiation loss cluster.
(B) Motif enrichment is plotted as absolute difference in abundance compared to background (yellow, higher abundance than background; blue, lower
abundance than background) for the top enriched motifs. Consistently identiﬁed transcription factor motifs include SPI1 at differentiation associated enhancers,
NF-kB at LPS enhancers, and EGR2 and MITF at BG enhancers. Abundance increase over background supports the level of importance score.
(C) A diagram of the transcription factor network based on EGR2 andMITFmotif occurrence at BG-induced lysosome and lipid metabolism genes. Purple arrows
indicate the direction of expression induced by BG exposure, and red arrows indicate the direction of expression induced by for LPS exposure. BG exposure
induces transient expression of the genes, while LPS exposure inhibits activation. The full network based on promoter abundance is shown in Figure S4B.
See also Figure S4.
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Figure 2. Motif Enrichment at Epigenetically Dynamic Promoters and Enhancers and Associated Transcription Factor Networks
Motif enrichment analysis was performed on ATAC-sequencing (nucleosome-free) peaks that overlap H3K27ac dynamic enhancers and H3K27ac promoters.
(A) Random forest (RF) and a partial least-squares (PLS) classiﬁers were trained using the TF motifs found by GIMME to determine features (TF motifs) based on
their ability to separate the 4 H3K27ac clusters shown in Figure 1C. Both classiﬁers produce a feature importance score (between 0 and 100), which is a measure
of how ‘‘characteristic’’ the presence or absence of the TF motif is for the considered cluster. Green dots represent positive features (motif over-represented in
cluster), and red dots represent negative features (motif under-represented in cluster). The EGR2motif was the strongest positive feature for the BG up/LPS down
(legend continued on next page)
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Figure 4. Histone Modiﬁcation Dynamics and Open Chromatin Analysis at Tolerized Gene Promoters
(A) Heatmap showing average expression of 777 LPS-responsive genes in naive-Mfs. Genes are ranked based on their induction in LPS-Mfs, ﬁrst by tolerance
group (G1, G2, and G3) and then by relative induction compared to naive-Mfs within each group. Response to LPS re-exposure is a gradient in LPS-Mfs, with the
most tolerized genes on the left and the most responsive genes on the right.
(B) Heatmap showing abundance of signiﬁcant motifs in the promoter regions of the three macrophage LPS-responsive gene groups. The tolerized gene pro-
moters are enriched for several transcriptional repressors, such as EGR2 and TP53, while the partially tolerized gene promoters are enriched for IRF and STAT
motifs.
(C) Random forest (RF) and a partial least-squares (PLS) classiﬁers importance score (between 0 and 100) for each tolerized gene cluster (G1, tolerized; G2,
partially tolerized; and G3, responsive). Green dots represent over-represented motifs, and red dots under-represented motifs. The top features of G1 gene
(legend continued on next page)
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cytokines, but maintain their ability to express other genes, such
as those required for tissue repair (Foster et al., 2007). Given the
wide-ranging epigenetic alterations in LPS-Mfs (Figure 1C; Table
S1), we sought to investigate the epigenetic basis for endotoxin
tolerance by exposing differentiated naive-Mfs, LPS-Mfs, and
BG-Mfs to LPS for 4 hr (LPS re-exposure) (Figure 3A). The overall
transcriptional and histonemodiﬁcation changes induced inmac-
rophages by LPS re-exposure are shown in Figure 3B, and few
differences were observed between naive-Mfs and BG-Mfs.
LPS-Mfs show an avid response to LPS re-exposure both tran-
scriptionally andwithH3K27ac deposition at promoters and distal
enhancers (observable as large shift in PC2; Figure 3B). This indi-
cates that tolerized macrophages can and do respond to LPS at
the epigenetic and transcriptional level. However, from H3K27ac
and H3K4me1 principal-component analysis (PCA), it is clear that
the epigenetic proﬁle of LPS-Mfs ismarkedly different from that of
naive-Mfs and BG-Mfs (observable as an LPS-Mfs lag on PC1;
Figure 3B).
Polytomous modeling was used to separate genes based on
their transcriptional response to LPS re-exposure (4 hr) in mac-
rophages at day 6. In total, 780 genes showed higher expression
(FC > 2, posterior probability > 0.3) in naive-Mfs following 4-hr
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Figure 3. Macrophage Endotoxin Tolerance Deﬁned at the Transcriptional Level following LPS Re-exposure
(A) The innate immune memory model, including data collection at LPS re-exposure at day 6.
(B) PCA plots of dynamic RNA-seq, H3K27ac at promoters and enhancers, and H3K4me1 peaks, including LPS re-exposure samples. After re-exposure to LPS,
signiﬁcant enhancer H3K27ac changes occur in LPS-Mfs, indicating that they are capable of activating their enhancers. However, the level of their response is
lower compared to monocytes, naive-Mfs, and BG-Mfs, which can be seen on the second principal component. Unlike RNA and H3K27ac, H3K4me1 does not
show signiﬁcant changes following LPS re-exposure in any of the three macrophage subtypes.
(C) The total macrophage transcriptional response (750 genes) to LPS was separated into three groups based on the induction of genes in LPS-Mfs, relative to
naive-Mfs and BG-Mfs, revealing a gradient in LPS-Mf response to LPS re-exposure. The groups are (G1) tolerized genes, (G2) partially tolerized genes, and (G3)
responsive genes.
See also Figure S5.
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Figure 4. Histone Modiﬁcation Dynamics and Open Chromatin Analysis at Tolerized Gene Promoters
(A) Heatmap showing average expression of 777 LPS-responsive genes in naive-Mfs. Genes are ranked based on their induction in LPS-Mfs, ﬁrst by tolerance
group (G1, G2, and G3) and then by relative induction compared to naive-Mfs within each group. Response to LPS re-exposure is a gradient in LPS-Mfs, with the
most tolerized genes on the left and the most responsive genes on the right.
(B) Heatmap showing abundance of signiﬁcant motifs in the promoter regions of the three macrophage LPS-responsive gene groups. The tolerized gene pro-
moters are enriched for several transcriptional repressors, such as EGR2 and TP53, while the partially tolerized gene promoters are enriched for IRF and STAT
motifs.
(C) Random forest (RF) and a partial least-squares (PLS) classiﬁers importance score (between 0 and 100) for each tolerized gene cluster (G1, tolerized; G2,
partially tolerized; and G3, responsive). Green dots represent over-represented motifs, and red dots under-represented motifs. The top features of G1 gene
(legend continued on next page)
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cytokines, but maintain their ability to express other genes, such
as those required for tissue repair (Foster et al., 2007). Given the
wide-ranging epigenetic alterations in LPS-Mfs (Figure 1C; Table
S1), we sought to investigate the epigenetic basis for endotoxin
tolerance by exposing differentiated naive-Mfs, LPS-Mfs, and
BG-Mfs to LPS for 4 hr (LPS re-exposure) (Figure 3A). The overall
transcriptional and histonemodiﬁcation changes induced inmac-
rophages by LPS re-exposure are shown in Figure 3B, and few
differences were observed between naive-Mfs and BG-Mfs.
LPS-Mfs show an avid response to LPS re-exposure both tran-
scriptionally andwithH3K27ac deposition at promoters and distal
enhancers (observable as large shift in PC2; Figure 3B). This indi-
cates that tolerized macrophages can and do respond to LPS at
the epigenetic and transcriptional level. However, from H3K27ac
and H3K4me1 principal-component analysis (PCA), it is clear that
the epigenetic proﬁle of LPS-Mfs ismarkedly different from that of
naive-Mfs and BG-Mfs (observable as an LPS-Mfs lag on PC1;
Figure 3B).
Polytomous modeling was used to separate genes based on
their transcriptional response to LPS re-exposure (4 hr) in mac-
rophages at day 6. In total, 780 genes showed higher expression
(FC > 2, posterior probability > 0.3) in naive-Mfs following 4-hr
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Figure 3. Macrophage Endotoxin Tolerance Deﬁned at the Transcriptional Level following LPS Re-exposure
(A) The innate immune memory model, including data collection at LPS re-exposure at day 6.
(B) PCA plots of dynamic RNA-seq, H3K27ac at promoters and enhancers, and H3K4me1 peaks, including LPS re-exposure samples. After re-exposure to LPS,
signiﬁcant enhancer H3K27ac changes occur in LPS-Mfs, indicating that they are capable of activating their enhancers. However, the level of their response is
lower compared to monocytes, naive-Mfs, and BG-Mfs, which can be seen on the second principal component. Unlike RNA and H3K27ac, H3K4me1 does not
show signiﬁcant changes following LPS re-exposure in any of the three macrophage subtypes.
(C) The total macrophage transcriptional response (750 genes) to LPS was separated into three groups based on the induction of genes in LPS-Mfs, relative to
naive-Mfs and BG-Mfs, revealing a gradient in LPS-Mf response to LPS re-exposure. The groups are (G1) tolerized genes, (G2) partially tolerized genes, and (G3)
responsive genes.
See also Figure S5.
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Figure 5. BG Can Reverse Both In Vitro and In Vivo LPS-Induced Tolerance and Reinstate Proper Cytokine Production in Macrophages
(A) The in vitro monocyte tolerance reversal model, with BG added therapeutically after 24 hr of LPS exposure (rescue-Mfs). The histone-mimic and inﬂammation
blocker IBET was used in a preventative (co-culture with LPS for 24 hr LPS-co-IBET-Mfs) and a therapeutic (added after 24 hr of LPS exposure [LPS + IBET-Mfs])
manner. Following several days of rest, macrophages were re-exposed to LPS and cytokine release measured after 24 hr.
(B) BG re-instates IL-6 release in tolerized macrophages. Data from six donors are shown for naive-Mfs, LPS-Mfs, and rescue-Mfs.
(legend continued on next page)
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LPS exposure (Figure 3C; Table S5). Transcriptional responsive-
ness to LPS re-exposure in LPS-Mfs is a gradient, with genes
showing complete tolerance (unresponsiveness) (cluster G1), a
partial response (G2), or a full response comparable to naive-
Mfs (G3) (Figures 3C and S5A). Cytokine genes were the most
enriched group and were spread across the LPS re-exposure
response gradient, withCXCL9 (G1) and TNF (G2) showing com-
plete or partial tolerance and IL6 and IL8 showing comparable
responsiveness to naive-Mfs (G3) (Figures S5B and S5C). The
normal induction of interleukin 6 (IL-6) mRNA expression and
the absence of response in ELISA assays therefore suggests
that tolerance is a complex phenotype that involves both damp-
ened transcriptional responses to LPS re-exposure and an
inability to release some cytokines (Figure S5C). The top toler-
ance-speciﬁc biological process was ‘‘cytokine production,’’
while the top pathway was ‘‘RIG-I-like signaling’’ and ‘‘p53
signaling’’ (Figure S5D).
Epigenetic Proﬁle of Tolerized Genes
To understand the molecular mechanisms involved in the altered
gene induction by LPS re-exposure in LPS-Mfs, we investigated
promoter motif enrichment at overlapping assay for transposase
accessible chromatin (ATAC) peaks. Because transcriptional
responsiveness to LPS re-exposure in tolerized macrophages
occurs on a gradient (Figure 4A), motif enrichment at promoters
was scanned in a sliding window of 100 promoters throughout
the response gradient from most tolerized (G1) to responsive
(G3) genes (Figure 4B). This analysis identiﬁed discrete motif sig-
natures in theG1andG2 tolerizedgroups. TheG1genepromoters
were enriched for several TF motifs, including EGR2, HIF1A, and
p53. The latter TF was also identiﬁed as a top tolerized pathway
(Figure S5D). The partially tolerized genes are enriched for IRF
and STAT motifs (Figure 4B). Random Forest analysis also indi-
cated that EGR2 was the top identiﬁer for the G1 group, while
IRF and STATmotifs are top identiﬁers for the G2 group. Interest-
ingly, theG3groupdoesnotcontainpositive identiﬁers (Figure4C).
IRF and STAT genes show a tolerized pattern (Figure S6A), indi-
cating that their unresponsiveness to LPS effects downstream
partially tolerized genes. On the other hand, NFKB1 and RELA
showed normal induction in LPS-Mfs (Figure S6B).
Dynamic H3K27ac change during differentiation and LPS or
BG exposure was plotted over the promoter regions of G1, G2,
and G3 genes (Figure 4D). Dynamic promoter H3K27ac was
observed for roughly half of all genes, with the rest showing
consistent high acetylation during all time-points, including
LPS re-exposure (not shown). Tolerized genes (G1) and partially
tolerized genes (G2) showed no or impaired accumulation of
H3K27ac, respectively, after LPS re-exposure in LPS-Mfs
compared to naive-Mfs and BG-Mfs (Figure 4D), while respon-
sive genes (G3) were equally acetylated after LPS re-exposure
in all subtypes (Figure 4D). H3K4me3 patterns at these pro-
moters closely matched those of H3K27ac (Figure S5B). This
ﬁnding suggests that LPS-Mfs fail to accumulate H3K27ac at to-
lerized genes either through absence of pro-inﬂammatory acti-
vators, such as IRF and STATs in the case of G2 genes, or
through presence of tolerance inducing TFs, such as HIF1A in
the case of G1 genes.
b-Glucan Exposure Can Reverse Tolerance in Both
In Vitro and In Vivo LPS-Exposed Monocytes
As indicated before, BG and LPS have an opposing effect on
EGR2 and MITF expression (Figure S4A), accumulation of
H3K27ac at target enhancers and promoters (Figure 1C), and
expression of genes involved in macrophage function, such as
lipid metabolism and lysosome and cytokine production (Fig-
ure 1E). These ﬁndings point to a potential for reversal of LPS-
induced tolerance by using BG to stimulate the dectin-1
pathway. To test this hypothesis, monocytes were exposed to
LPS for 24 hr and then to BG for 24 hr, followed by a rest period
before LPS re-exposure (Figure 5A). We refer to these macro-
phages as ‘‘rescue-Mfs’’. Additionally, we used the clinically
relevant small molecular histone mimic bromodomain and extra-
terminal domain family (BET) inhibitor (IBET)151 in a co-treat-
ment with LPS (‘‘preventative’’) or following LPS exposure
(‘‘reversal’’) setting (Figure 5A). ELISAs showed that BG expo-
sure was able to reverse LPS-induced tolerance and reinstate
normal levels of cytokine release in rescue-Mfs (Figure 5B). On
the other hand, IBET151 was only effective in preventing toler-
ance when used to block the LPS-induced response, but it did
not reverse tolerance when administered after LPS (Figure 5C).
This is in line with the ﬁnding that IBET151 is effective in blocking
inﬂammation-associated death in mice (Nicodeme et al., 2010)
but suggests that IBET151 is not an effective treatment in
monocytes that have already experienced an inﬂammatory
response. Therefore, BG represents a possible treatment option
for restoring proper macrophage cytokine release during the
post-inﬂammation tolerance phase.
The suitability of the in vitro tolerance model to mimic the
in vivo situation is a major question. Chieﬂy, does LPS exposure
in vivo induce the same transcriptional responses in monocytes,
and can in vivo LPS-induced tolerance be reversed by BG? To
answer these questions, we used an in vivo experimental human
endotoxemia model (Draisma et al., 2009) (Figure 5D). In this
model, healthy volunteers are injected with 2 ng/kg US Standard
Reference Endotoxin Escherichia coli O:113 LPS (Pharmaceu-
tical Development Section of the National Institute of Health, Be-
thesda, MD, USA), which leads to a sepsis-like state (reviewed in
Bahador and Cross, 2007). Study protocols were approved by
the local ethics committee of the Radboud University Nijmegen
Medical Centre. The volunteers experience transient fever and
cold chills as well as pro- and anti-inﬂammatory cytokine signa-
tures. The in vivo LPS-exposed monocytes show elevated
promoters are E2F3, EGR2, and ZBTB7B motifs. The top features for G2 gene promoters are IRF and STAT, while G3 promoters do not have over-represented
features but are depleted of EGR2, E2F3, and ZNF350.
(D) Median H3K27ac at dynamic promoters of G1, G2, and G3 group genes, shaded areas represent the 25th and 75th quartile. This shows that LPS-Mfs do not
accumulate H3K27ac at tolerized genes but do so at the promoters of responsive genes. See also Figure S6 for H3K4me3.
See also Figure S6.
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Figure 5. BG Can Reverse Both In Vitro and In Vivo LPS-Induced Tolerance and Reinstate Proper Cytokine Production in Macrophages
(A) The in vitro monocyte tolerance reversal model, with BG added therapeutically after 24 hr of LPS exposure (rescue-Mfs). The histone-mimic and inﬂammation
blocker IBET was used in a preventative (co-culture with LPS for 24 hr LPS-co-IBET-Mfs) and a therapeutic (added after 24 hr of LPS exposure [LPS + IBET-Mfs])
manner. Following several days of rest, macrophages were re-exposed to LPS and cytokine release measured after 24 hr.
(B) BG re-instates IL-6 release in tolerized macrophages. Data from six donors are shown for naive-Mfs, LPS-Mfs, and rescue-Mfs.
(legend continued on next page)
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LPS exposure (Figure 3C; Table S5). Transcriptional responsive-
ness to LPS re-exposure in LPS-Mfs is a gradient, with genes
showing complete tolerance (unresponsiveness) (cluster G1), a
partial response (G2), or a full response comparable to naive-
Mfs (G3) (Figures 3C and S5A). Cytokine genes were the most
enriched group and were spread across the LPS re-exposure
response gradient, withCXCL9 (G1) and TNF (G2) showing com-
plete or partial tolerance and IL6 and IL8 showing comparable
responsiveness to naive-Mfs (G3) (Figures S5B and S5C). The
normal induction of interleukin 6 (IL-6) mRNA expression and
the absence of response in ELISA assays therefore suggests
that tolerance is a complex phenotype that involves both damp-
ened transcriptional responses to LPS re-exposure and an
inability to release some cytokines (Figure S5C). The top toler-
ance-speciﬁc biological process was ‘‘cytokine production,’’
while the top pathway was ‘‘RIG-I-like signaling’’ and ‘‘p53
signaling’’ (Figure S5D).
Epigenetic Proﬁle of Tolerized Genes
To understand the molecular mechanisms involved in the altered
gene induction by LPS re-exposure in LPS-Mfs, we investigated
promoter motif enrichment at overlapping assay for transposase
accessible chromatin (ATAC) peaks. Because transcriptional
responsiveness to LPS re-exposure in tolerized macrophages
occurs on a gradient (Figure 4A), motif enrichment at promoters
was scanned in a sliding window of 100 promoters throughout
the response gradient from most tolerized (G1) to responsive
(G3) genes (Figure 4B). This analysis identiﬁed discrete motif sig-
natures in theG1andG2 tolerizedgroups. TheG1genepromoters
were enriched for several TF motifs, including EGR2, HIF1A, and
p53. The latter TF was also identiﬁed as a top tolerized pathway
(Figure S5D). The partially tolerized genes are enriched for IRF
and STAT motifs (Figure 4B). Random Forest analysis also indi-
cated that EGR2 was the top identiﬁer for the G1 group, while
IRF and STATmotifs are top identiﬁers for the G2 group. Interest-
ingly, theG3groupdoesnotcontainpositive identiﬁers (Figure4C).
IRF and STAT genes show a tolerized pattern (Figure S6A), indi-
cating that their unresponsiveness to LPS effects downstream
partially tolerized genes. On the other hand, NFKB1 and RELA
showed normal induction in LPS-Mfs (Figure S6B).
Dynamic H3K27ac change during differentiation and LPS or
BG exposure was plotted over the promoter regions of G1, G2,
and G3 genes (Figure 4D). Dynamic promoter H3K27ac was
observed for roughly half of all genes, with the rest showing
consistent high acetylation during all time-points, including
LPS re-exposure (not shown). Tolerized genes (G1) and partially
tolerized genes (G2) showed no or impaired accumulation of
H3K27ac, respectively, after LPS re-exposure in LPS-Mfs
compared to naive-Mfs and BG-Mfs (Figure 4D), while respon-
sive genes (G3) were equally acetylated after LPS re-exposure
in all subtypes (Figure 4D). H3K4me3 patterns at these pro-
moters closely matched those of H3K27ac (Figure S5B). This
ﬁnding suggests that LPS-Mfs fail to accumulate H3K27ac at to-
lerized genes either through absence of pro-inﬂammatory acti-
vators, such as IRF and STATs in the case of G2 genes, or
through presence of tolerance inducing TFs, such as HIF1A in
the case of G1 genes.
b-Glucan Exposure Can Reverse Tolerance in Both
In Vitro and In Vivo LPS-Exposed Monocytes
As indicated before, BG and LPS have an opposing effect on
EGR2 and MITF expression (Figure S4A), accumulation of
H3K27ac at target enhancers and promoters (Figure 1C), and
expression of genes involved in macrophage function, such as
lipid metabolism and lysosome and cytokine production (Fig-
ure 1E). These ﬁndings point to a potential for reversal of LPS-
induced tolerance by using BG to stimulate the dectin-1
pathway. To test this hypothesis, monocytes were exposed to
LPS for 24 hr and then to BG for 24 hr, followed by a rest period
before LPS re-exposure (Figure 5A). We refer to these macro-
phages as ‘‘rescue-Mfs’’. Additionally, we used the clinically
relevant small molecular histone mimic bromodomain and extra-
terminal domain family (BET) inhibitor (IBET)151 in a co-treat-
ment with LPS (‘‘preventative’’) or following LPS exposure
(‘‘reversal’’) setting (Figure 5A). ELISAs showed that BG expo-
sure was able to reverse LPS-induced tolerance and reinstate
normal levels of cytokine release in rescue-Mfs (Figure 5B). On
the other hand, IBET151 was only effective in preventing toler-
ance when used to block the LPS-induced response, but it did
not reverse tolerance when administered after LPS (Figure 5C).
This is in line with the ﬁnding that IBET151 is effective in blocking
inﬂammation-associated death in mice (Nicodeme et al., 2010)
but suggests that IBET151 is not an effective treatment in
monocytes that have already experienced an inﬂammatory
response. Therefore, BG represents a possible treatment option
for restoring proper macrophage cytokine release during the
post-inﬂammation tolerance phase.
The suitability of the in vitro tolerance model to mimic the
in vivo situation is a major question. Chieﬂy, does LPS exposure
in vivo induce the same transcriptional responses in monocytes,
and can in vivo LPS-induced tolerance be reversed by BG? To
answer these questions, we used an in vivo experimental human
endotoxemia model (Draisma et al., 2009) (Figure 5D). In this
model, healthy volunteers are injected with 2 ng/kg US Standard
Reference Endotoxin Escherichia coli O:113 LPS (Pharmaceu-
tical Development Section of the National Institute of Health, Be-
thesda, MD, USA), which leads to a sepsis-like state (reviewed in
Bahador and Cross, 2007). Study protocols were approved by
the local ethics committee of the Radboud University Nijmegen
Medical Centre. The volunteers experience transient fever and
cold chills as well as pro- and anti-inﬂammatory cytokine signa-
tures. The in vivo LPS-exposed monocytes show elevated
promoters are E2F3, EGR2, and ZBTB7B motifs. The top features for G2 gene promoters are IRF and STAT, while G3 promoters do not have over-represented
features but are depleted of EGR2, E2F3, and ZNF350.
(D) Median H3K27ac at dynamic promoters of G1, G2, and G3 group genes, shaded areas represent the 25th and 75th quartile. This shows that LPS-Mfs do not
accumulate H3K27ac at tolerized genes but do so at the promoters of responsive genes. See also Figure S6 for H3K4me3.
See also Figure S6.
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established distal enhancers that were modulated in the oppo-
site direction by BG or LPS exposure (Figure 1D). Deposition of
H3K27ac and H3K4me1 at these regions was accelerated by
BG exposure and delayed or completely blocked by LPS expo-
sure. Accordingly, expression of genes near these elements was
induced by BG, peaking at 24 hr post-exposure, while they re-
mained lowly expressed in LPS-exposed monocytes (Figure 1F).
These genes were involved in lipid metabolism and biosynthesis,
phagocytosis, and lysosomematuration (Figures 1G and S2) and
have clear TF motif signatures for EGR2, MITF, and ARNT (Fig-
ure 2A). Interestingly, EGR2, a TF downstream of the BG recep-
tor dectin-1, showed clear transient upregulation by BG but re-
mained inactive in LPS-exposed monocytes, suggesting a
possible role in modulating these pathways (Figure S4). TFs
and pathways linking lipid biosynthesis and inﬂammation have
been described (Spann et al., 2012). Further, macrophage
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Figure 6.Q1 Reversal of Tolerance by BG at the Transcriptional Level
(A) Heatmap of the transcriptional response of naive-Mfs, LPS-Mfs, and rescue-Mfs (BG reversed LPS-Mfs) to LPS re-exposure at day 6. The scale represents
relative expression between LPS exposed naive-Mfs (1) and LPS-Mfs (0). Rescue-Mfs exposed to LPS show the most similar proﬁle to naive-Mfs. On the top of
the heatmap is median expression (log2 RPKM) of tolerized genes at day 6 and LPS re-exposure in naive-Mfs (black), LPS-Mfs (red), LPS-co-IBET-Mfs (blue),
LPS + IBET-Mfs (light blue), and rescue-Mfs (purple).
(C) BG reverses the tolerization of key LPS-induced transcription factors, such as STAT2, STAT5A, IRF1, and IRF8. Log2 fold change increase in mRNA
expression is shown.
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mRNA expression of key cytokines at 4 hr (not shown) and fail to
release cytokines in response to a second ex vivo LPS exposure.
In this regard, they behave much like in vitro LPS-tolerized
monocytes. Monocytes were isolated from peripheral blood
taken before and after LPS administration, and then exposed
ex vivo to either culture medium alone, or with BG. Cytokine
release wasmeasured following LPS re-exposure in culture (Fig-
ure 5D). Ex vivo BG exposure increased the release of tumor ne-
crosis factor (TNF) and IL-6 in tolerized monocytes at LPS re-
exposure (Figures 5B and 5C). This ﬁnding indicates that BG
can restore cytokine production of in-vivo-tolerized monocytes.
Cumulatively, this conﬁrms that the mechanisms involved in the
establishment of tolerance by LPS in vivo and in vitro are similar,
validating the use of the in vitro model to study reversal of toler-
ance by BG. More importantly, it suggests that the BG effect on
monocyte tolerance may be transferred to the clinic in the future.
b-Glucan Recovers the Transcriptional Response to LPS
at Tolerized Genes
Next, we assessed whether BG reverses tolerance at the tran-
scriptional level. In this experimental setup, monocytes were
exposed to LPS followed by BG and then left to rest 24 hr or
4 days before LPS re-exposure for 4 hr (Figure 6A). Additionally,
monocytes were treated with a combination of LPS and IBET151
(preventative) and LPS followed by IBET151 (reversal). BG was
able to recover the induction of 60% of tolerized genes at day
6 (Figure 6A), including several pro-inﬂammatory TFs (Figure 6B).
Similar effects were observed when IBET151 was used in a pre-
ventative model, indicating that BG reversal of LPS-induced
tolerance leads to an outcome similar to that produced by block-
ing LPS-induced tolerance altogether. Overall BG reversal led to
a higher median expression of tolerized genes compared to both
preventative and reversal use of IBET151 (Figure 6A).
Epigenomic Analysis of b-Glucan Recovery of Tolerized
Macrophages
BG exposure following LPS exposure recovers the expression of
genes involved in lipid biosynthesis, phagocytosis, and cytokine
transport (Figures S7A and S7B). Recovery of expression was
observedasearly asday3 andmaintainedat a higher level inmac-
rophages at day 6 (Figure S7B). Interestingly, addition of BG to
naive and tolerized monocytes at day 1, elicited the expression
of EGR2 and MITF within 4 hr, with a lower induction in tolerized
monocytes (Figure S7C). These ﬁndings indicate that BG-induced
receptor pathways remainat least partially inducible after theLPS-
induced cytokine response and that these pathways can partially
recover the naivemacrophage epigenetic and transcriptional pro-
grams. Analysis of dynamic H3K27ac promoters and enhancers
in naive-Mfs, LPS-Mfs, rescue-Mfs, and LPS-co-IBET151-Mfs
revealed that BG exposure restores H3K27ac deposition at re-
gions where H3K27ac increase was not obtained following LPS
exposure (Figure 7). Interestingly, while IBET151 blocks 75%
of the transcriptional response to LPS in monocytes at 4 hr (data
not shown), LPS-co-IBET151-Mfs look more like LPS-Mfs at day
6, indicating noeffect of IBET151on the overall epigenomic proﬁle
of LPS-Mfs (Figure 7A, blue square). The effect of BGexposure on
H3K27ac deposition in LPS-Mfs was observable at both pro-
moters and distal enhancers of genes involved in metabolism
and lipid biosynthesis (Figures 7C and 7D).
DISCUSSION
Perturbation of normal monocyte-to-macrophage differentiation
by exogenous signals, such as high bacterial burden in sepsis,
can lead to a changed chromatin state and an associated devi-
ation from steady-state function (Amit et al., 2016). This phenom-
enon is known as innate immune memory, with the best-charac-
terized outcomes being endotoxin tolerance or trained innate
immunity (Netea et al., 2016). Trained immunity can have bene-
ﬁcial effects through priming of macrophages for stronger re-
sponses to subsequent infection and can be induced by a variety
of MAMPs, such as C. albicans (Quintin et al., 2012), Bacille
Calmette-Gue´rin (BCG) vaccine (Kleinnijenhuis et al., 2012),
and BG (Saeed et al., 2014). Conversely, exposure to high levels
of LPS can induce a tolerizedmacrophage phenotype, which is a
major cause of sepsis-associated mortality (SepsisReport,
2012). Previously, we showed that tolerized macrophages
(LPS-Mfs) and trained macrophages (BG-Mfs) have distinct
epigenetic (Saeed et al., 2014), and metabolic states (Cheng
et al., 2014). Mouse studies have shown that such distal element
markings are important for appropriate responses to infection
(Ghisletti et al., 2010; Ostuni et al., 2013) and identity of tissue-
resident macrophages (Amit et al., 2016; Lavin et al., 2014).
Nevertheless, until now, the epigenetic basis for endotoxin toler-
ance in humans has not been explored.
In the current study, our aim was to unveil the early epigenetic
and transcriptional events following monocyte exposure to LPS
or BG and how the resulting epigenetic landscapes determine
the function of tolerized and trained macrophages. LPS- and
BG-induced active histone dynamics were observed as early
as 1 hr and 4 hr after exposure, respectively (Figures 1B and
1C). Generally, H3K27ac accumulation was accompanied by
H3K4me1 accumulation, most obviously at BG-induced en-
hancers (Figure S1B). Contrary to this general pattern, LPS-
induced active enhancers, associated with an inﬂammation
response, showed discordance in time with accumulation of
H3K4me1 (Figure S1B), which remained at higher levels in
LPS-Mfs compared to naive-Mfs and BG-Mfs. This persistence
of H3K4me1 in LPS-Mfs contributes to the overall epigenetic
signature of this macrophage subtype and may account for
some of the tolerized phenotype (Figure 1B). More pointedly,
we discovered a set of more than 3,000 de novo macrophage
(C) Preventative use of IBET blocks the ﬁrst LPS response in monocytes, resulting in differentiation of macrophages that can release cytokines at the second LPS
exposure. Therapeutic use of IBET does not re-instate cytokine release in macrophages.
(D) Experimental human endotoxemia model, with ex vivo BG administration. Monocytes were isolated from 12 healthy volunteers before (naive) and 4 hr after
LPS injection (tolerized). Naive or tolerized monocytes were exposed to BG for 24 hr, followed by culture media, or culture media alone. After 3 days ex vivo,
monocytes were re-exposed to LPS, and cytokines were measured 24 hr later.
(E and F) BG recovered IL-6 release in 9 out of 12 tolerized monocytes (E) and TNF release in 8 out of 12 monocytes (F). Data are presented as mean ± SD.
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established distal enhancers that were modulated in the oppo-
site direction by BG or LPS exposure (Figure 1D). Deposition of
H3K27ac and H3K4me1 at these regions was accelerated by
BG exposure and delayed or completely blocked by LPS expo-
sure. Accordingly, expression of genes near these elements was
induced by BG, peaking at 24 hr post-exposure, while they re-
mained lowly expressed in LPS-exposed monocytes (Figure 1F).
These genes were involved in lipid metabolism and biosynthesis,
phagocytosis, and lysosomematuration (Figures 1G and S2) and
have clear TF motif signatures for EGR2, MITF, and ARNT (Fig-
ure 2A). Interestingly, EGR2, a TF downstream of the BG recep-
tor dectin-1, showed clear transient upregulation by BG but re-
mained inactive in LPS-exposed monocytes, suggesting a
possible role in modulating these pathways (Figure S4). TFs
and pathways linking lipid biosynthesis and inﬂammation have
been described (Spann et al., 2012). Further, macrophage
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Figure 6.Q1 Reversal of Tolerance by BG at the Transcriptional Level
(A) Heatmap of the transcriptional response of naive-Mfs, LPS-Mfs, and rescue-Mfs (BG reversed LPS-Mfs) to LPS re-exposure at day 6. The scale represents
relative expression between LPS exposed naive-Mfs (1) and LPS-Mfs (0). Rescue-Mfs exposed to LPS show the most similar proﬁle to naive-Mfs. On the top of
the heatmap is median expression (log2 RPKM) of tolerized genes at day 6 and LPS re-exposure in naive-Mfs (black), LPS-Mfs (red), LPS-co-IBET-Mfs (blue),
LPS + IBET-Mfs (light blue), and rescue-Mfs (purple).
(C) BG reverses the tolerization of key LPS-induced transcription factors, such as STAT2, STAT5A, IRF1, and IRF8. Log2 fold change increase in mRNA
expression is shown.
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mRNA expression of key cytokines at 4 hr (not shown) and fail to
release cytokines in response to a second ex vivo LPS exposure.
In this regard, they behave much like in vitro LPS-tolerized
monocytes. Monocytes were isolated from peripheral blood
taken before and after LPS administration, and then exposed
ex vivo to either culture medium alone, or with BG. Cytokine
release wasmeasured following LPS re-exposure in culture (Fig-
ure 5D). Ex vivo BG exposure increased the release of tumor ne-
crosis factor (TNF) and IL-6 in tolerized monocytes at LPS re-
exposure (Figures 5B and 5C). This ﬁnding indicates that BG
can restore cytokine production of in-vivo-tolerized monocytes.
Cumulatively, this conﬁrms that the mechanisms involved in the
establishment of tolerance by LPS in vivo and in vitro are similar,
validating the use of the in vitro model to study reversal of toler-
ance by BG. More importantly, it suggests that the BG effect on
monocyte tolerance may be transferred to the clinic in the future.
b-Glucan Recovers the Transcriptional Response to LPS
at Tolerized Genes
Next, we assessed whether BG reverses tolerance at the tran-
scriptional level. In this experimental setup, monocytes were
exposed to LPS followed by BG and then left to rest 24 hr or
4 days before LPS re-exposure for 4 hr (Figure 6A). Additionally,
monocytes were treated with a combination of LPS and IBET151
(preventative) and LPS followed by IBET151 (reversal). BG was
able to recover the induction of 60% of tolerized genes at day
6 (Figure 6A), including several pro-inﬂammatory TFs (Figure 6B).
Similar effects were observed when IBET151 was used in a pre-
ventative model, indicating that BG reversal of LPS-induced
tolerance leads to an outcome similar to that produced by block-
ing LPS-induced tolerance altogether. Overall BG reversal led to
a higher median expression of tolerized genes compared to both
preventative and reversal use of IBET151 (Figure 6A).
Epigenomic Analysis of b-Glucan Recovery of Tolerized
Macrophages
BG exposure following LPS exposure recovers the expression of
genes involved in lipid biosynthesis, phagocytosis, and cytokine
transport (Figures S7A and S7B). Recovery of expression was
observedasearly asday3 andmaintainedat a higher level inmac-
rophages at day 6 (Figure S7B). Interestingly, addition of BG to
naive and tolerized monocytes at day 1, elicited the expression
of EGR2 and MITF within 4 hr, with a lower induction in tolerized
monocytes (Figure S7C). These ﬁndings indicate that BG-induced
receptor pathways remainat least partially inducible after theLPS-
induced cytokine response and that these pathways can partially
recover the naivemacrophage epigenetic and transcriptional pro-
grams. Analysis of dynamic H3K27ac promoters and enhancers
in naive-Mfs, LPS-Mfs, rescue-Mfs, and LPS-co-IBET151-Mfs
revealed that BG exposure restores H3K27ac deposition at re-
gions where H3K27ac increase was not obtained following LPS
exposure (Figure 7). Interestingly, while IBET151 blocks 75%
of the transcriptional response to LPS in monocytes at 4 hr (data
not shown), LPS-co-IBET151-Mfs look more like LPS-Mfs at day
6, indicating noeffect of IBET151on the overall epigenomic proﬁle
of LPS-Mfs (Figure 7A, blue square). The effect of BGexposure on
H3K27ac deposition in LPS-Mfs was observable at both pro-
moters and distal enhancers of genes involved in metabolism
and lipid biosynthesis (Figures 7C and 7D).
DISCUSSION
Perturbation of normal monocyte-to-macrophage differentiation
by exogenous signals, such as high bacterial burden in sepsis,
can lead to a changed chromatin state and an associated devi-
ation from steady-state function (Amit et al., 2016). This phenom-
enon is known as innate immune memory, with the best-charac-
terized outcomes being endotoxin tolerance or trained innate
immunity (Netea et al., 2016). Trained immunity can have bene-
ﬁcial effects through priming of macrophages for stronger re-
sponses to subsequent infection and can be induced by a variety
of MAMPs, such as C. albicans (Quintin et al., 2012), Bacille
Calmette-Gue´rin (BCG) vaccine (Kleinnijenhuis et al., 2012),
and BG (Saeed et al., 2014). Conversely, exposure to high levels
of LPS can induce a tolerizedmacrophage phenotype, which is a
major cause of sepsis-associated mortality (SepsisReport,
2012). Previously, we showed that tolerized macrophages
(LPS-Mfs) and trained macrophages (BG-Mfs) have distinct
epigenetic (Saeed et al., 2014), and metabolic states (Cheng
et al., 2014). Mouse studies have shown that such distal element
markings are important for appropriate responses to infection
(Ghisletti et al., 2010; Ostuni et al., 2013) and identity of tissue-
resident macrophages (Amit et al., 2016; Lavin et al., 2014).
Nevertheless, until now, the epigenetic basis for endotoxin toler-
ance in humans has not been explored.
In the current study, our aim was to unveil the early epigenetic
and transcriptional events following monocyte exposure to LPS
or BG and how the resulting epigenetic landscapes determine
the function of tolerized and trained macrophages. LPS- and
BG-induced active histone dynamics were observed as early
as 1 hr and 4 hr after exposure, respectively (Figures 1B and
1C). Generally, H3K27ac accumulation was accompanied by
H3K4me1 accumulation, most obviously at BG-induced en-
hancers (Figure S1B). Contrary to this general pattern, LPS-
induced active enhancers, associated with an inﬂammation
response, showed discordance in time with accumulation of
H3K4me1 (Figure S1B), which remained at higher levels in
LPS-Mfs compared to naive-Mfs and BG-Mfs. This persistence
of H3K4me1 in LPS-Mfs contributes to the overall epigenetic
signature of this macrophage subtype and may account for
some of the tolerized phenotype (Figure 1B). More pointedly,
we discovered a set of more than 3,000 de novo macrophage
(C) Preventative use of IBET blocks the ﬁrst LPS response in monocytes, resulting in differentiation of macrophages that can release cytokines at the second LPS
exposure. Therapeutic use of IBET does not re-instate cytokine release in macrophages.
(D) Experimental human endotoxemia model, with ex vivo BG administration. Monocytes were isolated from 12 healthy volunteers before (naive) and 4 hr after
LPS injection (tolerized). Naive or tolerized monocytes were exposed to BG for 24 hr, followed by culture media, or culture media alone. After 3 days ex vivo,
monocytes were re-exposed to LPS, and cytokines were measured 24 hr later.
(E and F) BG recovered IL-6 release in 9 out of 12 tolerized monocytes (E) and TNF release in 8 out of 12 monocytes (F). Data are presented as mean ± SD.
10 Cell 167, 1–15, November 17, 2016
CELL 9229
Please cite this article in press as: Novakovic et al., b-Glucan Reverses the Epigenetic State of LPS-Induced Immunological Tolerance, Cell
(2016), http://dx.doi.org/10.1016/j.cell.2016.09.034
Processed on: 17-11-2016
506677-L-bw-habibi
106
CHAPTER 4
indicating that the mechanisms controlling monocyte tolerance
in vivo can also be reverted to a more responsive phenotype.
In order to determine the ability of BG to reverse tolerance at
the molecular level, we ﬁrst characterized the transcriptional
and epigenetic response to a second LPS exposure in tolerized
macrophages (Figures 3 and 4). Studies in mouse sepsis models
and human sepsis patients have shown that rather than being
inert in response to a second LPS exposure, tolerized macro-
phages show a shift in the speciﬁc pathways that they activate
(Foster et al., 2007; Shalova et al., 2015). In line with these
studies, we show that LPS-Mfs remodel both H3K27ac and
gene expression in response to LPS (Figure 3B). However, the
starting point of LPS-Mfs is signiﬁcantly different from that of
naive and BG-Mfs, most clearly for H3K4me1 marked en-
hancers, suggesting that while activation is occurring, the avail-
able enhancer repertoire of these cells is limited or not suited.
Our analysis identiﬁed a gradient in the LPS-Mf response to
LPS, with some genes showing a tolerized pattern (no induction)
and others showing a responsive pattern (Figure 3C). The most
tolerized gene promoters were enriched for EGR2, HIF1A, and
p53 motifs, among many others. A potential role for HIF1A is in
agreement with a recent transcriptional analysis in monocytes
from sepsis patients (Shalova et al., 2015), while the p53
pathway was a top-ranked tolerized identiﬁed by Gene Ontology
(GO) analysis (Figure S5D). The strongest enrichment at partially
tolerized genes was for the IRF and STAT TF motifs that show
strong tolerized expression patterns themselves, ie, IRF1,
IRF8, STAT2, and STAT5A (Figure S6A). IRF8 and its down-
stream target, KLF4, both of which are important regulators of
monocyte differentiation (Kurotaki et al., 2013), show a tolerized
proﬁle and enrichment at tolerized gene promoters (Figure 4B).
Other, non-TF regulators of tolerance, such as IRAK3, HIF1A,
SOCS3, and IDO1, are all more highly expressed in LPS-Mfs
compared to naive-Mfs and BG-Mfs and have previously been
associated with endotoxin-induced tolerance (Bessede et al.,
2014; Saeed et al., 2014; Shalova et al., 2015).
Rescue macrophages (BG exposed following LPS exposure)
were able to induce60%of tolerized genes at LPS re-exposure
(Figure 6). This indicates that BG reversal of tolerance at the tran-
scriptional level is not complete (Figure 6A). Fascinatingly, BG
recovered the expression of tolerized genes to a level greater
than that observed in macrophages treated with IBET and LPS
together (Figure 6A). This indicates that BG can reinstate a
responsive state at a higher level than that obtained by actually
blocking the initial LPS transcriptional response. This important
observation suggests that BG-associated pathways remain
intact even after large-scale epigenetic and transcriptional pro-
grams are induced by LPS. At the level of histone modiﬁcations,
BG recovers H3K27ac at regions that are silent in LPS-Mfs,
further supporting the notion that the molecular mechanisms
required for BG-induced chromatin remodeling remain after
the initial LPS response (Figures 7 and S7).
In conclusion, the hypothesis-free epigenomic and transcrip-
tomic analysis of monocyte-to-macrophage differentiation and
innate immune memory generated a number of testable hypoth-
eses. Our ﬁndings show that the innate immune ‘‘training stim-
ulus’’ b-glucan can reverse macrophage tolerance ex vivo. This
is an important step toward understanding how the tolerized
phenotype can be reversed in sepsis patients and ultimately pro-
vides the framework for future therapeutic developments in
innate immune diseases.
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response to infection requires a substantial amount of energy,
and shifts in metabolism and energy production are a whole
mark of macrophage polarization to M1 or M2 subtypes (Ghes-
quie`re et al., 2014), as well as for establishment of trained immu-
nity (Cheng et al., 2014).
Reversal of tolerance after the initial inﬂammation phase has
garnered interest because of the limited success of inﬂamma-
tion-blocking treatments to reduce overall sepsis mortality
(Angus and van der Poll, 2013) and because the majority of
sepsis deaths occur due to secondary hospital infection during
the tolerized phase (Gilroy and Yona, 2015). Our hypothesis
was that BG can reverse LPS-induced tolerance because it
discordantly regulated pathways that LPS also affected. Specif-
ically, LPS fails to activate key regulators of lipid, lysosome, and
metabolism genes, EGR2 and MITF, while BG induces their
expression (Figures 1 and 2). Recently, IFNG was shown to
partially recover metabolic function in tolerized monocytes
from sepsis patients, indicating that reversal of tolerance using
innate immune ‘‘trainers’’ is a viable therapeutic strategy (Cheng
et al., 2016). We show that BG exposure can indeed reverse the
tolerance in macrophages induced by LPS exposure, with
rescue-Mfs showing higher release of cytokines in response to
a second LPS stimulus (Figures 5A–5C). This was in contrast to
the inﬂammation blocker IBET151, which only prevented toler-
ance when used to block the initial LPS response but could not
reverse it when given to cells after LPS-induced inﬂammation
(Figure 5). In order to further relate our ﬁndings to the in vivo sit-
uation, we used an experimental human endotoxemia model to
induce tolerance in vivo (Draisma et al., 2009; Kox et al., 2014).
In terms of cytokine production, in-vivo-tolerized monocytes
behave similarly to their in-vitro-tolerized counterparts. The to-
lerized state of in vivo LPS-exposed monocytes is similar to
that of ex-vivo-exposed monocytes and, most importantly, can
also be rescued by ex vivo BG exposure (Figures 5D–5F),
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Figure 7. Reversal of Tolerance by BG at the Chromatin Level
(A) PCA plot of H3K27ac dynamics amongmonocytes, naive-Mfs, LPS-Mfs, rescue-Mfs, and LPS-co-IBET-Mfs. BG exposure of tolerizedmonocytes results in a
H3K27ac proﬁle more similar to naive macrophages, while co-incubation of monocytes with LPS and IBET does not lead to activation of these regions.
(B) Heatmap showing re-establishment of the naive-Mf H3K27ac signal by BG exposure in tolerized macrophages.
(C) PCA plot of H3K4me1 dynamics among monocytes, naive-Mfs, LPS-Mfs, Rescue Mfs, and LPS-co-IBET-Mfs, the effect is similar to H3K27ac, but to a lesser
extent. (C) H3K27ac tracks at ATP9B (glucose transport) gene enhancer and (D) LPL (lipid metabolism) gene promoter.
See also Figure S7.
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indicating that the mechanisms controlling monocyte tolerance
in vivo can also be reverted to a more responsive phenotype.
In order to determine the ability of BG to reverse tolerance at
the molecular level, we ﬁrst characterized the transcriptional
and epigenetic response to a second LPS exposure in tolerized
macrophages (Figures 3 and 4). Studies in mouse sepsis models
and human sepsis patients have shown that rather than being
inert in response to a second LPS exposure, tolerized macro-
phages show a shift in the speciﬁc pathways that they activate
(Foster et al., 2007; Shalova et al., 2015). In line with these
studies, we show that LPS-Mfs remodel both H3K27ac and
gene expression in response to LPS (Figure 3B). However, the
starting point of LPS-Mfs is signiﬁcantly different from that of
naive and BG-Mfs, most clearly for H3K4me1 marked en-
hancers, suggesting that while activation is occurring, the avail-
able enhancer repertoire of these cells is limited or not suited.
Our analysis identiﬁed a gradient in the LPS-Mf response to
LPS, with some genes showing a tolerized pattern (no induction)
and others showing a responsive pattern (Figure 3C). The most
tolerized gene promoters were enriched for EGR2, HIF1A, and
p53 motifs, among many others. A potential role for HIF1A is in
agreement with a recent transcriptional analysis in monocytes
from sepsis patients (Shalova et al., 2015), while the p53
pathway was a top-ranked tolerized identiﬁed by Gene Ontology
(GO) analysis (Figure S5D). The strongest enrichment at partially
tolerized genes was for the IRF and STAT TF motifs that show
strong tolerized expression patterns themselves, ie, IRF1,
IRF8, STAT2, and STAT5A (Figure S6A). IRF8 and its down-
stream target, KLF4, both of which are important regulators of
monocyte differentiation (Kurotaki et al., 2013), show a tolerized
proﬁle and enrichment at tolerized gene promoters (Figure 4B).
Other, non-TF regulators of tolerance, such as IRAK3, HIF1A,
SOCS3, and IDO1, are all more highly expressed in LPS-Mfs
compared to naive-Mfs and BG-Mfs and have previously been
associated with endotoxin-induced tolerance (Bessede et al.,
2014; Saeed et al., 2014; Shalova et al., 2015).
Rescue macrophages (BG exposed following LPS exposure)
were able to induce60%of tolerized genes at LPS re-exposure
(Figure 6). This indicates that BG reversal of tolerance at the tran-
scriptional level is not complete (Figure 6A). Fascinatingly, BG
recovered the expression of tolerized genes to a level greater
than that observed in macrophages treated with IBET and LPS
together (Figure 6A). This indicates that BG can reinstate a
responsive state at a higher level than that obtained by actually
blocking the initial LPS transcriptional response. This important
observation suggests that BG-associated pathways remain
intact even after large-scale epigenetic and transcriptional pro-
grams are induced by LPS. At the level of histone modiﬁcations,
BG recovers H3K27ac at regions that are silent in LPS-Mfs,
further supporting the notion that the molecular mechanisms
required for BG-induced chromatin remodeling remain after
the initial LPS response (Figures 7 and S7).
In conclusion, the hypothesis-free epigenomic and transcrip-
tomic analysis of monocyte-to-macrophage differentiation and
innate immune memory generated a number of testable hypoth-
eses. Our ﬁndings show that the innate immune ‘‘training stim-
ulus’’ b-glucan can reverse macrophage tolerance ex vivo. This
is an important step toward understanding how the tolerized
phenotype can be reversed in sepsis patients and ultimately pro-
vides the framework for future therapeutic developments in
innate immune diseases.
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response to infection requires a substantial amount of energy,
and shifts in metabolism and energy production are a whole
mark of macrophage polarization to M1 or M2 subtypes (Ghes-
quie`re et al., 2014), as well as for establishment of trained immu-
nity (Cheng et al., 2014).
Reversal of tolerance after the initial inﬂammation phase has
garnered interest because of the limited success of inﬂamma-
tion-blocking treatments to reduce overall sepsis mortality
(Angus and van der Poll, 2013) and because the majority of
sepsis deaths occur due to secondary hospital infection during
the tolerized phase (Gilroy and Yona, 2015). Our hypothesis
was that BG can reverse LPS-induced tolerance because it
discordantly regulated pathways that LPS also affected. Specif-
ically, LPS fails to activate key regulators of lipid, lysosome, and
metabolism genes, EGR2 and MITF, while BG induces their
expression (Figures 1 and 2). Recently, IFNG was shown to
partially recover metabolic function in tolerized monocytes
from sepsis patients, indicating that reversal of tolerance using
innate immune ‘‘trainers’’ is a viable therapeutic strategy (Cheng
et al., 2016). We show that BG exposure can indeed reverse the
tolerance in macrophages induced by LPS exposure, with
rescue-Mfs showing higher release of cytokines in response to
a second LPS stimulus (Figures 5A–5C). This was in contrast to
the inﬂammation blocker IBET151, which only prevented toler-
ance when used to block the initial LPS response but could not
reverse it when given to cells after LPS-induced inﬂammation
(Figure 5). In order to further relate our ﬁndings to the in vivo sit-
uation, we used an experimental human endotoxemia model to
induce tolerance in vivo (Draisma et al., 2009; Kox et al., 2014).
In terms of cytokine production, in-vivo-tolerized monocytes
behave similarly to their in-vitro-tolerized counterparts. The to-
lerized state of in vivo LPS-exposed monocytes is similar to
that of ex-vivo-exposed monocytes and, most importantly, can
also be rescued by ex vivo BG exposure (Figures 5D–5F),
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Figure 7. Reversal of Tolerance by BG at the Chromatin Level
(A) PCA plot of H3K27ac dynamics amongmonocytes, naive-Mfs, LPS-Mfs, rescue-Mfs, and LPS-co-IBET-Mfs. BG exposure of tolerizedmonocytes results in a
H3K27ac proﬁle more similar to naive macrophages, while co-incubation of monocytes with LPS and IBET does not lead to activation of these regions.
(B) Heatmap showing re-establishment of the naive-Mf H3K27ac signal by BG exposure in tolerized macrophages.
(C) PCA plot of H3K4me1 dynamics among monocytes, naive-Mfs, LPS-Mfs, Rescue Mfs, and LPS-co-IBET-Mfs, the effect is similar to H3K27ac, but to a lesser
extent. (C) H3K27ac tracks at ATP9B (glucose transport) gene enhancer and (D) LPL (lipid metabolism) gene promoter.
See also Figure S7.
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CHAPTER 4
CONTACT FOR REAGENTS AND RESOURCE SHARING
Further information and requests for reagents may be directed to, and will be fulﬁlled by the corresponding author Hendrik G. Stun-
nenberg (h.stunnenberg@ncmls.ru.nl).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Monocytes from Healthy Donors
All primary cells were isolated from healthy volunteers who gave written informed consent (Sanquin Blood bank, Nijmegen, the
Netherlands). Volunteers are of Northern European descent. Peripheral blood mononuclear cells were isolated by centrifugation in
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REAGENT or RESOURCE SOURCE IDENTIFIER
E.Coli Ligase New England Biolabs M0205L
Rnasin Plus Rnase Inhibitor Promega N2615
Ribonuclease H Life Technologies AM2293
T4 DNA polymerase New England Biolabs M0203L
Sodium Acetate (3M) Life Technologies AM9740
DNase I QIAGEN 79254
Qubit RNA HS assay kit Life Technologies Q32852
Ribozero Gold Kit Illumina MRZG12324
Rneasy Mini Kit QIAGEN 74106
Deposited Data
Raw data ﬁles for RNA sequencing This paper GEO: GSE85243
Raw data ﬁles for ChIP sequencing This paper GEO: GSE85245
Raw data ﬁles for ATAC sequencing This paper GEO: GSE87218
Experimental Models: Organisms/Strains
Human: primary monocytes from healthy
volunteers
Sanquin Blood Bank N/A
Sequence-Based Reagents
NEXTﬂex DNA Barcodes - 48 Bioo Scientiﬁc 514104
Primer EGR2: F 50 TTGACCAGATGAACGGAGTG
30R 50 GTTGAAGCTGGGGAAGTGAC 30
This paper N/A
Primer MITF: F 50 AACTCATGCGTGAGCAGATG
30R 50 TACTTGGTGGGGTTTTCGAG 30
This paper N/A
Primer CSF1: F 50 CAGATGGAGACCTCGTGCC
30R 50 GCATTGGGGGTGTTATCTCTG 30
This paper N/A
Primer LAMP1: F 50 TGAACAAGACAGGCCT
TCCC 30R 50 TGTGCAGCTCCAGAGTCACC 30
This paper N/A
Software and Algorithms
Bedtools (Quinlan and Hall, 2010) http://bedtools.readthedocs.io/en/latest/
Bamtools (Barnett et al., 2011) https://github.com/pezmaster31/bamtools
Samtools (Li and Durbin, 2009) http://samtools.sourceforge.net/
GSNAP (Wu and Nacu, 2010) http://research-pub.gene.com/gmap/
GimmeMotifs (van Heeringen and Veenstra, 2011) https://github.com/simonvh/gimmemotifs
Caret (Kuhn, 2008) http://cran.r-project.org/web/packages/caret/
index.html
HOMER (Heinz et al., 2010) http://homer.salk.edu/homer/motif/
DAVID (Huang da et al., 2009) https://david.ncifcrf.gov/
bwa (Li and Durbin, 2009) http://bio-bwa.sourceforge.net/
bowtie (Langmead et al., 2009) http://bowtie-bio.sourceforge.net/index.shtml
MACS2 (Zhang et al., 2008) https://github.com/taoliu/MACS
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Rabbit polyclonal anti-H3K27ac Diagenode pAb-196-050
Rabbit polyclonal anti-H3K4me1 Diagenode pAb-037-050
Rabbit polyclonal anti-H3K4me3 Diagenode pAb-003-050
Rabbit polyclonal anti-H3K27me3 Diagenode pAb-195-050
Rabbit polyclonal anti-H3K9me3 Diagenode pAb-193-050
Chemicals, Peptides, and Recombinant Proteins
IBET-151 GSK Epinova and Cellzome GSK1210151A
Human Serum Sigma-Aldrich H4522-100ML
RPMI 1640 Medium, GlutaMAX Thermo Fisher Scientiﬁc 61870036
Gentamycin Thermo Fisher Scientiﬁc 15750060
L-glutamine Thermo Fisher Scientiﬁc 25030081
Sodium Pyruvate Thermo Fisher Scientiﬁc 11360070
Percoll Sigma-Aldrich P1644-1L
Ficoll Paque Plus Sigma-Aldrich GE17-1440-03
Lipopolysaccharides from Escherichia coli
055:B5
Sigma-Aldrich L2880-10MG
b1,3(D)glucan (b-glucan) (Saeed et al., 2014) N/A
2-Mercaptoethanol Thermo Fisher Scientiﬁc 21985023
Actinomycin D Thermo Fisher Scientiﬁc 11805017
IGEPAL CA-630 Sigma-Aldrich I8896-50ML
Critical Commercial Assays
KAPA library preparation kit Kapa Biosystems KK8400
riboZero gold rRNA removal kit Illumina MRZG12324
Nextera DNA Library Prep Kit Illumina FC-121-1031
TruSeq SBS KIT v3 - HS (50 cycles) Illumina FC-401-3002
NextSeq 500/550 High Output v2 kit (75 cycles) Illumina FC-404-2005
NEBNext High-Fidelity 2 3 PCR Master Mix New England Biolabs M0541
iQ SYBR Green Supermix Bio-Rad 1708880
100 3 SYBR Green I Nucleic Acid Gel Stain Thermo Fisher Scientiﬁc S7563
Human IL-6 elisa Sanquin M9316
Human TNFa elisa R&D DY210
SPRIselect reagent kit Beckman Coulter B23218
E-Gel SizeSelect Agarose Gels, 2% Thermo Fisher Scientiﬁc G661002
CD3 MicroBeads, human Miltenyi Biotec 130-050-101
CD19 MicroBeads, human Miltenyi Biotec 130-050-301
CD56 MicroBeads, human Miltenyi Biotec 130-050-401
dNTP set 100 mM Life Technologies 10297-018
dUTP 100 mM Promega U119A
Glycogen (20 mg/ml) Life Technologies 10814-010
Random Hexamer primers Sigma-Aldrich 11034731001
Second Strand Buffer Life Technologies 10812-014
Superscript III Reverse Transcriptase Life Technologies 18080-044
DNA polymerase I, E. coli New England Biolabs M0209S
USER enzyme New England Biolabs M5505L
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CHAPTER 4
Library Preparation for Sequencing
Illumina library preparationwas done using the KapaHyper Prep Kit. For end repair and A-tailing double strandedDNAwas incubated
with end repair and A-tailing buffer and enzyme and incubated ﬁrst for 30 min at 20�C and then for 30 min at 65�C.Subsequently
adapters were ligated by adding 30ml ligation buffer, 10 Kapa l DNA ligase, 5 ml diluted adaptor in a total volume of 110ml and incu-
bated for 15min at 15�C. Post-ligation cleanupwas performed using Agencourt AMPure XP reagent and productswere eluted in 20 ml
elution buffer. Libraries were ampliﬁed by adding 25 ml 2x KAPA HiFi Hotstart ReadyMix and 5ml 10x Library Ampliﬁcation Primer Mix
and PCR, 10 cycles. Samples were puriﬁed using the QIAquick MinElute PCR puriﬁcation kit and 300bp fragments selected using
E-gel. Correct size selection was conﬁrmed by BioAnalyzer analysis. Sequencing was performed using Illumina HiSeq 2000
machines and generated 43bp single end reads. Samples for RNA-seqwere treated to the above protocol exactly, except for a single
additional step: After post-ligation cleanup, and before library ampliﬁcation, samples were incubated with 3 uL USER enzyme for
15 min at 37�C to digest the 2nd cDNA strand.
Assay for Transposase Accessible Chromatin
Monocytes ormacrophages (100,000 cells) were scrapped in a well of a 6-well plate with cold PBS and then spun down at 8003 g for
5 min at 4�C. Cells were washed with 50 ml of cold 1x PBS buffer, incubated in 50 ml of cold lysis buffer (10 mM Tris-HCL (pH 7.4),
10 mM NaCl, 3 mMMgCl2 0, 1% IGEPAL) and spun down at 8003 g for 10 min at 4�C. The nuclei were immediately resuspended in
the transposition reaction mix (22.5 ml TD buffer, 2.5 ml Tn5 Transposase, 25 ml NF H2O) and incubated for 30 min at 37�C. Following
transposition, 100 ml AMPure beads were added to the reaction (sample-to-bead ratio of 1:2), mixed thoroughly by pipetting, and
incubated for 15 min at RT. Samples and beads were washed on the magnetic rack with 80% ethanol, dried for 5 min, and resus-
pended in 15 ml EB buffer. DNA was ampliﬁed with 10 - 15 PCR cycles using the mix (15 ml transposed DNA, 0.3 ml 100x SYBR Green
I, 25 ml NEBNext High-Fidelity master mix, 2.5 ml Nextera Primer index N7.. (25 mM), 2.5 ml Nextera Primer index S5.. (25 mM), 4.7 ml NF
H2O). In order to reduce GC and size bias in PCR, the PCR reaction is monitored using qPCR to stop ampliﬁcation prior to saturation.
Following ampliﬁcation, samples were incubated puriﬁed twice using SPRI beads, ﬁrst using negative selection with a sample-to-
bead ratio of 1-0.65 and then positive selection with a sample-to-bead ratio of 1-1.8. After 80% Ethanol wash and drying, the sample
was eluted in 20 ml EB buffer, and quality checked before sequencing. Detailed protocol can be found on the Blueprint website (http://
www.blueprint-epigenome.eu/UserFiles/ﬁle/Protocols/ATAC_Seq_Protocol.pdf).
Whole Genome Bisulﬁte Sequencing
Genomic DNA (1-2 mg) was spikedwith unmethylated lDNA (5ng of lDNA per mg of genomic DNA) (Promega). TheDNAwas sheared
by sonication to 50-500bp using a Covaris E220 and fragments of size 150-300 bpwere selected using AMPure XP beads (Agencourt
Bioscience). Genomic DNA libraries were constructed using the Illumina TruSeq Sample Preparation kit (Illumina) following the
lllumina standard protocol: end repair was performed on the DNA fragments, an adenine was added to the 30 extremities of the frag-
ments and Illumina TruSeq adapters were ligated at each extremity. Adter adaptor ligation, the DNAwas treated with sodium bisulﬁte
using the EpiTexy Bisulﬁte kit (QIAGEN) following the manufacturer’s instructions for formalin-ﬁxed and parafﬁn-embedded (FFPE)
tissue samples. Two rounds of bisulﬁte conversion were performed to assure a high conversion rate. An enrichment for adaptor-
ligated DNA was carried out through 7 PCR cycles using the PfuTurboCx Hotstart DNA polymerase (Stratagene). Library quality
was monitored using the Agilent 2100 BioAnalyzer (Agilent), and the concentration of viable sequencing fragments (molecules car-
rying adaptors at both extremities) estimated using quantitative PCRwith the library quantiﬁcation kit from KAPA Biosystem. Paired-
endDNA sequencing (2x100 nucleotides) was then performed using the Illumina Hi-Seq 2000.WGBSdata are available upon request
from the BLUEPRINT consortium.
RNA-Seq Data Analysis
For quality control and visualization, RNA-seq reads were aligned to the hg19 reference genome using GSNAP (Wu and Nacu, 2010)
with non-default parameters -m 1 -N 1 -n 1 -Q -s Ensembl_splice_68. Each RNA-seq sample was subjected to a quality control step,
where, based on read distribution over the annotated genome, libraries that are outlierswere identiﬁed and discarded from further anal-
ysis. To infer gene expression levels, RNA-seq reads were aligned to the Ensembl v68 human transcriptome using Bowtie. Quantiﬁca-
tion of gene expression was performed using MMSEQ. Differential expression was determined using MMDIFF. A two model compar-
ison was used to identify differentially expressed genes that confer cellular identity Mo/Mf. The null-model is that the mean expression
levels are the same in both cell types, and the alternativemodel is that themean expression levels are allowed to differ between the two
cell types. Genes with a larger posterior probability for the second model, an RPKM value greater than 2 in any of Mo or Mf and mini-
mally a 2-fold expression change were considered as differentially expressed. Expression changes related to differentiation of each
treatment were studied using a 52-model comparison, a.k.a. polytomous comparison, under the null-model that assumes the mean
expression levels are the same across each time-point. Expression differences related to the treatments at each time-point were stud-
ied using a 5-model comparison, under the null-model that assumes the mean expression levels are the same across each treatment.
ChIP-Seq Data Analysis
Sequencing reads were aligned to human genome assembly hg19 (NCBI version 37) using bwa. Duplicate reads were removed after
the alignment with the Picard tools. For peak calling the BAM ﬁles were ﬁrst ﬁltered to remove the reads with mapping quality less
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Ficoll-Paque (GE Healthcare), followed by removal of T cells using an additional Percoll gradient. Monocytes were puriﬁed from
PBMCs using negative selection in an LD column magnet separator, with beads for CD3+ (T cells), CD19+ (B cells) and CD56+
(NK cells) positive cells (Miltenyi Biotech), yielding > 95% pure monocytes. Successful isolation of monocytes was conﬁrmed with
FACS, as previously described (Saeed et al., 2014).
In Vitro Monocyte-to-Macrophage Differentiation and Induction of Innate Immune Memory
Monocytes were differentiated into resting macrophages by ex vivo culture in RPMI 1640 medium (Sigma Aldrich) with 10% Human
Serum. Media was supplemented with 10 mg/mL gentamycin, 10 mM L-glutamine and 10 mM pyruvate (Life Technologies). Toleriza-
tion was induced by treatment of monocytes with 10-100ng/mL LPS for 24 hr, followed by washout and ﬁve days culture in RPMI +
10% human serum, while trained innate immunity was induced by treatment with 5 mg/mL BG for 24 hr, followed by washout and
5 days in culture. Establishment of tolerance or training in the resultingmacrophages at day 6was determined by TNF and IL6 release
at 24 hr following LPS stimulation using ELISA. For ChIP-seq, 10x106 monocytes were seeded in 10cm dishes, for RNaseq and
ATAC-seq 1.5 3 106 monocytes were seeded in 6 well plates. IBET151 (GSK) was diluted to 50 mM stock using DMSO. Following
dosage titration 5 uM was determined as the appropriate ﬁnal concentrations to prevent tolerization, without causing cell death.
IBET-151 was added to monocytes at the same time as LPS for 24 hr, followed by washout and ﬁve days culture in RPMI + 10%
human serum to macrophage differentiation.
Experimental Human Endotoxemia Model
In vivo endotoxin tolerance was examined in 12 healthy nonsmoking volunteers who participated in an experimental human endo-
toxemia study. The study is registered at Clinicaltrials.gov (NCT02602977) and study protocols were approved by the local ethics
committee of the Radboud University Nijmegen Medical Centre (NL53584.091.15/CMO 2015-1796). Written informed consent
was obtained from all study participants. Subjects were screened before the start of the experiment and had a normal physical ex-
amination, electrocardiography, and routine laboratory values. Throughout the study period, subjects were not allowed to take any
drugs, including acetaminophen, and were asked to refrain from alcohol and caffeine 24 hr and from food 12 hr before the start of the
endotoxemia experiment. All study procedures were conducted in accordance with the declaration of Helsinki including current re-
visions and Good Clinical Practice guidelines. Experimental human endotoxemia was conducted as described previously (Kox et al.,
2014). Brieﬂy, all subjects received an intravenous bolus injection of LPS (lipopolysaccharide derived from Escherichia coli O:113,
Clinical Center Reference Endotoxin, National Institutes of Health (NIH), Bethesda, MD) at a dose of 2 ng/kg. Blood was obtained
before LPS administration and 4 hr afterward, and monocytes were isolated. Monocytes were exposed to culture or BG ex vivo,
and cytokine production in the supernatants was measured following ex vivo LPS (10ng/ml) exposure. Cytokine production was
determined by ELISA following the protocol of the manufactures (IL-6, sanquin and TNFa, R&D systems).
METHOD DETAILS
Cytokine Assays
TNFa and IL-6 were measured using ELISA according to the manufacturer protocol (IL6: Sanquin; and TNFa: R&D). For cytokines
production assays the differences between groups were analyzed using the Wilcoxon signed-rank test. The level of signiﬁcance
was deﬁned as a p value < 0.05.
RNA Extraction and cDNA Synthesis
Total RNA was extracted from cells using the QIAGEN RNeasy RNA extraction kit (QIAGEN, Netherlands), using on-column DNaseI
treatment. Ribosomal RNA was removed using the riboZero rRNA removal kit (Illumina). RNA was then fragmented into 200bp frag-
ments by incubation for 7.5 min at 95C in fragmentation buffer (200 mM Tris-acetate, 500 mM Potassium Acetate, 150 mM Mag-
nesium Acetate [pH 8.2]). First strand cDNA synthesis was performed using SuperScript III (Life Technologies), followed by synthesis
of the second cDNA strand. Library preparation was performed using the KAPA hyperprep kit (KAPA Biosystems). Quality of cDNA
and the efﬁciency of ribosomal RNA removal was conﬁrmed using quantitative RT-PCR using the IQ Sybr Supermix, with primers for
GAPDH, 18S and 28S rRNA.
Chromatin Immunoprecipitation
Puriﬁed cells were ﬁxed with 1% formaldehyde (Sigma) at a concentration of approximately 10 million cells/ml. Fixed cell prepara-
tions were sonicated using a Diagenode Bioruptor UCD-300 for 3x 10 min (30 s on; 30 s off). 67 ml of chromatin (1 million cells) was
incubated with 229 ml dilution buffer, 3 ml protease inhibitor cocktail and 0.5-1mg of H3K27ac, H3K4me3, H3K4me1, H3K27me3,
H3K9me3 or H3K36me3 antibodies (Diagenode) and incubated overnight at 4C with rotation. Protein A/G magnetic beads were
washed in dilution buffer with 0.15% SDS and 0.1%BSA, added to the chromatin/antibody mix and rotated for 60 min at 4C. Beads
were washedwith 400ml buffer for 5min at 4Cwith ﬁve rounds of washes. After washing chromatin was eluted using elution buffer for
20 min. Supernatant was collected, 8 ml 5M NaCl, 3ml proteinase K were added and samples were incubated for 4 hr at 65C.Finally
samples were puriﬁed using QIAGEN; Qiaquick MinElute PCR puriﬁcation Kit and eluted in 20 ml EB. Detailed protocols can be found
on the Blueprint website (http://www.blueprint-epigenome.eu/UserFiles/ﬁle/Protocols/Histone_ChIP_May2013.pdf).
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Library Preparation for Sequencing
Illumina library preparationwas done using the KapaHyper Prep Kit. For end repair and A-tailing double strandedDNAwas incubated
with end repair and A-tailing buffer and enzyme and incubated ﬁrst for 30 min at 20�C and then for 30 min at 65�C.Subsequently
adapters were ligated by adding 30ml ligation buffer, 10 Kapa l DNA ligase, 5 ml diluted adaptor in a total volume of 110ml and incu-
bated for 15min at 15�C. Post-ligation cleanupwas performed using Agencourt AMPure XP reagent and productswere eluted in 20 ml
elution buffer. Libraries were ampliﬁed by adding 25 ml 2x KAPA HiFi Hotstart ReadyMix and 5ml 10x Library Ampliﬁcation Primer Mix
and PCR, 10 cycles. Samples were puriﬁed using the QIAquick MinElute PCR puriﬁcation kit and 300bp fragments selected using
E-gel. Correct size selection was conﬁrmed by BioAnalyzer analysis. Sequencing was performed using Illumina HiSeq 2000
machines and generated 43bp single end reads. Samples for RNA-seqwere treated to the above protocol exactly, except for a single
additional step: After post-ligation cleanup, and before library ampliﬁcation, samples were incubated with 3 uL USER enzyme for
15 min at 37�C to digest the 2nd cDNA strand.
Assay for Transposase Accessible Chromatin
Monocytes ormacrophages (100,000 cells) were scrapped in a well of a 6-well plate with cold PBS and then spun down at 8003 g for
5 min at 4�C. Cells were washed with 50 ml of cold 1x PBS buffer, incubated in 50 ml of cold lysis buffer (10 mM Tris-HCL (pH 7.4),
10 mM NaCl, 3 mMMgCl2 0, 1% IGEPAL) and spun down at 8003 g for 10 min at 4�C. The nuclei were immediately resuspended in
the transposition reaction mix (22.5 ml TD buffer, 2.5 ml Tn5 Transposase, 25 ml NF H2O) and incubated for 30 min at 37�C. Following
transposition, 100 ml AMPure beads were added to the reaction (sample-to-bead ratio of 1:2), mixed thoroughly by pipetting, and
incubated for 15 min at RT. Samples and beads were washed on the magnetic rack with 80% ethanol, dried for 5 min, and resus-
pended in 15 ml EB buffer. DNA was ampliﬁed with 10 - 15 PCR cycles using the mix (15 ml transposed DNA, 0.3 ml 100x SYBR Green
I, 25 ml NEBNext High-Fidelity master mix, 2.5 ml Nextera Primer index N7.. (25 mM), 2.5 ml Nextera Primer index S5.. (25 mM), 4.7 ml NF
H2O). In order to reduce GC and size bias in PCR, the PCR reaction is monitored using qPCR to stop ampliﬁcation prior to saturation.
Following ampliﬁcation, samples were incubated puriﬁed twice using SPRI beads, ﬁrst using negative selection with a sample-to-
bead ratio of 1-0.65 and then positive selection with a sample-to-bead ratio of 1-1.8. After 80% Ethanol wash and drying, the sample
was eluted in 20 ml EB buffer, and quality checked before sequencing. Detailed protocol can be found on the Blueprint website (http://
www.blueprint-epigenome.eu/UserFiles/ﬁle/Protocols/ATAC_Seq_Protocol.pdf).
Whole Genome Bisulﬁte Sequencing
Genomic DNA (1-2 mg) was spikedwith unmethylated lDNA (5ng of lDNA per mg of genomic DNA) (Promega). TheDNAwas sheared
by sonication to 50-500bp using a Covaris E220 and fragments of size 150-300 bpwere selected using AMPure XP beads (Agencourt
Bioscience). Genomic DNA libraries were constructed using the Illumina TruSeq Sample Preparation kit (Illumina) following the
lllumina standard protocol: end repair was performed on the DNA fragments, an adenine was added to the 30 extremities of the frag-
ments and Illumina TruSeq adapters were ligated at each extremity. Adter adaptor ligation, the DNAwas treated with sodium bisulﬁte
using the EpiTexy Bisulﬁte kit (QIAGEN) following the manufacturer’s instructions for formalin-ﬁxed and parafﬁn-embedded (FFPE)
tissue samples. Two rounds of bisulﬁte conversion were performed to assure a high conversion rate. An enrichment for adaptor-
ligated DNA was carried out through 7 PCR cycles using the PfuTurboCx Hotstart DNA polymerase (Stratagene). Library quality
was monitored using the Agilent 2100 BioAnalyzer (Agilent), and the concentration of viable sequencing fragments (molecules car-
rying adaptors at both extremities) estimated using quantitative PCRwith the library quantiﬁcation kit from KAPA Biosystem. Paired-
endDNA sequencing (2x100 nucleotides) was then performed using the Illumina Hi-Seq 2000.WGBSdata are available upon request
from the BLUEPRINT consortium.
RNA-Seq Data Analysis
For quality control and visualization, RNA-seq reads were aligned to the hg19 reference genome using GSNAP (Wu and Nacu, 2010)
with non-default parameters -m 1 -N 1 -n 1 -Q -s Ensembl_splice_68. Each RNA-seq sample was subjected to a quality control step,
where, based on read distribution over the annotated genome, libraries that are outlierswere identiﬁed and discarded from further anal-
ysis. To infer gene expression levels, RNA-seq reads were aligned to the Ensembl v68 human transcriptome using Bowtie. Quantiﬁca-
tion of gene expression was performed using MMSEQ. Differential expression was determined using MMDIFF. A two model compar-
ison was used to identify differentially expressed genes that confer cellular identity Mo/Mf. The null-model is that the mean expression
levels are the same in both cell types, and the alternativemodel is that themean expression levels are allowed to differ between the two
cell types. Genes with a larger posterior probability for the second model, an RPKM value greater than 2 in any of Mo or Mf and mini-
mally a 2-fold expression change were considered as differentially expressed. Expression changes related to differentiation of each
treatment were studied using a 52-model comparison, a.k.a. polytomous comparison, under the null-model that assumes the mean
expression levels are the same across each time-point. Expression differences related to the treatments at each time-point were stud-
ied using a 5-model comparison, under the null-model that assumes the mean expression levels are the same across each treatment.
ChIP-Seq Data Analysis
Sequencing reads were aligned to human genome assembly hg19 (NCBI version 37) using bwa. Duplicate reads were removed after
the alignment with the Picard tools. For peak calling the BAM ﬁles were ﬁrst ﬁltered to remove the reads with mapping quality less
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Ficoll-Paque (GE Healthcare), followed by removal of T cells using an additional Percoll gradient. Monocytes were puriﬁed from
PBMCs using negative selection in an LD column magnet separator, with beads for CD3+ (T cells), CD19+ (B cells) and CD56+
(NK cells) positive cells (Miltenyi Biotech), yielding > 95% pure monocytes. Successful isolation of monocytes was conﬁrmed with
FACS, as previously described (Saeed et al., 2014).
In Vitro Monocyte-to-Macrophage Differentiation and Induction of Innate Immune Memory
Monocytes were differentiated into resting macrophages by ex vivo culture in RPMI 1640 medium (Sigma Aldrich) with 10% Human
Serum. Media was supplemented with 10 mg/mL gentamycin, 10 mM L-glutamine and 10 mM pyruvate (Life Technologies). Toleriza-
tion was induced by treatment of monocytes with 10-100ng/mL LPS for 24 hr, followed by washout and ﬁve days culture in RPMI +
10% human serum, while trained innate immunity was induced by treatment with 5 mg/mL BG for 24 hr, followed by washout and
5 days in culture. Establishment of tolerance or training in the resultingmacrophages at day 6was determined by TNF and IL6 release
at 24 hr following LPS stimulation using ELISA. For ChIP-seq, 10x106 monocytes were seeded in 10cm dishes, for RNaseq and
ATAC-seq 1.5 3 106 monocytes were seeded in 6 well plates. IBET151 (GSK) was diluted to 50 mM stock using DMSO. Following
dosage titration 5 uM was determined as the appropriate ﬁnal concentrations to prevent tolerization, without causing cell death.
IBET-151 was added to monocytes at the same time as LPS for 24 hr, followed by washout and ﬁve days culture in RPMI + 10%
human serum to macrophage differentiation.
Experimental Human Endotoxemia Model
In vivo endotoxin tolerance was examined in 12 healthy nonsmoking volunteers who participated in an experimental human endo-
toxemia study. The study is registered at Clinicaltrials.gov (NCT02602977) and study protocols were approved by the local ethics
committee of the Radboud University Nijmegen Medical Centre (NL53584.091.15/CMO 2015-1796). Written informed consent
was obtained from all study participants. Subjects were screened before the start of the experiment and had a normal physical ex-
amination, electrocardiography, and routine laboratory values. Throughout the study period, subjects were not allowed to take any
drugs, including acetaminophen, and were asked to refrain from alcohol and caffeine 24 hr and from food 12 hr before the start of the
endotoxemia experiment. All study procedures were conducted in accordance with the declaration of Helsinki including current re-
visions and Good Clinical Practice guidelines. Experimental human endotoxemia was conducted as described previously (Kox et al.,
2014). Brieﬂy, all subjects received an intravenous bolus injection of LPS (lipopolysaccharide derived from Escherichia coli O:113,
Clinical Center Reference Endotoxin, National Institutes of Health (NIH), Bethesda, MD) at a dose of 2 ng/kg. Blood was obtained
before LPS administration and 4 hr afterward, and monocytes were isolated. Monocytes were exposed to culture or BG ex vivo,
and cytokine production in the supernatants was measured following ex vivo LPS (10ng/ml) exposure. Cytokine production was
determined by ELISA following the protocol of the manufactures (IL-6, sanquin and TNFa, R&D systems).
METHOD DETAILS
Cytokine Assays
TNFa and IL-6 were measured using ELISA according to the manufacturer protocol (IL6: Sanquin; and TNFa: R&D). For cytokines
production assays the differences between groups were analyzed using the Wilcoxon signed-rank test. The level of signiﬁcance
was deﬁned as a p value < 0.05.
RNA Extraction and cDNA Synthesis
Total RNA was extracted from cells using the QIAGEN RNeasy RNA extraction kit (QIAGEN, Netherlands), using on-column DNaseI
treatment. Ribosomal RNA was removed using the riboZero rRNA removal kit (Illumina). RNA was then fragmented into 200bp frag-
ments by incubation for 7.5 min at 95C in fragmentation buffer (200 mM Tris-acetate, 500 mM Potassium Acetate, 150 mM Mag-
nesium Acetate [pH 8.2]). First strand cDNA synthesis was performed using SuperScript III (Life Technologies), followed by synthesis
of the second cDNA strand. Library preparation was performed using the KAPA hyperprep kit (KAPA Biosystems). Quality of cDNA
and the efﬁciency of ribosomal RNA removal was conﬁrmed using quantitative RT-PCR using the IQ Sybr Supermix, with primers for
GAPDH, 18S and 28S rRNA.
Chromatin Immunoprecipitation
Puriﬁed cells were ﬁxed with 1% formaldehyde (Sigma) at a concentration of approximately 10 million cells/ml. Fixed cell prepara-
tions were sonicated using a Diagenode Bioruptor UCD-300 for 3x 10 min (30 s on; 30 s off). 67 ml of chromatin (1 million cells) was
incubated with 229 ml dilution buffer, 3 ml protease inhibitor cocktail and 0.5-1mg of H3K27ac, H3K4me3, H3K4me1, H3K27me3,
H3K9me3 or H3K36me3 antibodies (Diagenode) and incubated overnight at 4C with rotation. Protein A/G magnetic beads were
washed in dilution buffer with 0.15% SDS and 0.1%BSA, added to the chromatin/antibody mix and rotated for 60 min at 4C. Beads
were washedwith 400ml buffer for 5min at 4Cwith ﬁve rounds of washes. After washing chromatin was eluted using elution buffer for
20 min. Supernatant was collected, 8 ml 5M NaCl, 3ml proteinase K were added and samples were incubated for 4 hr at 65C.Finally
samples were puriﬁed using QIAGEN; Qiaquick MinElute PCR puriﬁcation Kit and eluted in 20 ml EB. Detailed protocols can be found
on the Blueprint website (http://www.blueprint-epigenome.eu/UserFiles/ﬁle/Protocols/Histone_ChIP_May2013.pdf).
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Figure S1. Summary of DynamicHistoneMarks and PCAPlots of Dynamic Active HistoneModiﬁcations at Promoters andRepressiveMarks,
Related to Figure 1
(A) Percentage of histone ChIP-seq peaks designated as dynamic across time-points and between treatments. H3K27ac was the most dynamic modiﬁcation,
with almost a third of regions showing signiﬁcant changes.
(B) Heatmap showing histone intensity of H3K27ac and H3K4me1 at dynamic H3K27ac enhancers with 12kb ± from center of the peak.
(C) PCA plots for all time-points for H3K27ac dynamic promoters, H3K4me3 dynamic promoters, dynamic H3K27me3 regions, and dynamic H3K9me3 regions.
H3K27ac and H3K4me3 at promoters behave similarly over time and in response to LPS or BG exposure, and reﬂect the behavior of H3K27ac at enhancers.
Unlike active marks, repressive marks show little dynamics up to day 1.
(D) Stacked plots showing chromatin state changes over differentiation at ‘‘LPS-Mf up’’ and ‘‘BG up / LPS down’’ H3K4me1 enhancers. These enhancers are
established through H3K27ac dynamics shown in Figure 1C. The genome was segmented into 9 chromatin states based on the 5 histone marks analyzed. This
analysis indicates that H3K4me1 increase is associated with loss of H3K27me3.
than 15, followed by fragment size modeling (https://code.google.com/archive/p/phantompeakqualtools/). MACS2 (https://github.
com/taoliu/MACS/) was used to call the peaks. H3K4me1,H3K9me3 and H3K27me3 peaks were called using the broad setting of
MACS2 while H3K27ac and H3K4me3 were called using the default (narrow) setting. For each histone mark dataset, the data
were normalized using theR packageDESeq2 and then pair-wise comparisonswere performed (fold change 3, adjusted p-adjvalue <
0.05 and RPKMR 2 in at least in any condition) to determine the differentially expressed genes per condition. The results from all
possible pairwise comparisons (within each condition and similar time points across all conditions per mark) were pooled and
merged to deﬁne the dynamic set of enriched regions. Promoters were deﬁned as regions between ± 2kb from TSSs for each
ensemble gene and enhancers were determined as enriched H3K27ac/H3K4me1 regions more than ± 2kb away from the TSS.
To ﬁnd different patterns over dynamic promoters or enhancers, we applied a K-means clustering procedure (with optimal number
of clusters per each dataset) to the dynamic datasets as described above.
ATAC-Seq Data Analysis
The full ATAC-seq protocol is available at the BLUEPRINT website (http://www.blueprint-epigenome.eu/UserFiles/ﬁle/Protocols/
ATAC_Seq_Protocol.pdf). ATAC-seq readsweremapped to the hg19 reference genome using BWA (Li andDurbin, 2009) with default
parameters. Non-uniquely mapped reads and PCR duplicates were removed. MACS2 (Zhang et al., 2008) was used to identify re-
gions of open chromatin (peaks) with parameters ‘‘–nomodel -p 1e-9.’’ Overlap peaks from different samples were merged.
DNA-Binding Motif Scanning
All the DNA-binding motifs used in this study are based on the cis-bp database described in (Weirauch et al., 2014). Only motifs with
direct evidence of binding in the species of vertebrate were selected.Within eachmotif family, as annotated by cis-bp, all motifs were
clustered using ‘gimme cluster’ from the GimmeMotifs package (van Heeringen and Veenstra, 2011) with a threshold of 0.9999. The
annotation of motifs is based on the annotation of human in the cis-bp database. Motifs were used for scanning if the assigned TF is
expressed (> 1 RPKM) in at least one time-point during the differentiation. Total ATAC-seq peaks were scanned for the presence of
motifs. We used Gimme motifs for scanning with dynamic motif scoring cut-offs targeting a false discovery rate (FDR) of both 0.01
and 0.05. To look at the motif enrichments in each set of regions (epigenetic cluster or gene cluster), ATAC-seq peaks were assigned
to the epigenomic cluster or the gene promoters by intersection. Motif occurrences were acquired by intersection of the assigned
ATAC-seq peaks with the motif scanning results on total ATAC-seq peaks. Total ATAC-seq peaks were divided into promoter set
and non-promoter set as the background for the calculation of motif enrichment. Enrichment of motifs in each set of regions was
deﬁned by applying a hypergeometric test using the motif frequency in the corresponding background. This results in TFs that pu-
tatively regulate the activities of the regulatory regions. Motifs in each heat map satisfy an arbitrary cutoff of > 5%motif presence and
a ﬁxed minimal presence difference from background in at least one cluster. Hierarchical clustering (Pearson correlation) was per-
formed in each heat map using the motif occurrence frequencies in the clusters. Based on the gene activity and dynamics, only one
TF was selected to represent a motif if multiple genes are assigned to the same motif. Scanning results from FDR of 0.01 and 0.05
were compared and do not affect the result of enrichment analysis.
Gene Ontology Analysis
Gene ontology analysis on dynamic lists of genes was performed using DAVID (Huang da et al., 2009). Gene ontology on dynamic
enhancer clusters was performed using GREAT (McLean et al., 2010). KEGG pathways and Biological Processes were ranked by p
value and the top terms were plotted.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical parameters including the exact value of n, the deﬁnition of center, dispersion, and precision measures (mean ± SEM) and
statistical signiﬁcance are reported in the Figures and the Figure Legends. Data are judged to be statistically signiﬁcant when p < 0.05
by two-tailed Student’s T-Test or 2-way ANOVA, where appropriate.
DATA AND SOFTWARE AVAILABILITY
Data Resources
Raw data ﬁles for the RNA and ChIP sequencing and analysis have been deposited in the NCBI Gene Expression Omnibus under
accession number: GSE85246.
Links to GEO SubSeries linked to GSE85246:
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE85243
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE85245
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE87218
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Figure S1. Summary of DynamicHistoneMarks and PCAPlots of Dynamic Active HistoneModiﬁcations at Promoters andRepressiveMarks,
Related to Figure 1
(A) Percentage of histone ChIP-seq peaks designated as dynamic across time-points and between treatments. H3K27ac was the most dynamic modiﬁcation,
with almost a third of regions showing signiﬁcant changes.
(B) Heatmap showing histone intensity of H3K27ac and H3K4me1 at dynamic H3K27ac enhancers with 12kb ± from center of the peak.
(C) PCA plots for all time-points for H3K27ac dynamic promoters, H3K4me3 dynamic promoters, dynamic H3K27me3 regions, and dynamic H3K9me3 regions.
H3K27ac and H3K4me3 at promoters behave similarly over time and in response to LPS or BG exposure, and reﬂect the behavior of H3K27ac at enhancers.
Unlike active marks, repressive marks show little dynamics up to day 1.
(D) Stacked plots showing chromatin state changes over differentiation at ‘‘LPS-Mf up’’ and ‘‘BG up / LPS down’’ H3K4me1 enhancers. These enhancers are
established through H3K27ac dynamics shown in Figure 1C. The genome was segmented into 9 chromatin states based on the 5 histone marks analyzed. This
analysis indicates that H3K4me1 increase is associated with loss of H3K27me3.
than 15, followed by fragment size modeling (https://code.google.com/archive/p/phantompeakqualtools/). MACS2 (https://github.
com/taoliu/MACS/) was used to call the peaks. H3K4me1,H3K9me3 and H3K27me3 peaks were called using the broad setting of
MACS2 while H3K27ac and H3K4me3 were called using the default (narrow) setting. For each histone mark dataset, the data
were normalized using theR packageDESeq2 and then pair-wise comparisonswere performed (fold change 3, adjusted p-adjvalue <
0.05 and RPKMR 2 in at least in any condition) to determine the differentially expressed genes per condition. The results from all
possible pairwise comparisons (within each condition and similar time points across all conditions per mark) were pooled and
merged to deﬁne the dynamic set of enriched regions. Promoters were deﬁned as regions between ± 2kb from TSSs for each
ensemble gene and enhancers were determined as enriched H3K27ac/H3K4me1 regions more than ± 2kb away from the TSS.
To ﬁnd different patterns over dynamic promoters or enhancers, we applied a K-means clustering procedure (with optimal number
of clusters per each dataset) to the dynamic datasets as described above.
ATAC-Seq Data Analysis
The full ATAC-seq protocol is available at the BLUEPRINT website (http://www.blueprint-epigenome.eu/UserFiles/ﬁle/Protocols/
ATAC_Seq_Protocol.pdf). ATAC-seq readsweremapped to the hg19 reference genome using BWA (Li andDurbin, 2009) with default
parameters. Non-uniquely mapped reads and PCR duplicates were removed. MACS2 (Zhang et al., 2008) was used to identify re-
gions of open chromatin (peaks) with parameters ‘‘–nomodel -p 1e-9.’’ Overlap peaks from different samples were merged.
DNA-Binding Motif Scanning
All the DNA-binding motifs used in this study are based on the cis-bp database described in (Weirauch et al., 2014). Only motifs with
direct evidence of binding in the species of vertebrate were selected.Within eachmotif family, as annotated by cis-bp, all motifs were
clustered using ‘gimme cluster’ from the GimmeMotifs package (van Heeringen and Veenstra, 2011) with a threshold of 0.9999. The
annotation of motifs is based on the annotation of human in the cis-bp database. Motifs were used for scanning if the assigned TF is
expressed (> 1 RPKM) in at least one time-point during the differentiation. Total ATAC-seq peaks were scanned for the presence of
motifs. We used Gimme motifs for scanning with dynamic motif scoring cut-offs targeting a false discovery rate (FDR) of both 0.01
and 0.05. To look at the motif enrichments in each set of regions (epigenetic cluster or gene cluster), ATAC-seq peaks were assigned
to the epigenomic cluster or the gene promoters by intersection. Motif occurrences were acquired by intersection of the assigned
ATAC-seq peaks with the motif scanning results on total ATAC-seq peaks. Total ATAC-seq peaks were divided into promoter set
and non-promoter set as the background for the calculation of motif enrichment. Enrichment of motifs in each set of regions was
deﬁned by applying a hypergeometric test using the motif frequency in the corresponding background. This results in TFs that pu-
tatively regulate the activities of the regulatory regions. Motifs in each heat map satisfy an arbitrary cutoff of > 5%motif presence and
a ﬁxed minimal presence difference from background in at least one cluster. Hierarchical clustering (Pearson correlation) was per-
formed in each heat map using the motif occurrence frequencies in the clusters. Based on the gene activity and dynamics, only one
TF was selected to represent a motif if multiple genes are assigned to the same motif. Scanning results from FDR of 0.01 and 0.05
were compared and do not affect the result of enrichment analysis.
Gene Ontology Analysis
Gene ontology analysis on dynamic lists of genes was performed using DAVID (Huang da et al., 2009). Gene ontology on dynamic
enhancer clusters was performed using GREAT (McLean et al., 2010). KEGG pathways and Biological Processes were ranked by p
value and the top terms were plotted.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical parameters including the exact value of n, the deﬁnition of center, dispersion, and precision measures (mean ± SEM) and
statistical signiﬁcance are reported in the Figures and the Figure Legends. Data are judged to be statistically signiﬁcant when p < 0.05
by two-tailed Student’s T-Test or 2-way ANOVA, where appropriate.
DATA AND SOFTWARE AVAILABILITY
Data Resources
Raw data ﬁles for the RNA and ChIP sequencing and analysis have been deposited in the NCBI Gene Expression Omnibus under
accession number: GSE85246.
Links to GEO SubSeries linked to GSE85246:
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE85243
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE85245
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Figure S3. DNA Methylation Dynamics in Monocyte-to-Macrophage Differentiation and Tolerance and Training, Related to Figure 1
(A) Correlation plot of DNA methylation values, showing clear separation of LPS d1 and LPS-d6 from other samples.
(B) Boxplot of 2,700 DMRs, showing that the general trend is loss of methylation during monocyte-to-macrophage differentiation.
(C) Chromatin context of DMRs. The majority (91%) of DMRs occur in distal regions marked by H3K4me1, 69 occur at H3K27ac marked enhancers and open
chromatin regions. Only 6% occur at promoters.
(D) Boxplots showing DNAmethylation over time for macrophage sub-type speciﬁc DMRs. Analysis identiﬁed DMRs common to all macrophages, and those that
are only established in LPS-Mf or not-established in LPS-Mf.
(E) Heatmap of H3K27ac changes at DMRs. Generally, DNA de-methylation at DMRs was associated with accumulation of H3K27ac.
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Figure S2. RNA-Seq Dynamics in Response to LPS and BG and Relationship to Histone Marks, Related to Figure 1
(A) Number of genes showing treatment (LPS or BG) speciﬁc expression at each time point (1h, 4h, d1, d6). LPS exposure induces the largest number of genes at
each time-point, with a minimum of 110 transcripts at 1h, and a maximum of 650 transcripts at day 1. Up to 100 genes maintain LPS-speciﬁc expression at d6.
Comparatively BG induced gene expression patterns peak at d1, a fraction of which is maintained to d6.
(B) Overlap between gene expression group and promoter H3K27ac cluster. LPS-induced H3K27ac accumulation at promoters correlates well with LPS induced
gene expression at all time-points. However, at day 1 and day 6, the ‘LPS-up’ genes are equally explained by a lag in differentiation-associated repression in LPS
treated cells. Conversely, BG exposure leads to faster expression of differentiation associated genes, with higher overlap between ‘BG-up’ genes and ‘differ-
entiation gain’ and BG-associated H3K27ac promoters.
(C) Example tracks of a BG induced/LPS repressed gene and an LPS induced gene, LPL (Lipoprotein Lipase).
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Figure S3. DNA Methylation Dynamics in Monocyte-to-Macrophage Differentiation and Tolerance and Training, Related to Figure 1
(A) Correlation plot of DNA methylation values, showing clear separation of LPS d1 and LPS-d6 from other samples.
(B) Boxplot of 2,700 DMRs, showing that the general trend is loss of methylation during monocyte-to-macrophage differentiation.
(C) Chromatin context of DMRs. The majority (91%) of DMRs occur in distal regions marked by H3K4me1, 69 occur at H3K27ac marked enhancers and open
chromatin regions. Only 6% occur at promoters.
(D) Boxplots showing DNAmethylation over time for macrophage sub-type speciﬁc DMRs. Analysis identiﬁed DMRs common to all macrophages, and those that
are only established in LPS-Mf or not-established in LPS-Mf.
(E) Heatmap of H3K27ac changes at DMRs. Generally, DNA de-methylation at DMRs was associated with accumulation of H3K27ac.
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Figure S2. RNA-Seq Dynamics in Response to LPS and BG and Relationship to Histone Marks, Related to Figure 1
(A) Number of genes showing treatment (LPS or BG) speciﬁc expression at each time point (1h, 4h, d1, d6). LPS exposure induces the largest number of genes at
each time-point, with a minimum of 110 transcripts at 1h, and a maximum of 650 transcripts at day 1. Up to 100 genes maintain LPS-speciﬁc expression at d6.
Comparatively BG induced gene expression patterns peak at d1, a fraction of which is maintained to d6.
(B) Overlap between gene expression group and promoter H3K27ac cluster. LPS-induced H3K27ac accumulation at promoters correlates well with LPS induced
gene expression at all time-points. However, at day 1 and day 6, the ‘LPS-up’ genes are equally explained by a lag in differentiation-associated repression in LPS
treated cells. Conversely, BG exposure leads to faster expression of differentiation associated genes, with higher overlap between ‘BG-up’ genes and ‘differ-
entiation gain’ and BG-associated H3K27ac promoters.
(C) Example tracks of a BG induced/LPS repressed gene and an LPS induced gene, LPL (Lipoprotein Lipase).
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Figure S4. Expression of Transcription Factors with Enriched Motifs at BG-Associated Promoters and Enhancers and Pathways Associated
with Downstream Genes, Related to Figure 2
(A) The expression of main genes enriched at ‘BG up / LPS down’ and ‘Differentiation gain’ promoters and enhancers is shown separately for each donor over
time. Naive cells are green, LPS exposed cells are red, and BG exposed cells are purple. EGR2 expression peaks transiently at 4 hr in BG exposed cells, but by
day 6, there is no difference between Naive, LPS-Mf or BG-Mf.CSF1 andMITF expression peaks at day 1 and then is reduced. Downstream TFUSF2 shares one
motif with MITF, and shows high expression in BG macrophages at day 6. LAMP1 is a major component of the lysosome, and together with LAMP2 makes up
50% of all lysosomal proteins. LAMP1 expression peaks late, and is signiﬁcantly higher in BG-Mf compared to naive and LPS-Mf. qPCR was used to validate
RNA-seq results in monocytes from multiple donors.
(B) Transcription Factor network based on EGR2 and MITF motif occurrence at BG induced lysosome and lipid metabolism genes. The size of the nodes
represents the number of connections. EGR2 motif is present in the MITF promoters (thick connection). EGR2 and/or MITF motifs are present in another 28 TFs,
which themselves have 14 distinct motifs (and are visible as a cluster. Most genes have a combination of EGR2, MITF and a downstream TF motifs (light brown
circle). The set of genes to the right do not have EGR2 or MITF motifs, but have motifs for one of the downstream TFs (light gray circle). Overall this network
explains 79% of BG-induced lipid metabolism and lysosome-associated genes, compared to 58% based on EGR2 and MITF scan alone. BG induces EGR2
expression, through its receptor, Dectin-1, and higher expression of MITF is observed, as well as its activator cytokine factor CSF1 (see also Figure S4).
Conversely, LPS treatment represses EGR2, CSF1 andMITF. Genes are labeled by time at which their expression peaks in BG exposed cells. EGR2 expression
peaks at 4 hr (brown),MITF and KLF9 at day 1 (gold). The rest of the downstream genes peak at day 1 (gold) or peak at day 6 (green). Connections between TFs
and downstream genes is shown as red lines.
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Figure S4. Expression of Transcription Factors with Enriched Motifs at BG-Associated Promoters and Enhancers and Pathways Associated
with Downstream Genes, Related to Figure 2
(A) The expression of main genes enriched at ‘BG up / LPS down’ and ‘Differentiation gain’ promoters and enhancers is shown separately for each donor over
time. Naive cells are green, LPS exposed cells are red, and BG exposed cells are purple. EGR2 expression peaks transiently at 4 hr in BG exposed cells, but by
day 6, there is no difference between Naive, LPS-Mf or BG-Mf.CSF1 andMITF expression peaks at day 1 and then is reduced. Downstream TFUSF2 shares one
motif with MITF, and shows high expression in BG macrophages at day 6. LAMP1 is a major component of the lysosome, and together with LAMP2 makes up
50% of all lysosomal proteins. LAMP1 expression peaks late, and is signiﬁcantly higher in BG-Mf compared to naive and LPS-Mf. qPCR was used to validate
RNA-seq results in monocytes from multiple donors.
(B) Transcription Factor network based on EGR2 and MITF motif occurrence at BG induced lysosome and lipid metabolism genes. The size of the nodes
represents the number of connections. EGR2 motif is present in the MITF promoters (thick connection). EGR2 and/or MITF motifs are present in another 28 TFs,
which themselves have 14 distinct motifs (and are visible as a cluster. Most genes have a combination of EGR2, MITF and a downstream TF motifs (light brown
circle). The set of genes to the right do not have EGR2 or MITF motifs, but have motifs for one of the downstream TFs (light gray circle). Overall this network
explains 79% of BG-induced lipid metabolism and lysosome-associated genes, compared to 58% based on EGR2 and MITF scan alone. BG induces EGR2
expression, through its receptor, Dectin-1, and higher expression of MITF is observed, as well as its activator cytokine factor CSF1 (see also Figure S4).
Conversely, LPS treatment represses EGR2, CSF1 andMITF. Genes are labeled by time at which their expression peaks in BG exposed cells. EGR2 expression
peaks at 4 hr (brown),MITF and KLF9 at day 1 (gold). The rest of the downstream genes peak at day 1 (gold) or peak at day 6 (green). Connections between TFs
and downstream genes is shown as red lines.
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(C) Expression of IL6 and TNF. Release of these proteins frommacrophages in response to LPS is considered the gold-standard for determining tolerance. At the
transcriptional level TNF is partially tolerized, while IL6 is responsive in LPS-Mf. Error bars represent standard deviation. IL6 and TNF protein release after LPS
restimulation is high in BG-Mf and absent in LPS-Mf compared to naive-Mf. The disconnect between transcription and release of IL6 can potentially be explained
by the larger size and higher lysosome content in BG-Mf, induced by early activation of lipid and lysosome pathways in BG exposed cells.
(D) Top 10 KEGG pathways enriched in tolerized and responsive gene groups from DAVID ontology analysis. Area relates to the number of genes within the
pathway, red font signiﬁes that the pathway only shows signiﬁcant enrichment in the tolerized gene group. Cytokine-cytokine receptor signaling was the top
pathway in both tolerized and responsive groups indicating that cytokine genes are equally spread across the gradient of LPS-Mf response to LPS re-exposure.
A Median expression of tolerized, partially tolerized and responsive genes  over the time -course
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Figure S5. Tolerance at the Transcriptional Level, Related to Figure 3
(A) Pattern of expression of tolerized and responsive genes during the time-course shown as median logFC of two donors (with ﬁrst and third quartiles shown as
shaded areas). The most tolerized (G1) genes did not show upregulation in response to the initial LPS exposure in monocytes, while responsive genes (G3)
showed high induction in monocytes.
(B) Notable examples of tolerized and responsive genes. Data are shown as mean RPKM and error bars are standard deviations. Data are represented as
mean ± SD.
(legend continued on next page)
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(C) Expression of IL6 and TNF. Release of these proteins frommacrophages in response to LPS is considered the gold-standard for determining tolerance. At the
transcriptional level TNF is partially tolerized, while IL6 is responsive in LPS-Mf. Error bars represent standard deviation. IL6 and TNF protein release after LPS
restimulation is high in BG-Mf and absent in LPS-Mf compared to naive-Mf. The disconnect between transcription and release of IL6 can potentially be explained
by the larger size and higher lysosome content in BG-Mf, induced by early activation of lipid and lysosome pathways in BG exposed cells.
(D) Top 10 KEGG pathways enriched in tolerized and responsive gene groups from DAVID ontology analysis. Area relates to the number of genes within the
pathway, red font signiﬁes that the pathway only shows signiﬁcant enrichment in the tolerized gene group. Cytokine-cytokine receptor signaling was the top
pathway in both tolerized and responsive groups indicating that cytokine genes are equally spread across the gradient of LPS-Mf response to LPS re-exposure.
A Median expression of tolerized, partially tolerized and responsive genes  over the time -course
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Figure S5. Tolerance at the Transcriptional Level, Related to Figure 3
(A) Pattern of expression of tolerized and responsive genes during the time-course shown as median logFC of two donors (with ﬁrst and third quartiles shown as
shaded areas). The most tolerized (G1) genes did not show upregulation in response to the initial LPS exposure in monocytes, while responsive genes (G3)
showed high induction in monocytes.
(B) Notable examples of tolerized and responsive genes. Data are shown as mean RPKM and error bars are standard deviations. Data are represented as
mean ± SD.
(legend continued on next page)
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Figure S7. Expression of Genes Involved in Lipid Biosynthesis and Metabolism following BG Reversal of LPS-Induced Tolerance, Related to
Figure 7
(A) Experimental set-up, indicating the collection of samples for gene expression analysis. Samples were collected at day 1 +4h, indicating that monocytes were
treated with media (RPMI) or LPS for 24 hr, at which point cells were exposed to BG for 4 hr and collected. Additionally samples were collected at day 3 and day6.
(B) BG exposure, following LPS, recovers the expression of genes involved in lipid biosynthesis and oxidative phosphorylation as early as day 3. LAMP1 is
an example of a lysosome gene that shows high expression in BG-Mf and low expression in LPS-Mf. BG exposure recovers the expression of this gene in
LPS-BG-Mf.
(C) BG addition at day 1 in Naive monocytes induces the expression of EGR2, MITF and CSF1, as it does when added at day 0 (Figure S4C). In tolerized
monocytes, BG induces the expression of EGR2 andMITF, but to a lesser degree. This indicates that BG receptor pathways are not completely disrupted by LPS
exposure, providing a basis for BG reversal of LPS-induced tolerance.
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Figure S6. Active Histone Mark Changes at Promoters of Tolerized and Responsive Genes and Overall Chromatin States at the Same
Promoters, Related to Figure 4
(A) Expression at day 6 and at LPS re-exposure for STAT2 and 5A, and IRF1 and 8 (mean RPKM of 4 donors, error bars represent standard deviation). These
pro-inﬂammatory TFs show a tolerized response in LPS-Mf to LPS re-exposure. The inability of these genes to be activated may play a role in the tolerance of
downstream targets, as suggested from the enrichment of their motifs in the G2 partially tolerized gene promoters (Figure 4B).
(B) expression at day 6 and at LPS re-exposure for NFKB1 and RELA. These TFs are responsive to LPS re-exposure in LPS-Mf, and their motifs are not
signiﬁcantly enriched in tolerized genes. This suggests that NF-kB signaling is not impaired at the level of transcription. Data are represented as mean ± SD.
(C) LPS-Mf do not accumulate H3K4me3 at tolerized genes, but do so at the promoters of responsive genes. This pattern is similar to that of H3K27ac shown in
Figure 4D.
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Figure S7. Expression of Genes Involved in Lipid Biosynthesis and Metabolism following BG Reversal of LPS-Induced Tolerance, Related to
Figure 7
(A) Experimental set-up, indicating the collection of samples for gene expression analysis. Samples were collected at day 1 +4h, indicating that monocytes were
treated with media (RPMI) or LPS for 24 hr, at which point cells were exposed to BG for 4 hr and collected. Additionally samples were collected at day 3 and day6.
(B) BG exposure, following LPS, recovers the expression of genes involved in lipid biosynthesis and oxidative phosphorylation as early as day 3. LAMP1 is
an example of a lysosome gene that shows high expression in BG-Mf and low expression in LPS-Mf. BG exposure recovers the expression of this gene in
LPS-BG-Mf.
(C) BG addition at day 1 in Naive monocytes induces the expression of EGR2, MITF and CSF1, as it does when added at day 0 (Figure S4C). In tolerized
monocytes, BG induces the expression of EGR2 andMITF, but to a lesser degree. This indicates that BG receptor pathways are not completely disrupted by LPS
exposure, providing a basis for BG reversal of LPS-induced tolerance.
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Figure S6. Active Histone Mark Changes at Promoters of Tolerized and Responsive Genes and Overall Chromatin States at the Same
Promoters, Related to Figure 4
(A) Expression at day 6 and at LPS re-exposure for STAT2 and 5A, and IRF1 and 8 (mean RPKM of 4 donors, error bars represent standard deviation). These
pro-inﬂammatory TFs show a tolerized response in LPS-Mf to LPS re-exposure. The inability of these genes to be activated may play a role in the tolerance of
downstream targets, as suggested from the enrichment of their motifs in the G2 partially tolerized gene promoters (Figure 4B).
(B) expression at day 6 and at LPS re-exposure for NFKB1 and RELA. These TFs are responsive to LPS re-exposure in LPS-Mf, and their motifs are not
signiﬁcantly enriched in tolerized genes. This suggests that NF-kB signaling is not impaired at the level of transcription. Data are represented as mean ± SD.
(C) LPS-Mf do not accumulate H3K4me3 at tolerized genes, but do so at the promoters of responsive genes. This pattern is similar to that of H3K27ac shown in
Figure 4D.
Processed on: 17-11-2016
506677-L-bw-habibi
Processed on: 17-11-2016
506677-L-bw-habibi
Discussion
5
Processed on: 17-11-2016
506677-L-bw-habibi
Processed on: 17-11-2016
506677-L-bw-habibi
127
DISCUSSION
5
General discussion 
Epigenetic (re)programming is a phenomenon in which epigenetic mechanisms play 
a major role during the transition from one cellular state to another. This phenomenon 
is intrinsic to normal development and happens in a range of pluripotent to lineage- 
committed cell types during early and late stages of development. In this thesis, we 
investigated epigenetic aspects of two distinct in vitro reprogramming events, 
serum-to-2i reprogramming in mESCs and monocytes-to-macrophages to gain 
insight into the underlying molecular mechanisms, their communalities and their 
differences and where appropriate draw parallels and extend to the ‘real’ in vivo 
process.
Part I.  Epigenetic Reprogramming between Two Distinct 
Interconvertible States of Pluripotency in Mouse Embryonic 
Stem Cells
Embryonic stem cells (ESCs) have the potential to differentiate into all somatic cell 
lineages and into germ line cells, referred to as pluripotency. Mouse ESCs are classically 
grown in the presence of serum, ‘‘serum ESCs,’’; they represent a metastable state 
characterized by the expression of many lineage-specifying genes (Hayashi et al., 
2008; Loh and Lim, 2011; Marks et al., 2012). More recently, ground state pluripotent 
ESCs have been derived in serum-free conditions supplemented with two small- 
molecule kinase inhibitors (2i): PD0325901 and CHIR99021 targeting mitogen- 
activated protein kinase (Mek) and glycogen synthase kinase-3 (Gsk3), respectively2. 
ESCs established in 2i, here referred to as ‘‘2i ESCs,’’ are more homogeneous than 
serum ESCs and represent the ground state of pluripotency (Ying et al., 2008). 
Recently, our group in collaboration with the laboratories of Austin Smith and Francis 
Stewart showed that the transcriptome and repressive histone mark H3K27me3, but 
not H3K9me3, is markedly different. Furthermore, they showed that the two states 
are interconvertible upon simple exchange of growth media (Marks et al., 2012).
Demethylation dynamics during serum-to-2i reprogramming
The major aim of the project was to understand the dynamics of DNA methylation 
during serum to 2i reprogramming. Surprisingly, initial quantifications of 5mC and 
5hmC by liquid chromatography followed by mass spectrometry (LC-MS) revealed 
their ~4-fold global reduction in “2i ESCs” as compared to “serum ESCs”. In line 
with the MS data, whole-genome bisulfite sequencing (WGBS) showed that 4.1% of 
all covered cytosines in the genome (71%) are methylated in serum ESCs, while 
methylation in the “2i ESCs” is reduced by a factor of three to four. This finding 
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became highly revealing when we compared the in vitro data to the DNA methylome 
of early mouse developmental stages (Habibi et al., 2013): inner cell mass (ICM) 
cells, from which ESCs are derived, are hypomethylated like “2i ESCs”, whereas 
serum ESCs are globally hypermethylated like E6.5 epiblast. This was a game 
changer not only that we now had a handle on this process but also because the 
‘artificial perceived’ 2i condition provides a situation in which cells can preserve the 
characteristics of their origin.  
To further understand the dynamics/kinetics of DNA demethylation during serum-to-2i 
reprogramming, we quantified 5mC and 5hmC levels in a time-resolved manner 
(Habibi et al., 2013; von Meyenn et al., 2016a). After medium replacement, DNA 
demethylation was apparent at 32h (about two rounds of replication) and gradually 
decreased further to reach a steady state level of ~1% 5mC after 15-18 days. A 
moderate increase in 5hmC level was apparent up to 72h implying the presence of 
TET activity. During the remainder of the time course, loss of 5hmC was proportional 
to the reduction in 5mC. These observations suggest that DNA demethylation in vitro 
is a slow process whereas the forward process that is deposition of DNA methylation 
from preimplentation (ICM) to post-implantation takes ~2 day to reach E6.5 epiblast. 
The basis for this difference remains unresolved.
Loss of DNA methylation from serum to 2i can be achieved by one or a combination 
of the following scenarios: (i) passive dilution through successive rounds of replication 
due to impaired maintenance; (ii) loss of de novo DNMT3 activity; or (iii) enzymatic 
removal of 5mC mediated by the Ten-Eleven Translocation 1-3 (TET1-3) family of 
proteins. Expression analysis showed that the major players of maintenance 
methylation (DNMT1, UHRF1, and PCNA) and active demethylation pathway (Tet1, 
Tet2, Aicda, and Tdg) are expressed at the similar level in both states, whereas de 
novo methyltransferases (DNMT3A/B/L) are strongly suppressed in the 2i state 
(Habibi et al., 2013; von Meyenn et al., 2016a). Therefore, it appeared that reduced de 
novo activity could be the main cause of gradual loss of methylation during serum-2i 
reprogramming that takes around two weeks. However, this observation was not fully 
in line with previous observations (Chen et al., 2003; Liang et al., 2002) since the 
global loss of methylation in Dnmt3 KO line is a substantially slow process that takes 
several months. Thus, further investigation were needed to elucidate the factors and 
detailed mechanisms behind this phenomenon. 
Mathematical modeling of DNA demethylation kinetics 
As we mentioned above, more than one mechanism might contribute to the loss of 
DNA methylation. To have a better understanding how the various factors and 
pathways involved in DNA (de)methylation contribute to the dynamic changes, we 
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used mathematical modeling as a systematic approach to estimate the relative 
contribution of these pathways (von Meyenn et al., 2016b). Over the past few years, 
several researchers attempted to model the dynamics of DNA demethylation using 
different approaches or by incorporating new biological concepts in existing 
mathematical models (Arand et al., 2012; Genereux et al., 2005; McGovern et al., 
2012; Otto and Walbot, 1990; Pfaffeneder et al., 2011). However, due to the lack of the 
necessary experimental data such as accurate time-resolved 5mC data in wild-type 
and related knock-outs, and genome-wide data to measure initial input values like 
TAB-seq (Yu et al., 2012) and hairpin bisulfite sequencing (Zhao et al., 2014) to 
measure 5hmC and hemi-5mC, these studies did not accurately estimate the 
contribution of individual enzymatic activities and could not predict the dynamic 
behavior of the process. In the work presented in this thesis, I used a combination of 
time-resolved MS data and accurate input values measured by sequencing data to 
estimate the parameters and modeled dynamics of DNA methylation during serum to 
2i reprogramming.  Surprisingly, estimated parameters (p1 for de novo, p2 for 
maintenance, and p3 for Tet-mediated) which reflect the individual activity and overall 
contribution of the three pathways to the DNA methylation dynamics, indicates that 
impaired maintenance methylation by DNMT1 has to be the major driver of the DNA 
demethylation much in contrast to our expectation. 
Global demethylation kinetics in mutants of the DNA methylation 
machinery 
In our experimental setup and later on in our collaboration with the Wolf Reik laboratory 
in Cambridge, we assessed the contribution of passive and active mechanisms 
using several knockout lines lacking one or more of the components of the DNA 
methylation machinery including Dnmt1 (Dnmt1fl/fl); Uhrf1 (Uhrf1fl/fl); Dnmt3a/b 
(Dnmt3afl/fl x Dnmt3bfl/fl) or constitutive deletion of Aicda (Aicda-/-); Tdg (Tdg-/-); Tet1/2 
(Tet1-/- x Tet2-/-); Tet1/2/3 (Tet1-/- x Tet2-/- x Tet3-/-) (von Meyenn et al., 2016b). Generating 
time-resolved MS data from these lines and their wild-type counterparts provided us 
with unique, comprehensive data to evaluate the predicted dynamics of demethylation. 
In line with in silico knock-out data predicted by the mathematical model, none of the 
knock-out lines except Dnmt1-/- and Uhrf1-/- could explain the observed kinetics. 
Therefore, impaired maintenance appeared to be the main cause of demethylation in 
2i. Although the observations and the modeling could explain the observed kinetics 
it was still not completely clear how mechanistically 2i leads to a failure in DNA 
methylation maintenance as DNMT1, UHRF1 and PCNA are similarly expressed at 
the RNA level in both conditions. 
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UHRF1: the missing piece of the demethylation puzzle?
Several studies have shown that UHRF1 (also known as NP95) is required for DNA 
methylation maintenance (Bostick et al., 2007; Sharif and Koseki, 2011; Sharif et al., 
2007). UHRF1 is a multi-domain protein possessing several DNA/chromatin binding 
domains, including tandem Tudor domains that bind H3K9me2/3 and an SRA 
domain that can bind to hemimethylated CpG. During replication, these domains 
facilitate and guarantee the recruitment of UHRF1 to the replication fork that in turn 
targets DNMT1 to the newly synthesized hemimethylated CpGs and ensures high 
fidelity maintenance of DNA methylation. Therefore, complete or even partial loss of 
bound UHRF1 could have a huge impact on methylation maintenance. 
Although our initial transcriptome analysis showed that Uhrf1 levels remain the same, 
Mass Spectrometry showed that its protein level is reduced by around two-fold in 2i 
compared to serum (von Meyenn et al., 2016b). This observation was confirmed 
using constitutive expression of a UHRF1-GFP fusion protein indicating a rapid loss 
of UHRF1-GFP after serum-to-2i medium replacement. In addition, co-localization of 
UHRF1 at the replication foci was significantly reduced in 2i compared to serum. 
Altogether, these results indicate that reduction of UHRF1 limits targeting of DNMT1 
to the replication foci causing impaired maintenance of DNA methylation.  
Another possible mechanism that might affect UHRF1 recruitment is loss of 
H3K9me2. It has been shown that loss of G9a (also known as EHMT2), a histone 
methyltransferase responsible for depositing H3K9me1 and H3K9me2, results in a 
global loss of DNA methylation (Bernstein et al., 2006; Citterio et al., 2004; Karagianni 
et al., 2008; Rothbart et al., 2012). Additionally, a recent study in PGC-like cells 
(PGCLCs) demonstrated that the H3K9me2 levels are strikingly reduced in day6 
PGCLCs, which in turn could result in reduced DNA methylation (Kurimoto et al., 
2015). In line with this observation in PGCLCs, we also observed a global reduction 
of H3K9me2 upon transition from serum-to-2i that might reduce the recruitment of 
UHRF1 and DNMT1 to the replication fork.
Collectively, our results suggest that the binding of UHRF1 at replication foci is the 
main cause of impaired maintenance and this factor play a critical role in maintenance 
of DNA methylation.
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In vivo Parallels of Primed and Naïve Pluripotent Stem Cells:  
a unifying model 
The difference between the methylation state of serum- and that of 2i-grown ESCs 
was striking as both have the same origin that is derived from inner cell mass (ICM) 
(Ficz et al., 2013; Habibi et al., 2013; Leitch et al., 2013; Smith et al., 2012). A comparison 
between these two states and published ex vivo methylation data sets performed on 
early embryo and developing PGCs showed that ESCs in serum are reminiscent of 
epiblast at around E6.5 representing a post-implantation embryonic state, while the 
2i condition catches ESCs in a hypomethylated state, resembling ICM at E3.5, or 
alternatively migratory PGCs at E9.5-E11.5 (Ficz et al., 2013; Habibi et al., 2013; Smith 
et al., 2012; von Meyenn et al., 2016b).  To obtain further insight into the dynamics/
kinetics of demethylation during in vivo and in vitro (re)programming, we mathematically 
modeled different stages of ICM and PGC development and compared the resulted 
parameters with the parameters extracted from wild-type and knockout lines adapted 
from serum-to-2i (von Meyenn et al., 2016b). To do so, we estimated parameters of 
maintenance and de novo DNA methylation and active demethylation from whole 
genome bisulfite sequencing data sets previously published for migratory PGCs 
(E6.5 to E11.5) (Seisenberger et al., 2012)  as well as from preimplantation embryos 
(2-cell stage to E4) (Okamoto et al., 2016; Wang et al., 2014). This showed that 
although de novo methylation is strongly suppressed, the main cause of the global 
loss of methylation is a failure in methylation maintenance. This result is in line with the 
data from PGCs and preimplantation embryos (Seisenberger et al., 2012). In PGCs, 
DNA methylation should be rapidly erased in a short time frame. Three events 
guarantee complete impaired maintenance: (i) UHRF1 proteins are immediately 
depleted from the nucleus, (ii) its gene will be transcriptionally silenced and (iii) 
H3K9me2 level is reduced. In preimplantation embryos from 2-cell stage to E4, low 
expression of DNMT1 causes impairment in DNA methylation maintenance and 
subsequently DNA methylation is rapidly reduced (Cirio et al., 2008; Dean, 2008). 
Taken together, loss of DNA methylation in ESCs, PGCs, and preimplantation 
embryos can be unified in a model in which impaired maintenance plays the main 
role. Reduced maintenance occurs through a reduction in UHRF1 protein level and 
global loss of H3K9me2 that both result in a less efficient recruitment of DNMT1 to the 
replication fork. Although the loss of de novo methylation causes long-term 
genome-wide hypomethylation, it cannot explain the rate of demethylation over such 
a short period of time (around three months).   
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Part II. Epigenetic programming during Mo–Mf differentiation
Sepsis is considered as the major generalized infection-related cause of death. 
Exposing monocytes/macrophages to LPS might cause endotoxin tolerance which is 
the main characteristics of sepsis and is associated with an immunosuppressive 
state. In such a situation, monocytes/macrophages are not able to mount an 
enhanced pro-inflammatory response to an infection. Therefore, determining and 
subsequently reversing LPS induced tolerance would be a promising therapeutic 
route to reduce overall sepsis mortality. 
A growing body of evidence demonstrates that epigenetic programming after the first 
exposure to infection is crucial to build up an “innate immune memory” (Cheng et al., 
2014; Foster et al., 2007; Ostuni et al., 2013; Quintin et al., 2012; Saeed et al., 2014). 
One of the best characterized outcomes of this type of immune memory is trained 
immunity, a phenomenon in which monocytes or macrophages are primed by a 
stimuli, such as C. albicans (Quintin et al., 2012), Bacille Calmette-Guérin (BCG) 
vaccine  and BG , to then mount an enhanced recall response upon a secondary 
infection by a variety of unrelated MAMPs.
In contrast, exposure of monocytes or macrophages to high levels of LPS causes 
immunoparalysis or LPS-induced tolerance. Tolerized cells are not able to mount a 
pro-inflammatory response when re-exposed to LPS. Previously, it has been shown 
that tolerized macrophages (LPS-Mf) and trained macrophages (BG-Mf) have 
distinct epigenetic (Saeed et al., 2014), and metabolic states (Cheng et al., 2014). 
Studies in mouse have shown that such epigenetic remodeling at regulatory elements 
particularly at enhancers is important for a proper responses to infection (Ghisletti 
et al., 2010; Ostuni et al., 2013) as well as determining the identity of tissue-resident 
macrophages. The epigenetic basis for endotoxin tolerance in humans needs to be 
further investigated and first steps in this direction are presented in this thesis.
Our aim was to unveil the early epigenetic and transcriptional events following 
monocyte exposure to LPS or BG, and whether and how the resulting epigenetic 
landscapes determine the immune responsiveness of tolerized and trained macro - 
phages. Upon BG exposure, ~3000 genomic elements became activated obtaining 
H3K27ac and H3K4me1 marks that subsequently resulted in increased expression of 
nearby genes. In contrast exposure to LPS caused either a delayed or no response 
at these sites. Interestingly, GO analysis revealed enrichment for pathways such as 
lipid metabolism and biosynthesis and lysosome maturation. Moreover, these genes 
are enriched for the EGR2 motif, one of the presumed critical transcription factors 
directly induced upon triggering of Dectin-1 by β-glucan. 
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The discordant effect of BG and LPS on activating the key regulators of lipid 
metabolism and biosynthesis, and lysosome function, pointed us to test the ability of 
the innate immune ‘trainers’ like BG to either completely or partially reverse the 
tolerance phenotype in macrophages. Therefore, we tested the ability of BG and 
iBET151 to reverse LPS-induced tolerance. As a synthetic compound, iBET mimics 
acetylated histones and therefore disrupts the interactions of BET proteins with 
regulatory regions (Filippakopoulos and Knapp, 2012). In mice IBETs have been 
shown to inhibit the expression of key inflammatory genes such as TLR4-induced 
genes, resulting in reduced endotoxic LPS-induced shock and sepsis (Nicodeme 
et al., 2010).
By exposing monocytes to LPS for 24h, followed by 24 hours BG, and then a rest 
period, the so-called “rescue-Mfs” were able to reinstate normal levels of cytokine 
release when re-exposed to LPS. We confirmed this result with the in vivo situation 
using a human endotoxemia model (Draisma et al., 2009) and showed that in terms 
of cytokine production both in vivo and in vitro tolerized monocytes behave similarly. 
Additionally, both in vivo and in vitro LPS exposed monocytes are similar and can also 
be rescued by ex vivo exposure to BG. In contrast, our results showed that iBET151 is 
only able to prevent tolerance when used at the same time as LPS (LPS co-iBET) to 
block the initial LPS response, but it cannot reverse the tolerance after LPS-induced 
inflammation (LPS+iBET). This is in line with mouse studies and suggests that IBET 
is not a viable treatment option in sepsis patients that already show symptoms. 
To determine the ability of BG to reverse tolerance at the molecular level, we first 
characterized the transcriptional and epigenetic response to a second LPS exposure 
in tolerized macrophages. Our data showed that re-exposing LPS-Mf to a second 
LPS stimulus for 4h results in epigenetic changes that are different from those of 
naive-Mf and BG-Mf. At the transcriptional level, the responsiveness of genes in 
re-exposed LPS-Mf to LPS is a gradient and can be categorized into three groups: (i) 
complete tolerance; (ii) partial response; or (iii) full response comparable to naive-Mf. 
Upon LPS re-exposure, rescue-Mfs were able to induce about 60% of tolerized 
genes. However, although the reversal of tolerance at the transcriptional level is 
incomplete, the expression of tolerized genes was higher than iBET plus LPS, 
indicating the ability of BG to reinstate a responsive state at a level higher than actually 
blocking the initial LPS transcriptional response. Therefore, it seems that BG- 
associated pathways remain intact even after the large-scale epigenetic and 
 transcriptional remodeling induced by LPS. BG exposure recovers H3K27ac 
deposition at both promoters and distal enhancers that are silent in LPS-Mf, indicating 
that the molecular mechanisms required for BG induced chromatin remodeling 
remain after the initial LPS response.
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Our results show that BG, an innate immune trainer, can reverse macrophage 
tolerance ex vivo. This is an important step towards understanding how the tolerized 
phenotype can be reversed in sepsis patients, and ultimately provides the framework 
for future therapeutic developments in innate immune diseases.
Epigenetic Plasticity of Naïve and Mature cells 
According to the Waddington’s metaphor, development can be visualized as a 
landscape including a set of branching valleys separated by hills with different 
heights. It depicts a progressive narrowing down of cell fate potential during normal 
development. Cells can take different routes depending on the incoming signals 
received from the environment. Currently, this landscape is seen as orchestrated 
epigenetic and transcriptional changes that occur during differentiation. Once 
committed to a specific lineage, cells progressively lose their plasticity to switch 
between lineages. 
In this thesis, we investigated dynamics of epigenetic aspects during two distinct (re)
programming events, reflecting in vitro models for early and late stages of development. 
Mouse pluripotent stem cells either in 2i or serum are in cellular states that can be 
positioned on top of the hills in the Waddington landscape. These cells are highly 
plastic, interconvertible and have high differentiation potential. Monocytes should be 
positioned at the bottom of the landscape as it is a more terminal cell sates that 
display less plasticity and are developmentally more committed, but are still capable 
of differentiating into different ‘final’ cell states namely macrophages, dendritic cells, 
and osteoclasts. Hence, comparing these two model systems provides us valuable 
insight into how and to what extent epigenetic events regulate cellular reprogramming 
at different stages of development. 
One of the main characteristics of serum-to-2i reprogramming is the dynamics in 
DNA methylation. Transition from serum to 2i coincides with a genome-wide wave of 
demethylation that happens twice during very early stages of development, from 
2-cell to ICM stages during blastula formation and in migratory PGCs (E6.5-E11.5). 
Therefore, it seems that DNA methylation reprogramming is one of the key epigenetic 
events that is necessary for erasing epigenetic memory and establishing a naïve/
ground state of pluripotency during early stages of development. It has been shown 
that although DNA methylation machinery per se is not required for the maintenance 
and self-renewal of pluripotent stem cells, it is needed for cellular lineage commitment 
(Li et al., 2012; Weinberger et al., 2016). In contrast, DNA methylation serves as a 
fingerprint of cellular identity during cell differentiation (de la Rica et al., 2013; Kulis et 
al., 2015; Nishikawa et al., 2015). During B cell differentiation, a massive perturbation 
was observed in the methylome (Kulis et al., 2015). However, during monocyte- 
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to-macrophage differentiation, we only observed small changes (few hundred 
differentially methylated regions (DMRs)) in DNA methylation suggesting a minor role 
for this epigenetic feature at this stage of development. However, although Mo-Mf 
differentiation model does not show a global changes in DNA methylation level, 
detecting these DMRs at regulatory regions suggesting an active role for local 
changes possibly mediated by TET-dependent active demethylation. Human cells 
are not able to produce vitamin C per se and it is not unlikely that TET enzymes show 
the least activity due to the lack of their co-factor. Therefore, further activation of TET 
enzymes (e.g. by adding vitamin C) might speed up the process of differentiation in 
macrophages.
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SUMMARY
Summary
Epigenetic (re)programming occurs naturally during different stages of normal 
development. This phenomenon refers to remodeling of epigenetic marks, such as 
DNA methylation and histone modifications during the transition from one cellular 
state to another. In the current thesis, we investigated epigenetic aspects of two 
distinct in vitro reprogramming events, serum-to-2i reprogramming in mESCs and 
monocytes-to-macrophages. Chapter 1 provides a general introduction to the 
concepts related to our works in this thesis including major epigenetic mechanisms, 
two model systems, and previous findings. 
In chapter 2, our quantification of 5mC by time-resolved mass spectrometry and 
whole-genome bisulfite sequencing showed that transition from serum to 2i is 
accompanied by a methylome reprogramming resulting in a hypomethylated state in 
2i. We observed that during serum to 2i conversion different parts of the genome 
show different dynamics: while the bulk of the genome becomes gradually 
demethylated with a slow kinetics, some loci like endogenous retroviruses (ERVs) 
and imprinted loci which are decorated by H3K9me3, methylation level remains at a 
comparable level compared to serum. Conversely, TET-enriched regions like 
enhancers showed a fast demethylation kinetics even in very early hours of adaptation 
indicating a role for active demethylation pathways. Comparing the methylation state 
of serum and 2i ESCs with their in vivo parallels at early developmental stages 
showed that inner cell mass (ICM) cells, from which ESCs are derived, are 
hypomethylated like “2i ESCs”, whereas serum ESCs are globally hypermethylated 
like E6.5 epiblast. This surprising observation revealed that the ‘artificial perceived’ 2i 
condition provides a situation in which cells can preserve the characteristics of their 
origin.  
In chapter 3, we further investigated the dynamics/kinetics of DNA demethylation 
and the contribution of different pathways in this process during serum-to-2i 
reprogramming. Loss of DNA methylation from serum to 2i can be explained by one 
or a combination of the following scenarios: (i) passive dilution through successive 
rounds of replication due to impaired maintenance; (ii) loss of de novo DNMT3 
activity; or (iii) enzymatic removal of 5mC mediated by the Ten-Eleven Translocation 
1-3 (TET1-3) family of proteins. To check the contribution of passive and active 
mechanisms, we mathematically modeled and experimentally assessed the kinetics/
dynamics of demethylation using several knockout lines lacking one or more of the 
components of the DNA methylation machinery. Our results showed that the impaired 
maintenance is the main cause of demethylation in 2i. Maintenance of DNA 
methylation during replication is guaranteed by a multidomain protein called UHRF1 
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that can bind either to H3K9me2/3 or hemimethylated CpG at replication fork and 
recruit DNMT1. Our results indicated that reduction of UHRF1 at the protein level and 
a global reduction of H3K9me2 upon transition from serum-to-2i might reduce the 
recruitment of UHRF1 and limits targeting of DNMT1 to the replication foci causing 
impaired maintenance of DNA methylation.  A comparison between serum-2i model 
and published ex vivo methylation data sets performed on early embryo (ICM) and 
developing PGCs showed that loss of DNA methylation in ESCs, PGCs, and preim-
plantation embryos can be unified in a model in which impaired maintenance plays 
the main role. Reduced maintenance occurs through a reduction in UHRF1 protein 
level and global loss of H3K9me2 that both result in a less efficient recruitment of 
DNMT1 to the replication fork. Although the loss of de novo methylation causes 
long-term genome-wide hypomethylation, it cannot explain the rate of demethylation 
over such a short period of time (around three months).   
Exposing monocytes/macrophages to lipopolysaccharide (LPS) might cause 
endotoxin tolerance which is the main characteristics of sepsis. In such a situation, 
monocytes/macrophages are not able to mount an enhanced pro-inflammatory 
response to an infection. Innate immune memory is the phenomenon whereby innate 
immune cells undergo functional reprogramming after exposure to microbial 
components. Trained immunity (induced by BG) and endotoxin (induced by LPS) 
tolerance are two examples of innate immune memory. Trained immunity is the 
phenomenon in which monocytes or macrophages can be primed by a first stimulus 
(infection or vaccine) in order to mount an enhanced and stronger recall response 
upon reinfection. In contrast, treating monocytes or macrophages with LPS inhibits 
cell function and causes immunoparalysis such that they are not able to enhance a 
pro-inflammatory response to re-stimulation, a process called LPS-induced tolerance. 
A growing body of evidence demonstrates that epigenetic programming after the first 
exposure to infection is crucial to build up an “innate immune memory”. In chapter 4 
our aim was to unveil the early epigenetic and transcriptional events following 
monocyte exposure to LPS or β-glucan (BG), and whether and how the resulting 
epigenetic landscapes determine the immune responsiveness of tolerized and 
trained macrophages. By applying an integrated epigenomic and transcriptomic 
approach, we characterized the molecular events involved in LPS-induced tolerance 
in a time-dependent manner. Compared to BG, LPS-treated monocytes fail to 
accumulate active histone marks (H3K27ac and H3K4me1) at promoter and 
enhancers of genes involved in the lipid metabolism and biosynthesis, and lysosome 
function. Transcriptional inactivity in response to a second LPS exposure in tolerized 
macrophages is accompanied by a failure to deposit active histone marks at 
promoters of tolerized genes. In contrast, BG could partially reverse the tolerance 
phenotype in macrophages in vitro. Importantly, we showed that ex vivo BG treatment 
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of monocytes from volunteers with experimental endotoxemia can re-instate their 
capacity for cytokine production. Tolerance is reversed at the level of distal element 
histone modification and transcriptional reactivation of otherwise unresponsive 
genes. Our results show that BG, an innate immune trainer, can reverse macrophage 
tolerance ex vivo. This is an important step towards understanding how the tolerized 
phenotype can be reversed in sepsis patients, and determining and subsequently 
reversing LPS induced tolerance would be a promising therapeutic route to reduce 
overall sepsis mortality.
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Samenvatting
Epigenetische (her)programmering komt in de natuur voor tijdens verschillende 
stadia van de  normale ontwikkeling. Dit verschijnsel heeft betrekking op het her inrichten 
van epigenetische modificaties, zoals DNA methylering en histon modificaties, tijdens 
de overgang van de ene cellulaire staat naar de andere. In dit proefschrift onder- 
zochten wij de epigenetische aspecten van twee verschillende in vitro herprogrammering 
gebeurtenissen, te weten de serum-naar-2i herprogrammering in mESCs en de 
epigenetische herprogrammering tijdens differentiatie van monocyten tot macrofagen. 
Hoofdstuk 1 geeft een algemene inleiding in de concepten beschreven in dit proefschrift, 
inclusief belangrijke epigenetische mechanismen, de twee modelsystemen en eerdere 
bevindingen.
In hoofdstuk 2 laat onze kwantificering van 5mC door time-resolved mass spectometry 
en genoomwijde sequencing zien dat de overgang van serum naar 2i condities 
gepaard gaat met een methyloom herprogrammering resulterend in een gehypo- 
methyleerde toestand in 2i. We zagen dat tijdens de conversie van serum naar 2i 
verschillende delen van het genoom een andere dynamiek vertoonden: terwijl het 
grootste deel van het genoom geleidelijk gedemethyleerd wordt met een langzame 
kinetiek, blijft het methylatie niveau van sommige loci, zoals die van endogene 
retrovirussen (ERV) en loci die voorzien zijn van H3K9me3, vergelijkbaar ten opzichte 
van serum. Omgekeerd, TET-verrijkte regio’s zoals enhancers vertoonden een snelle 
demethylering kinetiek zelfs in zeer vroege uren van adaptatie, dat een rol suggereert 
voor actieve demethylerings mechanismen. Het vergelijken van de methylatie status 
van serum en 2i ESCs met hun in vivo parallellen in de vroege ontwikkelingsstadia 
toonde aan dat de binnenste celmassa (ICM) cellen, waaruit ESC worden verkregen, 
net als “2i ESC” gehypomethyleerd zijn, terwijl zowel het genoom van serum ECSs 
als dat van E6.5 epiblast cellen gehypermethyleerd is. Deze verrassende waarneming 
toonde aan dat de “kunstmatige geachte” 2i omstandigheden ervoor zorgen dat 
cellen kenmerken van hun oorsprong kunnen bewaren.
In hoofdstuk 3 hebben we de dynamiek/kinetiek van DNA demethylering en de 
bijdrage van de verschillende processen tijdens de serum-naar-2i herprogrammering 
verder onderzocht. Verlies van DNA methylatie tijdens conversie van serum naar 2i 
kan worden verklaard door een of meer van de volgende processen: (i) passieve 
verdunning door opeenvolgende ronden van DNA replicatie en het ontbreken van 
processen welke zorgen voor behoud van DNA methylatie; (ii) het verlies van de novo 
DNMT3 activiteit; of (iii) de enzymatische verwijdering van 5mC gemedieerd door de 
Ten-Eleven Translocatie 1-3 (TET1-3) eiwitten. Om de bijdrage van passieve en 
actieve mechanismen te bestuderen hebben we de demethylering kinetiek/dynamiek 
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mathematisch gemodelleerd en experimenteel onderzocht in meerdere knockout 
lijnen die één of meer van de componenten van de DNA methylatie machine misten. 
Onze resultaten toonden aan dat het verminderde behoud van methylatie de 
belangrijkste oorzaak van demethylering in 2i is. Behoud van DNA-methylatie tijdens 
DNA replicatie wordt gegarandeerd door een multidomein eiwit genaamd UHRF1 dat 
kan binden aan ofwel H3K9me2/3 of hemimethylated CpG bij de replicatie vork en 
zorgt voor het recruteren van DNMT1. Onze resultaten gaven aan dat vermindering 
van UHRF1 op eiwitniveau en een totale verlaging van H3K9me2 door de overgang 
van serum naar 2i het  recruteren van UHRF1 kan verminderen alsmede de targeting 
van DNMT1 naar de replicatie foci, resulterend in een verminderd behoud van  DNA 
methylatie. Een vergelijking van het serum-2i model met reeds gepubliceerd data 
met betrekking tot ex vivo methylering in het vroege embryo (ICM) en tijdens de 
ontwikkeling van PGC’s toonde aan dat het verlies van DNA methylatie in ESCs, 
PGCs en pre-implantatie embryo’s verenigd kan worden in een model waarin 
verminderde behoud de belangrijkste rol speelt. Verminderd behoud is het gevolg 
van een verlaging van de UHRF1 eiwitgehalte en het  verlies van H3K9me2 over het 
genoom dat beide leidt tot minder efficiënte recrutering van DNMT1 naar de replicatie 
vork. Hoewel het verlies van de novo methylatie langdurige genoomwijde hypomethylatie 
veroorzaakt, kan het de mate van demethylering over zo’n korte tijdsinterval (ongeveer 
drie maanden) niet verklaren.
Het blootstellen van monocyten/macrofagen aan lipopolysaccharide (LPS) kan 
tolerantie tegen endotoxine veroorzaken dat een van de  belangrijkste kenmerken 
van sepsis is. In een dergelijke situatie zijn monocyten / macrofagen niet in staat om 
een  verbeterde pro-inflammatoire reactie te initieren als reactie op een infectie. Het 
aangeboren immuunsysteem geheugen is een mechanisme waarbij naïve immuun - 
cellen functionele herprogrammering ondergaan na blootstelling aan microbiële 
componenten. Getrainde immuniteit (geïnduceerd door BG) en endotoxine (geïnduceerd 
door LPS) tolerantie zijn twee voorbeelden van het aangeboren immuunsysteem 
geheugen. Getrainde immuniteit is het verschijnsel waarbij monocyten of macrofagen 
door een eerste stimulus (infectie of vaccin) een  verbeterde gevoeligheid ontwikkelen 
en sterker kunnen reageren op een tweede infectie. Het behandelen van monocyten 
of macrofagen met LPS daarentegen remt de celfunctie en veroorzaakt immuno-
paralyse zodat zij niet in staat zijn een pro-ontstekingsrespons te initieren na een 
tweede stimulatie, een proces genaamd LPS-geïnduceerde tolerantie. Een groeiende 
hoeveelheid bewijsmateriaal toont aan dat epigenetische herprogrammering na de 
eerste blootstelling aan infecties cruciaal is voor de opbouw van een “aangeboren 
immuunsysteem geheugen”. In hoofdstuk 4 was ons doel om de vroege transcriptie 
en epigenetische gebeurtenissen na blootstelling van monocyten aan LPS of 
β-glucan (BG) in kaart te brengen, en of en hoe de verkregen epigenetische 
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eigenschappen de immuunreactiviteit van tolerante en getrainde macrofagen 
bepaalt. Door een geïntegreerde epigenomisch en transcriptoom benadering toe te 
passen hebben we de moleculaire gebeurtenissen betrokken bij LPS-geïnduceerde 
tolerantie in kaart gebracht. In tegenstelling tot BG-behandelde monocyten verkrijgen de 
LPS-behandelde monocyten geen actieve histon markeringen (H3K27ac en H3K4me1) 
op de promoters en enhancers van genen betrokken bij biosynthese, vetmetabolisme 
en lysosoom functie. Transcriptionele inactiviteit in respons op een tweede LPS 
blootstelling in tolerante macrofagen gaat gepaard met het onvermogen om 
actieverende histon modificaties deponeren op de promoters van genen betrokken 
bij tolerantie. Daarentegen zou BG het tolerante fenotype in macrofagen in vitro 
gedeeltelijk ongedaan kunnen  maken. Wij hebben aangetoond dat ex vivo BG 
behandeling van monocyten van vrijwilligers met experimentele endotoxemie de 
 cytokineproductie van deze monocyten weer kan heractiveren. Tolerantie wordt 
omgekeerd op het niveau van de histon modificaties aanwezig op de zogenaamde 
distale elementen en heractivering van transcriptioneel anders inactieve genen. Onze 
resultaten tonen aan dat BG, een aangeboren immuunsysteem trainer, tolerantie in 
macrofagen ex vivo ongedaan kan maken. Dit is een belangrijke stap in de richting 
van het begrijpen hoe de tolerante fenotype teruggedraaid kan worden in sepsis 
patiënten. Het bepalen en vervolgens omkeren van LPS-geïnduceerde tolerantie zou 
een veelbelovende therapeutische route kunnen zijn naar verminderde sterfte door 
sepsis.
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